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ABSTRACT 
BACKGROUND   
Schizophrenia is a heterogeneous disorder, which has been shown to have 
both environmental and genetic risk factors.  Since family history (genetic 
loading) of psychosis appears to be one of the strongest risk factors for the 
development of schizophrenia, the investigation of affected sib pairs can be 
used to explore shared familial factors.  The Xhosa-speaking inhabitants in 
the Western, Eastern and Southern Cape provinces, an African population of 
relatively homogeneous ethnicity, provided a sample of the first large clinical 
phenotype of schizophrenia.  
 
AIM 
The main aim of this study was to identify shared symptoms or symptom 
clusters in a sample of Xhosa-speaking sib pairs, with the aid of structured 
assessment tools.   
 
METHODS 
PARTICIPANTS 
Xhosa participants with schizophrenia were recruited from in- and outpatient 
hospital services and community clinics throughout the Western, Southern 
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and Eastern Cape Provinces of South Africa.  The participants were affected 
individuals without an affected sib (n=299) and sib pairs (104 sibships [100 
pairs, 2 trios, 2 fours]).  For the purpose of this study the sib pairs were 
extracted for analysis.   
 
 
 
ASSESSMENT 
The patients were assessed by means of the Diagnostic Interview for Genetic 
Studies (DIGS 2.0) which includes the Schedule for the Assessment of 
Negative Symptoms (SANS) and the Schedule for the Assessment of Positive 
Symptoms (SAPS).   
 
DATA ANALYSIS  
Exploratory factor analyses (one in which factors with eigenvalues > 1 were 
retained, and a forced 5 factor analysis) were performed on the nine global 
ratings and on the individual items of the SANS and SAPS in both the sib pair 
and non-sib pair groups, to identify factors unique to the sib group.  The factor 
solution was then rotated using the varimax procedure.  Sib pairs selected for 
the factor analysis were used for concordance analysis to determine the 
degree of agreement between siblings on SAPS and SANS items.   
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RESULTS   
Factor analysis yielded a two-factor solution (a positive and a negative factor) 
when eigenvalues < 1 were discarded.  The forced five-factor analysis 
generated results similar to those previously reported in non-sib pair samples 
and produced positive, negative and disorganised factors.  Several individual 
and global items of the SANS and SAPS showed higher than expected 
concordance between sib pairs.  Stratification of the sib pair group into gender 
groups (male-male versus mixed gender group) reduced the items with a 
higher than expected concordance.  Subsequent investigation of the 
associations between possible confounding factors and concordance between 
sib pairs, using only the items that had shown higher than expected 
concordance, revealed that the items most likely to be linked to shared familial 
factors were eye contact, auditory hallucinations, the global hallucination 
score and delusions of control. 
 
CONCLUSIONS   
Factor analysis failed to reveal any significant phenomenological differences 
between the “ more strongly familial”  sib pair group and the “ non related”  
non-sib pair group.  Eye contact, auditory hallucinations, the global 
hallucination score and delusions of control had higher than expected 
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concordance. The item, delusions of control was considered the most 
promising candidate for further genetic linkage studies.   
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ABSTRAK 
AGTERGROND  
Skisofrenie is ‘ n multifaktoriale siekte met beide omgewings- en genetiese 
risikofaktore.  Aangesien familiegeskiedenis (genetiese lading) van psigose 
een van die sterkste risikofaktore vir die ontwikkeling van skisofrenie blyk te 
wees, kan sibpare gebruik word om die gedeelde familiële faktore na te vors. 
Die relatief etnies homogene groep Xhosa-sprekende inwoners in die Wes, 
Suid en OosKaap het die eerste groot kliniese fenotipering van skisofrenie in 
‘ n Afrikane groep verskaf. 
  
DOELWIT 
Die doelwit van die studie was om gedeelde simptome of simptoomkomplekse 
in ‘ n groep Xhosa sprekende sibpare te identifiseer met die hulp van 
gestruktureerde evaluasieskale.   
 
METODOLOGIE 
DEELNEMERS 
Xhosa deelnemers met skisofrenie is ingesamel vanaf binne- en buite-pasiënt 
hospitaal en kliniekdienste in die Wes, Suid en OosKaap van Suid Afrika.  Die 
deelnemers was individue (n=299) en sibpare (n=104, 100 pare, 2 trios en 2 
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sibgroepe van 4 elk) van Xhosa oorsprong met ‘ n diagnose van skisofrenie.  
Vir die doel van die studie is die sibpare uitgesonder vir analise. 
 
EVALUASIE 
Die pasiënte is geevalueer met behulp van die “ Diagnostic Interview for 
Genetic Studies”  (DIGS), weergawe 2.0 (Nurnberger et al., 1994). Die skaal 
bevat die “ Schedule for the Assessment of Negative Symptoms”  (SANS) 
en die “ Schedule for the Assessment of Positive Symptoms”  (SAPS).   
 
DATA ANALISE 
‘ n Voorlopige ontledende faktor ontleding (eigenwaardes > 1 en ‘ n 
geforseerde 5-faktor ontleding) is gedoen op die globale en individuele items 
van die SANS en SAPS resultate van beide die sibpaar en non-sibpaar groep.  
Die faktor ontleding is geroteer met gebruik van die varimax prosedure.  
Hierna is ‘ n konkordansie analise van die SANS en SAPS items gedoen 
(gegrond op voorheen gepubliseerde metodologie) op die sibpaar groep.  
Hierdeur kon ondersoek ingestel word na moontlike gedeelde familiële faktore 
deur te kyk na die vlak van ooreenkomste binne sibpare.   
 
RESULTATE   
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Die faktor ontleding het ‘ n twee faktor uitkoms opgelewer (‘ n positiewe en 
negatiewe faktor).  Die geforseerde 5 faktor ontleding was soortgelyk aan die 
van vorige publikasies in nie-sibpare en het verdeel in positiewe, negatiewe 
en gedisorganiseerde faktore.  Verskeie individuele en globale items van die 
SANS en SAPS het hoër as verwagte konkordansie getoon. Verdeling van die 
sibpaar groep op grond van geslagte (manlik-manlik versus gemengde groep) 
het die konkordante faktore verminder nadat prevalensie as ‘ n verwarrende 
(“ confounding” ) faktor geïnkorporeer is.  Vervolgens het die modellering 
van die ander verwarrende faktore getoon dat oogkontak, 
gehoorshallusinasies, die globale hallusinasie telling en wane van beheer die 
mees waarskynlike items is wat gekoppel kan word aan moontlike gedeelde 
familiële faktore.   
 
AFLEIDINGS EN SAMEVATTING   
Die faktor analise het geen verskille getoon tussen die meer familiële sibpare 
en die non-sibpare.  Ten einde die Xhosa populasie dus beter te subtipeer is 
geslag en verwarrende faktore in berekening gebring.  Die proses het die 
simptome van belangstelling verminder tot oogkontak, gehoors- hallusinasies, 
globale hallusinasie telling en wane van beheer.  Wane van beheer blyk die 
mees toepaslike kandidaat vir verdere genetiese studie te wees.  
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1. THE NEED FOR RESEARCH IN SCHIZOPHRENIA 
 
Schizophrenia is a relatively common chronic disorder with a prevalence rate 
of approximately 1%.  It is associated with substantial morbidity and high 
health care expenditure.   Indeed, the morbidity associated with schizophrenia 
is comparable to that of diabetes mellitus and cardiovascular disease [2;3].  
Furthermore, although myocardial infarction affects 12 times as many people, 
the per case cost is 6 times higher for schizophrenia [4].  The cost of 
schizophrenia, which is made up of both direct costs (hospital/institution costs, 
provider fees, prescription drugs) and indirect costs (including loss of 
productivity of family members) is the largest mental health expenditure item 
[5].  In the United States, the treatment of patients with schizophrenia 
consumes an estimated 2.5% of the annual total health care budget and an 
estimated 368 522 years of lost productivity among males [2;6;7].  
 
Given the devastating impact of schizophrenia on the sufferers, care-givers 
and the health care system, it is imperative that the prevention and effective 
management of schizophrenia remain a priority for researchers and other 
health care practitioners. 
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2. THE SCHIZOPHRENIA PHENOTYPE AND ITS 
RELATIONSHIP WITH ETIOLOGICAL HETEROGENEITY 
The main clinical features of schizophrenia include positive symptoms such as 
delusions, hallucinations, disorganized thinking, disorganized or catatonic 
behaviour, and negative symptoms, such as affective flattening, alogia and 
avolition (DSM-IV - Criteria A)[8].  However, even the earliest writings 
recognized its considerable clinical heterogeneity; Kraepelin considered 
“ dementia praecox”  a “ number of disease entities" [9]. 
 
The clinical heterogeneity reflects the heterogeneous nature of susceptibility 
factors for schizophrenia.  To date, several risk factors have been identified: 
(1) a family history of schizophrenia, (2) lower social class, (3) gender (earlier 
onset in men), (4) infective processes (low incidence of rheumatoid arthritis in 
schizophrenia), (5) winter birth, (6) obstetric, birth and early developmental 
insults, (7) substance abuse, (8) stress, and (9) geographic location i.e. urban 
environment [10].  
 
 Of these, family history of schizophrenia is considered a strong confirmed 
susceptibility factor, with estimated heritability approaching 80% and a life-
time morbid risk of 4.8 for relatives of affecteds, based on a large dataset of 
family studies that, despite methodological differences, support the hypothesis 
of inherited factors in schizophrenia susceptibility [11-13].  In addition, the 
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susceptibility risk for schizophrenia and its spectrum disorders seems to be 
higher if a narrow spectrum definition is used [12].  A broad-spectrum 
diagnosis, which does not exclude patients with alcoholism, anxiety disorders 
and mood disorders (unipolar and bipolar), shows less convincing results.  
This is also reflected in twin studies where broadening of the phenotype leads 
to a reduction in the risk of family members developing schizophrenia [14]. 
 
Taken together, these factors suggest a constitutional model and, by 
implication, a genetic component influenced by environmental factors, for the 
development of schizophrenia [15;16].  Furthermore, it seems that 
schizophrenia display a degree of genetic heterogeneity and/or epistatic gene 
interaction [17].  Therefore, it is necessary to use techniques (family based 
association studies such a transmission disequilibrium testing and haplotype 
relative risk design) that are able to detect genes with a less robust overall 
effect.  The power of these methods depends heavily on careful phenotyping 
of clinical samples [18].  The need for careful phenotyping is underlined by the 
preliminary finding that a single gene (WKL 1) may confer a risk for the 
development of a subtype of schizophrenia, namely catatonic subtype [4;19-
22].  Stober et al. (2001) suggested that this gene acts in concert with 
predisposing factors, a fact that again calls attention to the heterogeneity of 
schizophrenia, and also offers hope of researchers finding other subtypes 
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linked to specific genes which may have comparatively substantial effects in 
phenotypic subgroups [23].   
 
The possibility therefore exists that putative drug targets or mutable 
susceptibility factors may be unlocked through genetic studies.  The 
implications for prevention and treatment programs are far-reaching.  Tailored 
treatment strategies based on the genetic make-up of the individual promise 
to be a powerful tool for the treating physician.  However, finding other genes 
linked to specific phenotypes will depend heavily on careful phenotyping of 
schizophrenic patients. 
 
Researchers who carry out genetic studies involving schizophrenic subjects 
should, therefore, aim to describe each subject’ s phenotype accurately, and 
attempt to assemble clinically homogeneous samples. 
 
 
3. METHODS OF LIMITING HETEROGENEITY 
Considerable attempts have been made to elucidate the heterogeneity of the 
schizophrenia phenotype by exploring the relationships between the various 
symptom dimensions and possible subtypes. Several divisions or subtypes 
have been proposed based on proposed susceptibility factors and theories on 
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the pathophysiology of schizophrenia [24-27].  These range from positive 
versus negative dimensions to deficit versus non-deficit subgroups.  
 
Most studies attempting to identify subtypes rely on factor analysis as a 
means of delineating the subgroups.  Factor analysis of symptom rating 
scales such as the SANS and SAPS have thus far converged towards a 
three-dimensional model if global scores are considered (a negative and two 
positive symptom factors) [28;29].  The global ratings for avolition/apathy, 
anhedonia/asociality and affective flattening constituted the negative 
dimension, hallucinations and delusions constituted a "psychosis" dimension, 
and bizarre behaviour and formal thought disorder constituted a 
"disorganisation dimension" [1;30-34;35].  Analysis of individual items led to a 
separation of the negative factor into two components (negative signs and 
social dysfunction), while the “ psychosis”  factor separated into delusions 
and hallucinations [36].   Toomey et al. (1997) also reported two negative 
symptom factors (diminished expression and disordered relating) and two 
positive symptom factors (bizarre delusions and auditory hallucinations) in 
addition to the disorganisation symptom dimension [37].  
 
Emsley et al. (2001) reported on a heterogeneous Xhosa sample of 422 
subjects [38].  Principal component and analytic methods revealed a five-
factor solution for the global items of the SAPS and SANS and accounted for 
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55% of the variance.  The five factors were negative symptoms, psychotic 
symptoms, disorganization, impaired attention and alogia. When individual 
symptom items were analysed, a five-factor model, similar to those in 
Caucasian studies, was found.  The five factors included diminished 
expression, disordered relating, psychosis, thought disorder and bizarre 
behaviour and accounted for 55% of the total variance.  Thus despite 
methodological differences, studies seem to reveal similar symptom 
dimensions.  
 
 
4. THE USE OF SIB PAIR STUDIES IN LIMITING 
HETEROGENEITY  
From a genetic perspective, it would be important to establish whether these 
symptom subtypes or dimensions reflect shared familial factors or whether 
they merely indicate random events.  The use of concordant siblings assumes 
that shared clinical features and - by implication - subtypes, are likely to be 
related to shared familial factors that could include both environmental and 
genetic factors.  Subtypes generated in studies of concordant sib pairs are 
more likely to represent “ true”  familial subtypes.   
   
Affected sib pair studies, despite methodological differences (retrospective 
versus prospective, different diagnostic criteria) and small sample size (8/14 
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studies reported on less than 90 sib pairs), revealed significant concordance 
for a range of symptoms and symptom factors.  Loftus et al. (2000) found two 
symptom factors that accounted for 67% of the total variance in a principal 
component analysis involving 103 sib pairs with either schizophrenia or 
schizo-affective disorder (DSM-III-R) [39].  Factor 1 (49.8% of variance) 
included thought broadcasting, thought insertion, thought withdrawal and 
delusions of control.  Factor two (16.9% of variance) was characterized by 
third-person auditory hallucinations, running commentary and thought echo.  
Kendler et al. (1997) also performed factor analysis and latent class analysis 
on the 11 items of the Major Symptoms of Schizophrenia Scale and found a 
three symptom factor model and a five class solution to be the best fit [40].  
The three symptom factors included a negative symptom factor (affective 
deterioration, poor outcome, chronic course and negative thought disorder), a 
positive symptom factor (hallucinations, any delusions and Schneiderian 
delusions) and an affective symptom factor (manic symptoms) and positive 
thought disorder.  The five class solution suggested that class 1 more closely 
resembled schizo-affective disorder, class 2 core or negative symptoms, class 
3 poorer outcome against a background of positive and negative symptoms, 
class 4 paranoid schizophrenia and class 5 remitting or relapsing catatonic 
schizophrenia.  This separation of catatonic schizophrenia into a separate 
class is of interest, considering reports suggesting a possible genetic 
susceptibility gene in catatonic schizophrenia [41].  Burke et al. (1996) 
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reported a similar three-factor solution of which the negative and reality 
distortion factors closely resembled those of Kendler et al. (1997) [42].  The 
third factor, a disorganised symptom factor, included positive thought disorder 
and inappropriate affect. 
   
It is difficult to compare the results obtained from mixed samples  (familial and 
sporadic cases) with those found in sib pair samples, since no exact 
methodological replication studies exist.  Nevertheless, Cardno et al. (1998) 
found no statistically significant within-pair correlations for seven SAPS/SANS 
symptoms, namely inappropriate affect, affective flattening, alogia, 
hallucinations, delusions, bizarre behaviour and positive formal thought 
disorder [43].  To address this paucity of data the factor structure of the SAPS 
and SANS rating scales in sib pairs should be investigated and compared with 
findings of non-sib pair studies’  results.  
 
 
5. WHY USE AN AFRICAN POPULATION? 
Since the majority of factor analysis and sib pair studies have focused on 
Caucasian samples, it is essential that indigenous African populations also be 
investigated.  The suggestion of ethno-specific loci in an African-American 
and African sample and an apparent ethno-specific pharmacological response 
to atypical antipsychotic treatment offer further promise for unique etiological 
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findings in this group [44-47].  Nevertheless, the seemingly uniform core 
symptom profile reported in both Caucasian and African groups (including the 
Xhosas) makes a symptom-based approach possible [48].   
 
It is therefore important to investigate an indigenous African population in 
order to identify unique clinical subtypes that may account for ethno-specific 
loci.  The Xhosa people are an appropriate group to study, as they are 
culturally distinct and genetically related to the above-mentioned African 
grouping.  This population diverged within the last 2000 years providing a 
similar genetic background [49-54].   The marked paucity of clinical and 
susceptibility data amongst Xhosa-speaking schizophrenic subjects is another 
compelling reason for genetic research in this group. 
 
 
6. SUMMARY 
 
 
In summary, schizophrenia seems to be a heterogeneous disorder  
(1.) In which both environmental and genetic risk factors and causes are 
present (discussed in Chapter 2).   
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(2.) In which family history (genetic loading) of psychosis seems to be one 
of the strongest risk factors for the development of schizophrenia 
(discussed in Chapter 2).  
 
(3.) In which affected sib pairs can highlight the shared familial factors 
(discussed in which Chapter 3). 
 
(4.) In which exploratory factor analysis can highlight symptom factor 
differences between the sib pair and non-sib pair1 group (discussed in 
Chapter 3).  
 
(5.) These symptom factor differences should then more likely represent 
“ true”  shared familial factors (higher genetic loading) and could be of 
value if one wants to subtype this population for genetic analysis  
(discussed in Chapter 3). 
 
(6.) There is a large Xhosa-speaking population in the Western, Eastern 
and Southern Cape, a fact which can present researchers with a unique 
opportunity to investigate an African population of relatively homogenous 
ethnicity.  The advantages of examining this population in terms of 
heritable and non-heritable factors are two-fold: first, there is the 
                                                 
1 Non-sib pair group refers to participants (single individuals with schizophrenia) with no affected 
sibling  
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opportunity of assembling the first large clinical phenotype of 
schizophrenia in a Xhosa population, and second, the lessons learned 
from this study in terms of methodological and ethical challenges should 
enable us to design appropriate follow-up studies (Discussed in Chapter 4 
and 5).     
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CHAPTER 2 
 
SCHIZOPHRENIA AS A HETEROGENEOUS 
ILLNESS: THE ROLE OF GENETIC AND 
ENVIRONMENTAL RISK FACTORS.  
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1. BACKGROUND 
 
The search for risk factors for schizophrenia has been an ongoing effort, 
resting on the possibility that risk factors may be avoidable and/or mutable, 
thus offering some hope of amelioration or even prevention of psychotic 
illness.  Three groups of variables postulated to contribute to schizophrenia 
have been arbitrarily classified as (a) demographic variables, (b) innate 
predisposing or protective factors and (c) environmental stressors [1]. 
 
Demographic risk factors include social class, age, gender and marital status, 
whereas innate predisposing or protective factors extend to season of birth, 
developmental complications, infective or autoimmune factors, substance 
abuse and familial background.  Environmental stress includes maternal 
stress in utero, familial and social stress and geographic stressors [2]. 
 
According to Bromet et al. (1999) these risk factors can be classified into two 
levels of scientific certainty (viz. confirmed and possible risk factors) [3].  
Confirmed factors can be subdivided into confirmed strong and potentially 
strong risk factors. 
 
In line with current knowledge, confirmed strong risk factors constitute family 
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history (innate factor) and social class (demographic factor), while the 
confirmed, potentially strong factors include age and gender (demographic 
factor), rheumatoid arthritis, season of birth and developmental complications 
(innate/protective factors). Substance abuse (innate factor), stress and 
geographic location (environmental factors) are classified as possible risk 
factors for the development of schizophrenia [4].  Since the more influential 
studies supporting these risk factors investigated mainly Caucasian 
populations, of which Finnish, Dutch, British and North American samples 
predominated [5], very little is known about the role of these factors in 
indigenous African populations.   Since this study will investigate the role of 
sib pairs in the heterogeneity of schizophrenia, the discussion will focus 
mainly on family history as a risk factor. However, other risk factors will be 
briefly discussed here in order to provide a background for the reader.  
 
 
2. POSSIBLE RISK FACTORS: SUBSTANCE ABUSE, STRESS 
AND GEOGRAPHIC LOCATION 
2.1. SUBSTANCE ABUSE 
It is difficult to establish whether substance abuse is a risk factor for 
schizophrenia or whether it merely hastens its onset. A risk factor does not 
necessarily have to cause an illness, but merely elevate its risk [6].  The 
inability to differentiate between cause and risk is illustrated by the results of a 
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15-year follow-up study of 45 750 Swedish army recruits [7].  It showed that 
recruits who had smoked cannabis on more than 15 occasions were 6 times 
more likely to develop schizophrenia than those who had used less frequently, 
or not at all.  The majority of findings seem to suggest that cannabis either 
causes schizophrenia or triggers its onset in vulnerable individuals [8;9].  
However, the results could also be interpreted as reflecting the predilection of 
pre-patients with schizophrenia for cannabis use [10].  The latter explanation 
was offered in view of the fact that the increase in cannabis use over the past 
few decades has not been accompanied by a concomitant rise in the 
incidence of schizophrenia.  The precise role that cannabis plays in the 
pathophysiology of schizophrenia is still unclear [11].   
 
 
2.2. STRESS AS A RISK FACTOR 
Studies on the roles of stress have focused on maternal stress during 
pregnancy and on early life events, including familial stress.  Maternal stress 
as a risk factor is supported by a recent finding that children of mothers who 
had experienced bomb raids in the first trimester of pregnancy during World 
War II were at increased risk of developing schizophrenia [12].  However, a 
similar study on women who had been pregnant during the Israeli War did not 
reveal an increased risk for schizophrenia in their offspring and thus the 
evidence remains insufficient to draw firm conclusions in this regard [13].  
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Numerous other possible stressful life-events have also been the focus of 
investigations and migration serves as excellent example of the complexities 
involved in assigning causality.  Studies in the United Kingdom have shown 
migratory populations to have a higher risk for schizophrenia than those in 
their native country.  However, the second generation were at an even higher 
risk for the development of schizophrenia, indicating that factors other than 
migration elevate this risk even further [14].   
 
The interpretation of these results is complicated by the influence of other 
environmental and genetic factors and our inability to quantify the effects of 
stress.  
 
High expressed emotion within family environments has now been linked to 
an increase in the number of relapses and is no longer considered a risk 
factor for the development of schizophrenia.  It has also been shown to play a 
similar role in other psychiatric disorders [15;16]. 
 
 
2.3. GEOGRAPHIC LOCATION 
The incidence of narrowly defined schizophrenia seems to be similar across 
diverse populations, according to a World Health Organization study [17].  
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The risk of schizophrenia may be elevated in persons residing in certain 
geographic localities, especially urban environments.  
 
A study by Lewis et al. (1992) of 50 000 Swedish conscripts, found that being 
raised in an urban environment increased the risk 1.65 times [18].  
Demographic pockets with higher than expected rates of schizophrenia have 
been found, but the generation of specific hypotheses is difficult since factors 
such as morbidity, service availability, comorbidity, selective migration and 
social and physical environmental factors may have had an influence on these 
patterns [19;20].  
 
The Xhosa population has undergone rapid geographic relocation.  Since the 
abolition of the “ pass laws”  in 1986, rapid urbanization has taken place 
[21], resulting in the establishment of shanty towns on the periphery of Cape 
Town.  They are characterised by poverty and overcrowded living conditions.  
One such settlement is Khayelitsha, which has a population of about 350 000 
people, is predominantly informally organized and is made up of both serviced 
and unserviced shacks.  Only one in five dwellings are classified as houses.  
The population is in constant flux because of continual migration from rural 
areas into Khayelitsha and movement within the settlement itself.  Most 
inhabitants are migrants who were born in the Eastern Cape.  Two-thirds are 
estimated to be unemployed, and of the working inhabitants more than half 
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earn less than the Household Subsistence Level.  Nearly a quarter of the 
population is functionally illiterate [21].  The resultant socio-economic 
status/class could at best be considered a proxy marker for factors linked 
directly to the risk of schizophrenia in the Xhosa population.  Exposure to 
infections or toxic agents and other non-biological factors such as social and 
psychological stress may even be causative [22]. 
 
 
3. CONFIRMED, POTENTIALLY STRONG RISK FACTORS: 
OBSTETRIC, BIRTH AND EARLY CHILDHOOD 
COMPLICATIONS; AGE AND AUTO-IMMUNE/INFECTIVE 
MARKERS. 
 
3.1. OBSTETRIC, BIRTH, AND EARLY CHILDHOOD 
COMPLICATIONS  
The neurodevelopmental model of schizophrenia is based on the assumption 
that early abnormal brain development due to genetic and/or environmental 
factors can give rise to schizophrenia [23;24]. The most robust findings seem 
to implicate prenatal nutritional deprivation [25], prenatal brain injury, and 
prenatal influenza [26]. 
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3.1.1. PERINATAL FACTORS 
3.1.1.1. OBSTETRIC COMPLICATIONS 
Obstetric complications have been the most frequently studied environmental 
factors and there is evidence that they are associated with an increase in the 
risk for developing schizophrenia [24].  It is, however, important to note that 
most neonates who have experienced obstetric complications do not develop 
schizophrenia.  In identifying patients in whom schizophrenia has been 
associated with obstetric complications, we may be looking either: (a) at a 
subgroup of schizophrenia sufferers in whom this factor (viz., obstetric 
complications) has increased their risk substantially [27] or (b) at factors that 
may merely have brought forward the age of onset of symptoms [28].   
 
A meta-analysis of 18 studies looking at different pregnancy complications 
(including pre-eclampsia, low maternal weight, rhesus incompatibility, small 
head circumference and fetal distress) found an odds ratio of 2.0 (95% CI: 
1.6-2.4) for schizophrenia following any obstetric complication [29].  While this 
seems to support the prenatal stress theory, publication bias and selection 
bias may have influenced the findings of the meta-analysis. 
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3.1.1.2. NUTRITIONAL DEPRIVATION 
Perinatal nutritional deprivation may increase the risk of schizophrenia.  The 
Dutch Hunger Winter study of 1944-1945 [30;31] showed that children (both 
male and female) born to nutritionally deprived mothers during the Dutch 
Hunger Winter were twice as likely to develop schizophrenia than those who 
were not.  The Swedish National Birth Register study which analysed data 
pertaining to over 500 000 children born between 1973 and 1977 [32] showed 
that children exposed to malnutrition in utero were at increased risk, 
especially for early onset schizophrenia.  These findings suggest that pre- and 
perinatal complications confer a risk for earlier onset schizophrenia [33]. 
 
 
3.1.1.3. VIRAL INFECTIONS 
Exposure to viral infections in utero has been associated with an increased 
risk of schizophrenia [34].  There are several viral hypotheses of 
schizophrenia.  One hypothesis states that a viral infection coincides with the 
onset of the illness.  This hypothesis stems from the observation that the 1918 
influenza epidemic seems to have triggered the activation of latent psychosis 
in a number of individuals [35]. 
 
A second possibility is that a latent viral infection becomes active only later in 
life.  The classic example is herpes simplex virus infection.  Activation of latent 
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infection can cause encephalitis, which in the early stages may resemble 
schizophrenia [36]. 
 
A third theory is that a virus may produce subtle alterations in cellular function, 
such as changes in the production and stability of neurohormones, cytokines 
and other neurospecific substances [37].  A viral hypothesis is clearly 
compatible with the prenatal stress theory since pregnant women who are 
subjected to various stressors might by virtue of a compromised immune 
system be vulnerable to viral infections.  This hypothesis stems from the 
association between type A2/Singapore influenza infection during the second 
trimester of pregnancy and the later development of schizophrenia [38].  
However, despite more than 20 studies, the results remain ambiguous to date 
as the existence of DNA or RNA viral components in the cells of 
schizophrenia sufferers has not been consistently demonstrated [39-41].  The 
evidence for infective markers remains circumstantial and until prospective 
studies report on confirmed viral infections diagnosed during pregnancy this 
theory should be viewed with caution. 
 
 
3.1.1.4. PERINATAL AND EARLY CHILDHOOD BRAIN INJURY 
Prenatal brain damage or mental impairment in childhood evidenced by 
delayed motor development, speech problems, lower educational test scores 
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and a preference for solitary play [42] may be associated with an increase in 
the risk for schizophrenia [43].  The predictive power of such evidence is 
modest and the specific etiological underpinning is uncertain, but it at least 
lends some support to the idea of a neurodevelopmental model [44;45]. 
 
In Stockholm County, 524 schizophrenia patients and 1 043 age, gender, 
hospital and parish of birth matched controls were compared in terms of birth 
complications, specifically asphyxia (Apgar score < 7 at birth) on the basis of 
a retrospective assessment of birth records.  After adjustment for other 
obstetric complications, maternal history of psychotic illness and social class, 
asphyxia at birth was associated with the development of schizophrenia (OR 
4.4; 95% CI 1.9-10.3) independent of gender or early onset [46].  This finding 
is in accordance with other studies that have shown foetal distress [47], high 
scores on the Risk for Asphyxia Scale [48] and the need for postnatal 
resuscitation [49] to be associated with an increased risk for schizophrenia.  
Hultman, et al. (1999) [50] reported an association between schizophrenia 
and intra-uterine growth retardation, but only in male patients (p<0.05).  
 
Despite evidence for an association between schizophrenia and perinatal 
asphyxia, this finding is by no means consistent.  Other community based 
studies [51;52] failed to demonstrate a significant effect of asphyxia on the 
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risk for schizophrenia but direct comparisons between these studies is 
complicated by several methodological differences [53;54].   
 
The associations that have been demonstrated between birth complications 
and schizophrenia can be explained by three possible mechanisms: first, the 
patient was at risk for developing schizophrenia before the birth complications 
arose [55]; second, birth complications themselves cause schizophrenia [56]; 
and third, genetic determinants of schizophrenia increase the risk of birth 
complications [57].  
 
It is difficult to arrive at a mechanism whereby perinatal factors might heighten 
the risk for schizophrenia.  Nutrient deficiency during pre-eclampsia is a 
possible mechanism.  Hypoxia may cause damage through acidosis or the 
generation of waste products, such as amino acids and free radicals [58;59].   
N-methyl-D-aspartate receptors may play a central role in producing damage 
that is mostly located in the brainstem nuclei, hippocampus and cortex [60].  It 
is of note that reduced hippocampal volume has been described in patients 
with schizophrenia with a history of obstetric complications [61].  It has long 
been thought that this reduced hippocampal volume may account for the over-
representation of non-right-handedness in schizophrenia and a recent meta-
analysis of 19 studies on handedness in schizophrenia confirmed the 
overrepresentation of non-right-handedness in schizophrenia [62].  
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However, subtle brain damage is unlikely to be the sole explanation for the 
development of schizophrenia, since comparison of schizophrenic patients 
with those suffering from neurological and other psychiatric disorders 
indicated that non-right-handedness was still significantly greater in the 
schizophrenia group [63].  This finding introduces the opportunity to propose a 
more fundamental explanation for the decreased cerebral lateralization in 
schizophrenia, namely genetic mechanisms.  The possibility of genetic 
mechanisms is suggested by the fact that healthy relatives of schizophrenia 
patients seem to have a higher prevalence of non-righthandedness than 
would be expected [64;65].  Genetic mechanisms will be discussed more fully 
later on in this chapter. 
 
 
3.2. AGE AND GENDER  
The 1-year prevalence rates of schizophrenia were 0.5% for males and 0.6% 
for females in the National Comorbidity study [66] although minor variations 
have been reported [67].  Although these studies could not prove conclusively 
that the development of schizophrenia is independent of gender, several 
studies focusing on treated cases have suggested a male excess in first-
episode schizophrenia studies, especially if onset was before the age of 35 
years [68-70].  It has been suggested that males have a younger age of onset 
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and are younger at first hospitalisation [71-73].  The earlier age of onset in 
males may not be limited to schizophrenia: the Suffolk County Study revealed 
earlier age of onset in three diagnostic categories namely 
schizophrenia/schizo-affective disorder (25 years for males and 28 years for 
females), psychotic bipolar disorder (23 years versus 29 years) and psychotic 
depression (27 years versus 33 years) [74]. 
 
 
Males and females have been shown to demonstrate differences in disease 
presentation.  In men, the onset tends to be more insidious, with a larger 
number of negative symptoms [75-77].  Other studies, however, have failed to 
demonstrate these differences and some have even reported a greater 
frequency of typical hallucinations and delusions in men than in women [78].  
Studies on the duration of untreated psychosis also showed contradictory 
results where gender is concerned [74;79].  
 
Could these inconsistent patterns be explained by the inclusion of individuals 
experiencing familial transmission of schizophrenia?  DeLisi et al. (1994) were 
unable to demonstrate differences between males and females in terms of 
age of onset in a sample of subjects suffering from familial schizophrenia [80].  
This corroborates the findings of Hafner et al. (2003) who found that a strong 
family history of schizophrenia ameliorated the gender effect [81].  He argued 
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that the protective nature of estrogen may account for the early differences 
between men and premenopausal women [81]. 
 
Hultman, et al. (1999) reported an association between schizophrenia and 
intra-uterine growth retardation in male patients (p<0.05) [82]. Byrne et al. 
(2000) also demonstrated a gender effect; they observed a strong association 
between a definite history of birth complications and male schizophrenia 
manifesting before the age of 30 years [83].  In a study of subjects recruited 
from the Swedish Stockholm County inpatient register (January 1971 to June 
1994), the effect of male gender failed to reach statistical significance; 
however this may have been due to insufficient power as a result of an 
inadequate sample size [74;84].  Many questions regarding the 
interrelationships between gender and intra-uterine brain damage in 
schizophrenia therefore remain unanswered. 
 
 
3.3. AUTOIMMUNE DISEASE  
The viral hypothesis of schizophrenia has been mentioned earlier.  
Autoimmune factors may also have some bearing on the risk of developing 
schizophrenia.  Several studies, despite methodological difficulties, have 
alluded to a finding that could prove to be important in defining the 
pathogenesis of schizophrenia, namely that rheumatoid arthritis (RA) is 
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uncommon in schizophrenia (prevalence of RA 0.047% in schizophrenia, 
versus 0.16% in the general population) [85].  This suggests that an inverse 
relationship exists between protective factors for RA and those for 
schizophrenia.  
 
The association between RA and schizophrenia has been the subject of 
several reviews and a meta-analysis of the more than 15 available studies 
reported an odds ratio (OR) of 0.29 (p< 0.0001; 95% CI 0.22-0.38) for RA in 
schizophrenia versus other psychiatric disorders [86; 87;88].  The nine studies 
that focused on schizophrenia revealed a median frequency of comorbid RA 
and schizophrenia of only 0.05%.  It is argued that this figure could be 
artificially low, given the possibility that patients with schizophrenia might not 
be able to clearly communicate or appreciate RA symptoms.  However, non-
schizophrenic RA patients had lower scores on paranoid ideation (SCL-90 
questionnaire) than did controls without RA, suggesting a negative 
association between paranoid ideation and RA on the dimensional level [89].  
 
Since a negative association between RA and schizophrenia has been 
reported in large, controlled studies in several countries, it may suggest that a 
protective immune or genetic mechanism may be at play.  Possible 
mechanisms include genetic mechanisms via HLA polymorphisms (DR4 
antigen as possible candidate), tryptophan metabolism, serum interleuken 
receptor concentration, IGF II or microglia abnormalities [90].   
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3.4. SEASON OF BIRTH 
Winter birth has been found to lead to a disproportionately larger number of 
patients with schizophrenia in later life (5-15% higher than other seasons), a 
finding that has not been replicated in other major psychiatric disorders (with 
the possible exception of autism) [91].  This differential was larger for females 
and where a positive family history was present [92-94].  More than 250 
studies have examined season of birth as a risk factor for the development of 
schizophrenia [91].  These studies have almost consistently shown a winter-
spring excess of 5-8%.   Several possible reason for this have been proposed, 
including infective processes, genetic factors, obstetric complications, 
variations in light, environmental toxins, nutrition, climatic changes and even 
procreational habits of at-risk parents [92].  
 
It has been argued that the excess could be explained by an age-incidence 
effect (individuals born earlier in the year should be at higher risk because 
they are older at the time of the investigation).  However, a winter excess is 
still present even when the age-incidence has been controlled for [95]. 
  
Season of birth has also been associated with different subtypes of 
schizophrenia, differences in prognosis, demographic factors and clinical 
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presentation.  Bralet et al. (2002) reported an excess of July births in French 
Kraepelin subtype patients with schizophrenia [96].  Summer births have also 
been reported in patients with deficit syndrome of schizophrenia [97;98].  
Several other studies have suggested a more benign course for winter born 
patients with schizophrenia.  Higher levels of anhedonia have also been 
reported (although not consistently) in schizophrenic patients born one month 
after a winter season with a high rate of infections.  Troisi et al. (2001) 
reported that female patients born in winter and early spring had higher 
negative and anergia PANSS scores than those born in the other seasons, 
while males born in the other seasons had higher scores on the anergia factor 
[99]. 
  
Several other studies have found no relationship between season of birth and 
various variables such as age of onset, marital status, total duration of 
hospitalisation and number of hospitalisations [100;101]. 
 
To date, twelve southern hemisphere studies have been done and a meta-
analysis of ten of these studies - involving over twenty thousand patients with 
schizophrenia - showed no specific winter birth excess [102].  There were 
many methodological problems, however, of which matching of controls and 
small sample sizes were the most important.  According to Torrey and Miller 
(1997) [100], only one study was methodologically sound and this did show a 
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significant winter-spring excess of births [103].  The season of birth may 
however be only a proxy for several other underlying factors, such as viral 
infections and diet.  At any rate, the overall contribution of this factor to the 
risk of schizophrenia appears to be relatively small [100;101].   
 
 
4. STRONG CONFIRMED RISK FACTORS (SOCIAL CLASS AND FAMILY 
HISTORY) 
 
4.1. SOCIAL CLASS 
Several studies have pointed out that people with schizophrenia are more 
likely to occupy lower socio-economic positions and live in areas of higher 
social deprivation at the time of their first diagnosis than people without 
schizophrenia [104-106].  Social class is considered one of the strong 
predictors of illness [107] and an increased ratio has been calculated for the 
rate of schizophrenia in persons born into the lowest social classes compared 
to the rate in people born into the highest social classes [108].  It is still 
unclear to which extent social segregation caused by the prodromal 
symptoms may contribute to this.    
 
Two possible explanations have been offered for this difference in rates. The 
first hypothesis states that adverse environmental factors may precipitate the 
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onset of schizophrenia (social causation). The second hypothesis (social drift 
theory) focuses on the fact that patients with schizophrenia may not reach 
their potential due to the clinical features associated with the premorbid, 
prodromal and early illness phases.  
 
 
Harrison et al. (2001) [109] found an increased risk in those individuals in 
whom paternal social class had been lower than maternal social class or 
where the births had taken place in a deprived area (OR=2.1; 95% CI 0.8-5.5) 
[110].  If both of these factors were present, the odds ratio increased to 8.1 
(95% CI; 2.7-23.9).  While other studies support their findings [111], Done et 
al. (1994) (UK sample) [112] and Jones et al. (1994) (UK sample) [113] 
demonstrated an association between schizophrenia and higher, not lower, 
paternal social class.  However, since the latter two studies were small and 
differed from each other in sample selection, the precise role of paternal 
social class on the development of schizophrenia needs further research, 
using larger, well-defined samples.   
 
Of the theories pertaining to social class and schizophrenia, the social drift 
theory remains the most widely supported.  However, all of these hypotheses 
may be valid depending on the subgroup of schizophrenia under 
consideration [114].  Further research may shed more light on the roles of 
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each of these hypotheses.  The present study is unlikely to add materially to 
the understanding of the role of social class in the pathogenesis of 
schizophrenia: in South Africa, geographic location cannot be used as a 
measure of social class, because of the rapid urbanization that has taken 
place amongst Xhosa-speaking people [115].   
 
Dohrenwend et al. (1992) [116], in their research into the social determinants of 
mental illness in Israel, investigated a birth cohort of 4914 Israeli-born adults in 
terms of social selection.  They concluded that social selection might be of greater 
importance than social causation in producing the social class effects found in 
schizophrenia.  
 
 
4.2. FAMILY HISTORY AS A RISK FACTOR 
Numerous reviews on the genetics of schizophrenia support the notion of 
familial transmission of schizophrenia [117-119].  However, establishing the 
role of familial inheritance in schizophrenia is by no means straightforward.  
The first layer of complexity to be dealt with is to determine whether the 
condition is truly inherited in the genetic sense, whether one is dealing with 
the effects of nurture, or whether random, non-genetic factors that create 
phenocopies are involved.  The latter situation may occur when someone 
 58
   
suffers a non-genetic event (e.g., a head injury), and subsequently develops a 
psychiatric disorder such as schizophrenia [120]. 
 
Several lines of evidence point toward the involvement of inherited factors in 
the disease process. Family studies, including twin studies, have offered 
some revealing insights into the role of the genetic determinants of 
schizophrenia.  The consistently higher concordance rate for schizophrenia in 
monozygotic twins as opposed to dizygotic twins (approximately 50% vs. 
approximately 17%) [121], whether they were reared apart or not [122], 
suggests some shared susceptibility factors.  However, the concordance rate 
in schizophrenia is not 100%, as one would expect if schizophrenia were 
solely a genetic disorder.  It follows that a strong likelihood exists that gene-
environment interactions contribute materially to the development of 
schizophrenia.  
 
A large number of family studies conducted between 1921 and 1987, despite 
methodological differences, support the possibility of inherited factors in 
schizophrenia susceptibility [123].  They found the lifetime morbid risk  (MR) 
for schizophrenia in the general population to be in the order of 1% while 
increased risks ranging from 2 to 48 times higher were demonstrated in 
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biological relatives of individuals with schizophrenia [124;125] (Figure 1). 
FIGURE 1. LIFET IME MORBID RISK FOR SCHIZOPHRENIA (%) AS 
A FUNCT ION OF FAMILY HIST ORY
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Criticisms levelled against these family studies include lack of proper controls, 
potential sampling errors, differing diagnostic criteria and the unblinded status 
of family members.  These limitations should be borne in mind when 
interpreting the results.  Kendler and Diehl (1993) [126] analyzed seven 
studies designed to address these problems.  A lifetime MR of 0.5% for 
relatives of controls was reported compared to 4.8% for relatives of patients 
with schizophrenia.  The estimated heritability was as high as 60- 80% 
[127;128].   
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The susceptibility risk for schizophrenia and its spectrum disorders seems to 
be higher if a narrow spectrum definition is used [126].  Less convincing 
results occur with a broad-spectrum diagnosis, i.e., one in which patients 
suffering from comorbid alcoholism, anxiety disorders and mood disorders 
(unipolar or bipolar) are included. This finding is also reflected in twin studies 
where broadening of the phenotype leads to a decreased estimate of risk for 
schizophrenia in family members [129]. 
 
A century of research therefore points towards a constitutional model for - and 
by implication a genetic component to - the development of schizophrenia.  
The translation of the observed familial patterns found in schizophrenia into 
molecular proof has not been easily forthcoming. It thus seems fair to state, 
that, while nearly a century of pre-clinical and clinical studies concerning the 
causes of schizophrenia have improved our knowledge about this disabling 
disease, we need new tools of discovery if we hope to uncover the secrets of 
schizophrenia. 
 
The development and modernization of molecular biology automation 
technologies and statistical methodology now makes the identification of 
susceptibility loci for major psychiatric disorders such as schizophrenia a 
possibility [130].  The completion of the draft sequence of the human genome, 
and other associated projects, have provided researchers with a wealth of 
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information regarding the genetic make-up of the human species.  Many of 
the suspected twenty-seven to forty thousand genes and their products may 
directly or indirectly influence the development, presentation and course of 
psychiatric disorders.  It is hoped that by investigating the wealth of naturally 
occurring variants of the genes that have been uncovered by the genome 
project, those variants or combinations of variants that predispose an 
individual to developing psychiatric disorders will be delineated.  However, it is 
already clear that psychiatric disorders such as schizophrenia result from a 
complex layer of influences, not all of which are genetic, and that dissecting 
out the genetic component is far from simple.  Considering the multitude of 
possible combinations of factors operating in the pathogenesis of the disease, 
the flood of disparate findings cited in the literature (positive and negative, 
association and non-association, linkage and non-linkage, agreement and 
disagreement) is not wholly unexpected [131].  The prevailing sentiment 
regarding schizophrenia, namely that it is an excellent example of 
heterogeneity, was echoed in an editorial review on the current status of 
genetic studies in schizophrenia.  Tsuang (2000) stated, "we can now 
conclusively reject the idea that there is one gene of major effect that causes 
schizophrenia" and the search is now on for the various genes that could be 
involved in the clinical expression of the disease of schizophrenia [131].  
Schizophrenia in an individual could result from many genes of small effect.  
Certain subgroups of schizophrenia could also be brought about by single 
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genes of moderate effect [131].  An example of the latter is a susceptibility 
gene (Meyer et al. (2001) (WKL1 on chromosome 15) which confers a major 
risk for the development of a subtype of schizophrenia, namely catatonic 
subtype [132].  The fact that this gene most likely acts in concert with 
(currently unknown) predisposing factors provides further evidence for the 
heterogeneity of schizophrenia.  It also bodes well for the quest for links 
between other subgroups of schizophrenia and specific genes of relatively 
major effect. 
  
Although these findings together with results of family and twin studies 
support a role for genetic factors in the development of schizophrenia, they do 
not help to define the mode of inheritance.  Neither have they been able to 
enumerate the inherited susceptibility factors that influence the molecular 
pathophysiology of schizophrenia.  The mode of inheritance of a disorder 
determines the analysis needed to delineate the implicated gene(s); genes 
involved in simple Mendelian inheritance are more easily identified than those 
involved in complex polygenic or multifactorial disorders.  It seems that in 
most psychiatric disorders a complex mode of inheritance is involved although 
psychiatric disorders inherited by classical Mendelian inheritance do exist.  
For instance, Brunner et al. (1993) studied a Dutch family in which five males 
exhibited low intellect and episodes of abnormal and overly aggressive 
behaviour, including arson, attempted murder and exhibitionism [133].  
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Genetic analysis of these five males led to the diagnosis of a form of X-linked 
borderline mental retardation characterized by behavioural abnormalities.  
MAO-A activity is absent in such individuals because of a single point 
mutation in exon 8 of the MAO-A gene.  However, phenomena such as 
incomplete penetrance (in which someone carries the disease-causing or -
predisposing gene variant in which symptoms of the disease are attenuated or 
delayed) and variable trinucleotide expansion (the mechanism underlying 
Huntington’ s chorea and possibly schizophrenia and bipolar disorder), 
indicate that even classical Mendelian inheritance can be complicated by 
additional genetic or non-genetic factors [134]. 
 
Segregation analysis studies among European schizophrenic samples 
selected according to standard criteria indicated that neither the generalized 
single locus model (commonly used in linkage analysis) nor the multifactorial 
threshold model (MD) sufficiently explained the risk patterns observed in 
schizophrenia [135] .  Of the two, the MD model showed the best fit.  As has 
been found in OCD sufferers, a mixed model (multifactorial, with no single 
major gene) seems to best explain inheritance in schizophrenia at a genetic 
level [136].    
 
Estimating the number of loci contributing to this model might be complicated 
by the occurrence of epistatic interactions.  In epistatic interactions, the total 
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susceptibility/risk conferred by any number of genes is greater than the sum 
of the individual susceptibility genes.  The fall in rate of concordance may be 
used to estimate the number of epistatic loci [137].  Using this technique, data 
from US studies suggested 3-4 epistatic loci in schizophrenia [137].  However, 
the utility of these results is complicated by the fact that the individual loci will 
show smaller effects than if the loci act in an additive manner.  Furthermore, 
these loci must be biologically related (functionally, temporally or spatially) 
and therefore the genotype/phenotype of one gene must influence the 
genotype/phenotype of another gene.  Further modelling will depend upon 
penetration at the different loci.  Given the paucity of data on candidate gene 
loci, modelling is not currently possible. 
 
The classical approach to disease gene mapping strategies, namely linkage 
analysis, is still extensively employed in schizophrenia (Appendix 1).  In 
linkage analysis one computes the probability that multiple affected individuals 
in a family share a particular chromosomal segment (identified by specified 
genetic variations called markers) more often than would be predicated by 
chance alone. 
 
Significant successes of the linkage method include the identification of 
amyloid beta precursor, presenilin-1 and 2 genes, as causal factors in early-
onset Alzheimer’ s disease (AD), and APO E as a susceptibility factor for 
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late-onset AD [138].  However, although linkage studies have singled out 
some chromosomal areas (including chromosome 12 and 18) as possibly 
harboring genes of importance in schizophrenia and bipolar mood disorder 
subsequent studies have not been able to replicate all these findings, even 
using the same family resources [139]. If strict criteria are followed (a lod 
score of 3.3 for parametric and 3.6 for non-parametric methods) no study has 
thus far yielded significant linkage results [140].  One reason for the 
inconsistent linkage analysis findings in schizophrenia could be that this 
method reliably detects only genetic factors that have a major influence on 
disease development.  Possibly, multiple genes of smaller effect account for 
the development of schizophrenia.  Alternatively, these diseases may not 
comprise single disorders at all, but could be manifestations of genetic 
heterogeneity; i.e., they may constitute similar clinical entities caused by 
different genes or gene-combinations.  This is certainly plausible, given the 
demonstration of a single gene accounting for a major effect in catatonic 
schizophrenia [141;142].  As in OCD, different symptom factors in 
schizophrenia may result from differences in heritability [143].   
 
Thus, it is becoming clear that most psychiatric disorders, like schizophrenia 
and OCD, display some genetic heterogeneity and/or epistatic gene 
interaction (where two or more genes act in concert to cause a psychiatric 
disorder).  Therefore it is necessary to use techniques that can detect genes 
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with a minor effect.  The power of these methods depends heavily on careful 
phenotyping of appropriate clinical samples.  
 
Given the strength of familial risk factors for schizophrenia and the rapid 
development of genetic laboratory and statistical methods, the study of 
familial risk factors in a relatively heterogeneous clinical sample, such as one 
that can be drawn from the Xhosa population, may offer unique insights into 
the etiology of schizophrenia.      
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APPENDIX 1. GENE MAPPING STRATEGIES 
 A. Linkage studies 
B B 
D E 
F F 
A B 
C C 
G G 
B B 
E D 
G G 
B B 
C E 
G G 
A B 
C D 
F G  
 A B 
C E 
G G 
 
A B 
C D 
G F 
 
 
Linkage analysis (which can also include affected sibpair and affected pedigree member 
analysis) considers whether multiple affected individuals in a family share a particular 
chromosomal segment more often that would be expected by pure chance. The figure shows 
that the chromosome containing the maternal segment ABF (in blue) is linked to the disease 
(filled symbols) and that those recombination events (red arrows) limit the disease gene-
containing area to the AC segment (in blue). 
 
B. Association studies 
1. Population based case-control association studies 
   AA     AA     AB    AB    AB                     AA     AA   BB     BB     BA 
 
                       Affected            Controls 
Case-control association compares genotype distribution and allele frequencies of patient and 
appropriately matched control groups. The figure shows that allele A occurs more frequently 
in the patient group than in the control group. 
 2. Family-based association studies 
  AB        CE    AC         CE   BB        AE AB        CE     CE          BB  
   
 
 
 AE AE AB AC BE
Family-based association studies use non-transmitted alleles (shown in red) as control 
samples.  
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2.1. Haplotype Relative Risk (HRR) 
  Alleles in affected   Alleles in unaffected  
  AE, AE, AB, AC, BE   BC, CC, BE, BE, BC 
2.2. Transmission disequilibrium test (TDT) 
   
AB AC AE AB
 AE    AE       AB        AC  
 
HRR uses non-transmitted alleles (shown in red) from parents as controls. 
TDT compares the frequency of transmitted (in blue) and non-transmitted (in red) parental 
alleles from heterozygous parents (Adapted from Burmeister 1999).  
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Chapter 3 
 
THE ROLE OF AFFECTED SIB PAIR STUDIES IN 
LIMITING THE HETEROGENEITY OF SCHIZOPHRENIA
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1. INTRODUCTION 
 
In this chapter, the principles underlying studies of sib pairs will be discussed, 
reference will be made to the statistical methods commonly employed in their 
analysis, and a review of several seminal sib pair studies on schizophrenia 
will be performed.  In considering the published sib pair studies, sample size, 
patient population, diagnostic criteria and statistical methods are important 
determinants of the validity of any one study. 
 
Schizophrenia, according to current classification schemes, is not a single 
entity, but can be considered a spectrum of disorders displaying considerable 
heterogeneity in terms of clinical manifestations, age of onset, course and 
prognosis.   Numerous attempts have been made to characterize the 
heterogeneity of the schizophrenia phenotype by exploring relationships 
between the various symptom dimensions and possible subtypes.  It is highly 
probable that the observed clinical heterogeneity is a reflection of an 
underlying genetic heterogeneity.   
 
Although the mode of inheritance remains elusive, studies suggest that it is 
most likely to be heterogeneous, with incomplete penetrance.  Whether this 
susceptibility results in disease and what form it takes, is clearly influenced by 
environmental risk factors [1;2]. 
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Studies involving concordant siblings are useful since investigators are able to 
examine genetic and environmental factors simultaneously.  These studies 
are based on the assumption that shared clinical features are likely to be 
related to shared familial (environmental or genetic) factors [3]. 
 
Concordant sib pairs are particularly useful to detect genes of moderate effect 
in complex disorders by means of an allele sharing linkage method.  In these 
studies, linkage is suggested by pairs of sibs inheriting the same alleles (at a 
specific locus) more often than expected by chance.  This method has been 
used with success and a study by Owen (2000) has identified three areas of 
suggestive linkage namely on chromosome Xcen, 4p and 18q.  Given the 
suggested polygenic (many genes of small effect) or oligogenic (few genes of 
moderate effect) models for the genetic basis of schizophrenia, it is expected 
that 600-800 sib pairs will be needed to identify alleles that confer an 
increased risk of 1.5-3 in an oligogenic model.  If a polygenic model is 
followed, the number of sib pairs reaches into the thousands and association 
studies become a more viable option given the difficulties recruiting large sib 
pair samples.  Sib pair studies afford a practicable means of identifying 
candidate genes based on hypotheses generated from well-characterized 
clinical phenotypes.  
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This review addresses twelve sib pair studies conducted over a period of 102 
years on schizophrenic patients [4-17].  The earliest reported sib pair data set 
is that of Zender 1940 (Switzerland).  This was followed by eleven further 
studies [18]. 
 
 
 
 
2. SUBJECTS AND METHODS 
2.1 SUBJECTS 
These studies reported on subjects from various countries: the United 
Kingdom (7 reports), the USA (3), France (2), the Island of Réunion (2), 
Switzerland (1) and Taiwan (1).  It is important to note, however, that several 
of these reports probably include the same participants.  Although it is difficult 
to compute the exact degree of overlap between study samples, it is probably 
safe to assume that Ross et al. (2000) [19], Kendler et al. (1997) [20] and 
Burke et al. (1996) [21] shared the subjects recruited in Ireland and Northern 
Ireland.  Cardno et al. (1998) [22] recruited a sample from the UK and Wales.  
Two French studies (Fouldrin et al. (2001) [23] and Leboyer et al. (1992) [14]) 
both include a sample from Réunion and Normandy.  Loftus et al. (1998, 
2000) [24;25] reported two sets of findings on a sample from the USA, 
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London, Oxford and Dublin.  DeLisi et al. (1987) [26] reported on a pure 
United States sample recruited from 22 states.    An apparently independent 
sample was reported in Taiwan (Hwu et al. (1997)) [27].    In summary, it can 
be assumed that sib pair studies include eight independent samples, namely 
a sample from Ireland/Northern Ireland, a sample from the UK and Wales, a 
UK only sample, a French sample, a pure US sample, one Taiwanese 
sample, one mixed sample from the USA, UK and Ireland, and finally, a Swiss 
sample.  
 
In several studies, psychiatric hospitals were used as recruitment sites ([28] 
Ross et al. (2000); [29] Kendler et al. (1997); [15] Tsuang (1967); [30] Fouldrin 
et al. (2001); [14] Leboyer et al. (1992); [31] Kendler and Adler (1984)).  Burke 
et al. (1996) [32] (part of a large genetic study) and Hwu et al. (1997) [33] did 
not specify their recruitment sites.  Loftus et al. (1998; 2000) [34;35] and 
Cardno et al. (1998) [36] recruited subjects from local psychiatric services and 
consumer groups.  DeLisi et al. (1987) [37] used advertisements and targeted 
psychiatric services and consumer groups.   
 
 
2.2 METHODS: ASSESSMENT OF SUBJECTS 
The assessment tools were mostly DSM-III-R based ([14;38-44] (Appendix 1). 
Some researchers, however, used other instruments: ICD [15], RDC [45], 
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DSM-III [46] and DSM-IV [47].  Leboyer et al. (1992) [14] and Kendler and 
Adler (1994) [48] also used ICD-10 and ICD-9 criteria, respectively, as well as 
DSM-III and Tsuang-Winokur criteria.  The researchers used a variety of 
methods and diagnostic instruments to identify subjects with schizophrenia 
and to rate various symptoms (Appendix 1).  
 
Apart from a re-analysis of Zender’ s sample (initially personal interviews) 
[49], a case report based study by Tsuang (1967) [15], a study using a 
combination of case reports and personal interviews [50;51]and telephonic 
interviews [52], most of the patients were interviewed personally by 
psychiatrists or trained social scientists.  Most studies included blinded or 
independent raters and consensus diagnosis of the sib pairs by two or more 
raters.  
 
The diagnostic spectrum included schizophrenia (including simple 
schizophrenia) [53] and schizo-affective disorder (Appendix 1).   
 
 
2.3 METHODS: CHARACTERISTICS OF STUDY SAMPLES 
The gender distribution of these samples shows a clear male preponderance 
(65.4%, assuming no study overlap), with only Tsuang (1967) [15] reporting 
on a sample consisting mostly of female patients (Appendix 2).  Whether this 
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male preponderance reflects recruitment bias is not certain, but it is not 
representative of the roughly equal gender distribution expected in 
schizophrenia and, to a lesser extent, schizo-affective disorder.   Very few 
studies gave clear indications of the gender groupings within the sib pairs, but 
as expected from the above-mentioned gender disparity, male-male pairs 
were most commonly reported (Appendix 2).  
 
Because participants in such studies differ regarding the stage of illness at 
interview, it is important that confounding variables such as age at interview 
[discussed first], age of onset, and duration of illness should be reported.  Ten 
studies reported interviewees’  ages.  Except for the Hwu et al. study (1997) 
[54], participants were in their middle thirties to late forties.  The age of onset 
(eight studies reported this data) varied from 19.2 to 27.8 years and the 
duration of illness (data available for 5 studies) from 9 to 19.9 years (Appendix 
2). 
  
 
2.4 METHODS: STATISTICAL APPROACHES 
A wide variety of approaches were followed to analyze psychiatric symptoms 
shared by affected sib pairs (Appendix 4).  Researchers  tried to identify 
specific symptom factors that could be used to subtype schizophrenia.  This 
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approach rests on the assumption that symptoms in affected sib pairs may 
cluster together if they share a familial loading (either genetic or 
environmental).  The second approach rests on the assumption that 
symptoms with a shared familial background will be more likely to be present 
in both siblings.  
 
These approaches can thus be broadly classified into: 
A. Methods that identify symptoms which cluster together  
1. Factor analysis with varimax rotation [55-58]  
2. Latent Class analysis [59] 
 
B. Methods that identify symptoms which are shared by sib pairs 
1. Kappa statistic [60]  
2. Spearman correlation [61;62] 
3. Likelihood ratio statistics [63] 
4. Chi-square based techniques include the following:   
a. Sib pair method [64-66]  
b. Sibship method [14;67]  
c. Within pair association study [68;69] 
d. Observed versus Expected ratios [15]    
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2.4.1. METHODS THAT IDENTIFY SYMPTOMS WHICH 
CLUSTER TOGETHER  
2.4.1.1 FACTOR AND LATENT CLASS ANALYSIS  
Factor analysis is concerned with describing and interpreting 
interdependencies within a set of variables (such as interviewer ratings of 
psychiatric signs and symptoms) and reducing the number of variables into a 
smaller group, called factors.  These factors cannot be understood  intuitively 
until the reference axes are rotated, and derived factors are extracted.  They 
can be viewed as biologically meaningful variables derived from the original 
data and can be used in further analyses, such as analysis of concordance 
between sib pairs.  The eigenvalues of the extracted factors give an indication 
of the proportion of the total variance accounted for by the factors.  Only 
factors with Eigenvalues > 1 are retained.    
 
 
2.4.2. METHODS THAT IDENTIFY SYMPTOMS WHICH ARE 
SHARED BY SIB PAIRS 
Which statistical methods should be used to examine concordance between 
sib pairs remains a dilemma.  The most commonly used statistical methods 
entail the use of Chi-square based techniques since the complex nature of the 
clinical data (linear and non-linear) makes other forms of analysis, such as the 
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Kappa statistic, less likely to yield valid results.  The sibship method, a Chi-
square based technique, relies heavily on diagnostic concordance between all 
siblings in a sibship.  If, for example, only three out of four siblings are 
concordant for symptom Y, this sibship will not be viewed as concordant.  This 
invariably leads to underreporting of possible concordance in a given sibship.  
It is important to determine criteria for sibship selection carefully, since sibship 
size (i.e., the number of affected siblings in each pedigree) directly influences 
statistical significance and may bias the results in favour of studies with large 
sibship sizes (Appendix 3).   
 
In contrast to this method, the sib pair method, which is based on 
concordance of symptoms between two siblings, tends to overestimate 
concordance (relative to the sibship method) if the pair is part of a larger 
sibship (Appendix 3).  When interpreting studies using the sib pair method, it 
is important to determine which criterion was used for extraction of sib pairs.  
The criterion for selection of a sib pair from a sibship should preferably be 
based only on random extraction, since selection based on, for example, 
“ first two to become ill”  (DeLisi et al. 1987) [70] could reflect only the 
difference in ages of onset, and not necessarily concordance of symptom Y.  
Even though Hodge’ s weighting technique could be applied to adjust for this 
discrepancy, this is still only an approximation of the “ true”  results.  Ideally, 
a study sample should have the smallest possible number of sibships with 
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more than two affected individuals in order not to rely on approximations such 
as Hodge’ s weighting technique.   
 
 
3. INTERPRETATION OF RESULTS: INDIVIDUAL SYMPTOM 
AND SUBTYPE RESULTS 
Interpretation of the results is influenced first by the sample sizes of the 
studies which vary from 62 [71] to 466 subjects [72] with all but the Irish 
samples [73;74] constituting less than 200 participants. In addition to this, the 
statistical methods used in most studies relied on extracting two affected 
siblings for comparison, a sibship of 3 affecteds would have led to over-
representation of larger sibships in the final statistical analysis.     It is of note 
that sets consisting of only two affected siblings range from 16 [75] to 148 
[76].   
 
Despite these methodological difficulties, results from these studies have 
yielded valuable information on shared familial factors.  Increased intra-pair 
correlation or concordance has been found for several of the symptoms and 
signs of schizophrenia (Appendix 5).   
 
 
3.1. POSITIVE SYMPTOMS 
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Burke et al. (1996) [77] demonstrated significant intra-pair correlation for 
positive symptoms, both as a single factor, and as a group of symptoms.  
Although Loftus et al. (1998) [78] did not find support for such a correlation, 
Hwu et al. (1997) [79] reported a Kappa score of 0.55 for the same set of 
positive symptoms in a Taiwanese sample. 
 
 
3.1.1. HALLUCINATIONS  
Hallucinations as a group of symptoms were found to show significant 
correlation in the Kendler et al. (1997) study [80].  Third person auditory 
hallucinations showed significant concordance in the 2000 study by Loftus et 
al. [81] but not in an earlier report by the same group [82].  DeLisi (1987) [83] 
and Cardno et al. (1998) [84] also failed to find a significant concordance for 
auditory hallucinations.  Visual hallucinations were concordant according to 
DeLisi (1987) [85]. 
 
 
3.1.2. DELUSIONS 
Delusions as a group of symptoms were found to be significantly concordant 
by Kendler et al. (1997) [86], but not by Cardno et al. (1998) [87].  
Nevertheless, the latter study did find the presence of delusions of influence 
as a single symptom to be significantly concordant in the sib pair sample, 
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which is in keeping with the positive finding of Loftus et al. (2000) [88] for 
delusions of control.  Except for thought broadcasting in the latter study and 
grandiosity in the study of Cardno et al. (1998) [89], no support was found for 
individual delusions in any of the other studies.    
 
 
3.1.3 POSITIVE THOUGHT DISORDER AND INAPPROPRIATE 
AFFECT 
Loftus et al. (1998) [90] and Kendler et al. (1997) [91] found positive thought 
disorder and inappropriate affect to be concordant between siblings , while 
Burke et al. (1996) [92] found only partial support for this notion.  Hwu (1997) 
[93] reported a Kappa score of 0.21 for thought disorder.  DeLisi (1987) [94] 
and Cardno et al. (1998) [95] did not find significant concordance for this 
factor.  
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3.2. NEGATIVE SYMPTOMS 
Kendler et al. (1997) [96] found negative thought disorder and affective 
deterioration to be significantly correlated between siblings.  Similarly, Burke 
et al. (1996) [97] found the group of negative symptoms, namely negative 
thought disorder, flat affect, anhedonia and avolition, to show significant intra-
pair correlations.  
 
In contrast to these findings, DeLisi (1987) [98], Cardno et al. (1998) [99]  and 
Loftus et al. (1998) [100] did not find significant concordance for negative 
symptoms.  Hwu (1997) [101] found a Kappa of 0.29 for the group of 
symptoms: flat affect, alogia and asociality.  
 
 
3.3. CATATONIA 
The concordance of catatonic symptoms was supported by both Kendler et al. 
(1997) [102] and Tsuang (1967) [15].  Cardno et al. (1998) [103], however, did 
not support this observation. 
 
 
3.4. MOOD SYMPTOMS 
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Support for significant concordance for depressive symptoms came from 
three studies [15;104;105].  However, a few other studies reported negative 
findings for depressive [106;107;108]  and manic symptoms [109;110]. 
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3.5. OTHER SUBTYPES 
DSM-R, DSM-II-R, ICD-10 and Tsuang Winokur based subtypes were found 
not to be concordant in the sib pair samples [14].  Deficit versus non-deficit 
[111;112] subtypes found mixed support, with Ross et al. (2000) reporting 
significance and Fouldrin et al. (2001) reporting significant concordance only 
in a small non-Caucasian subsample.  Some support was found for paranoid 
opposed to non-paranoid subtypes (ICD-9 and DSM-III) [113].   Neither 
classifying subjects into type 1, 2 and mixed subtypes nor into paranoid, 
hebephrenic and undifferentiated schizophrenic subtypes were successful in 
showing significant concordance [114]. 
 
 
4. FINDINGS FROM LATENT CLASS ANALYSIS OF SIB PAIRS 
Kendler et al. (1997) [115] reported a five class solution (Appendix 6).  
Scrutiny of these individual classes reveals these observations: class one 
seems to resemble a more schizoaffective status, while class four seems to 
resemble the paranoid subtype described in DSM-IV.  Class five suggests a 
catatonic subtype while classes two and three seem to represent the more 
typical positive and negative symptom complexes.    
 
 
5. RESULTS FROM FACTOR ANALYSIS OF SIB PAIRS 
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Three of the sib pair studies employed factor analysis.  They all reported two 
[116] or three factors [117;118] (Appendix 7).    Burke et al. (1996) found 
negative, reality distortion and disorganized symptom factors with mixed 
support from the analysis of variance.  Kendler et al. (1997) [119] reported a 
similar solution, i.e., a negative symptom factor, a positive symptom factor 
and an affective/manic symptom factor.  In accordance with Burke’ s results, 
the manic/affective factor also contained positive thought disorder [120].  
Each of these factors showed significant concordance within sib pairs.  Loftus 
et al. (2000) [121] reported a two factor solution which roughly translated into 
a hallucinations symptom factor and a delusions symptom factor.  The low 
number of factors in these solutions is of concern, since the smaller the 
number of factors, the less reliable factor analysis becomes, and it would be 
important to interpret these results on this background of uncertain validity.   
 
 
6. SUMMARY 
The main value of sib pair studies lies in the possibility of identifying shared 
familial factors.  These shared factors can be used to investigate underlying 
pathophyisiological processes by means of genetic or environmental studies.  
Given the large genetic contribution - estimated to be in excess of 70% - 
identification of shared factors promises to be of considerable value in genetic 
studies of schizophrenia. 
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Sib pair studies on the symptomatology of schizophrenia basically address 
two related though different issues.  The first group of studies look for 
symptoms that cluster together in sib pairs (factor and latent class analysis).  
Of these, the large sample size (n=256 sib pairs), single geographic origin and 
the use of established factor analysis methods by Kendler et al. (1997) makes 
this study’s results of particular interest.  However, of concern are the 
inclusion of items of which the criteria may be difficult to replicate precisely 
(e.g., poor outcome and chronic course), and the use of less stringent 
eigenvalue criteria in the statistical analysis.  In designing our study we 
therefore focused on a homogenous population (less genetic variation), used 
strict diagnostic criteria measured with a widely accepted assessment tool 
and employed a more rigorous eigenvalue criterion.  
 
The second group of studies evaluate the concordance of symptoms within 
sib pairs.  Here, not only is sample size an important determining factor, but 
the choice of statistical method can materially affect a researcher’s results.  
Chi-square techniques that incorporate the sib pair method seem to be the 
most widely used and the studies that employed them were of specific interest 
to us in developing the protocol for this study [122;123]. Ideally our study 
should therefore include one diagnostic category (most studies used 
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schizophrenia and schizo-affective patients), use the sib pair method (only 
include one sib pair per sibship) and rely on chi-square statistical methods. 
 
After a critical appraisal of the methodology employed in published studies on 
shared familial characteristics in schizophrenia, we selected the sib pair 
method (including only one sib pair per sibship) and utilized chi-square based 
statistical tests.  Unlike most other studies, which used both schizophrenic 
and schizo-affective patients, we decided on only one diagnostic category, in 
order to assemble as homogeneous a patient sample as possible. 
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APPENDIX 1.  STRUCTURED ASSESSMENT TOOLS 
USED IN SIB PAIR STUDIES 
 
Study* Ross 
et al. 
2000 
Kendler 
et al. 
1997 
Burke 
et al. 
1996 
Fouldrin et 
al. 2001 
Leboyer et 
al. 1992 
Loftus 
et al. 
2000 
Loftus 
et al. 
1998 
Hwu 
et al. 
1997 
DeLisi 
et al. 
1987 
Cardno 
et al. 
1998 
SCID-III-R 
(modified) 
X X X        
SADS-L    X X X X  X  
DIGS       X X    
PSE-9          X 
Major 
symptoms of 
schizophrenia 
scale 
 X         
OPCRIT          X 
SAPS      X X   X 
SANS   X   X X   X 
Chinese 
PANSS 
       X   
Schedule for 
the deficit 
syndrome of 
schizophrenia  
X   X       
Krawiecka 
scale 
      X  X  
Premorbid 
social 
adjustment  
        X  
Levels of 
functioning 
scale 
  X        
SIS X X         
 136
   
Relative 
psychiatric 
history 
questionnaire 
     X X    
Family 
structured 
interview 
        X  
GAS      X X   X 
* Tsuang (1967) and Kendler and Adler (1984) used clinical diagnosis only. 
SCID-IIIR = Structured Clinical Interview for DSM-III-R; SADS-L= Schedule for affective 
disorders and schizophrenia-lifetime version; DIGS= Diagnostic Interview for Genetic 
Studies; PSE-9=Present State Examination; OPCRIT= Operational Criteria; 
SAPS=Schedule for the assessment of positive symptoms; SANS=Schedule for the 
assessment of negative symptoms; SIS = Structured interview for schizotypy for 
schizophrenia spectrum personality disorder. 
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APPENDIX 2.SUMMARY OF CHARACTERISTICS OF SUBJECTS 
IN SIB PAIR STUDIES 
 
Ross
et al. 2000
N=466 
2 sibs 148
Kendler 
et al. 1997
Burke 
et al. 1996
Tsuang 
1967
Fouldrin
et al. 2001
Leboyer 
et al. 1992
Loftus 
et al. 2000
Hwu 
et al. 1997
DeLisi 
et al. 1987
Cardno 
et al. 1998
Kendler & Adler 
1984
3 sibs  31 
4 sibs  15  
5 sibs    1   
6 sibs    2   
N=383 
2 sibs 139
3 sibs  27 
4 sibs    6  
5 sibs    0   
6 sibs    0   
N=169 
2 sibs  71 
3 sibs    9  
4 sibs    0  
5 sibs    0   
6 sibs    0   
N=134 
2 sibs  65 
3 sibs    0  
4 sibs    1  
5 sibs    0   
6 sibs    0   
N=109 
2 sibs  32 
3 sibs   11 
4 sibs    3  
5 sibs    0   
6 sibs    0   
N=109 
2 sibs  32 
3 sibs    8  
4 sibs    1  
5 sibs    1  
6 sibs    0   
Loftus
et al. 1998
N=171* 
2 sibs  64 
3 sibs    9  
4 sibs    2  
5 sibs    0  
6 sibs    0   
N=185 
2 sibs  75 
3 sibs    9  
4 sibs    2  
5 sibs    0  
6 sibs    0   
N=92 
2 sibs  46 
3 sibs    0  
4 sibs    0  
5 sibs    0  
6 sibs    0   
N=123 
2 sibs  42 
3 sibs    7  
4 sibs    3  
5 sibs    0  
6 sibs    1   
N=191 
2 sibs  82 
3 sibs    9  
4 sibs    0  
5 sibs    0  
6 sibs    0   
N=62 
2 sibs  16 
3 sibs    6  
4 sibs    3  
5 sibs    0  
6 sibs    0   
S-A/Schiz   Schiz   Schiz Schiz Schiz Schiz S-A/Schiz S-A/Schiz Schiz   S-A/Schiz S-A/Schiz   S-A/Schiz   
M=309
F=172 *    
M=252
F=131   
M=110
F=59    
M=56
F=78   
M=61
F=48   N/A   
M=134
F=37   
M=139
F=46   
M=53
F=39   
M=85
F=38   
M=133
F=58  N/A  
N/A   N/A   
M/M=44
M/F=39
F/F=15   
M/M=17
M/F=24
F/F=30   
N/A   N/A   
M/M=64
M/F=34
F/F=5   
M/M=40
M/F=27
F/F=8   
N/A   
M/M=25 
M/F=21 
F/F=7  
M/M=53  
M/F=36   
F/F=10     
N/A
24.1 yrs   24.8 yrs   N/A   N/A   2527.8 yrs   N/A   21.02 yrs   20.5 yrs   
19.5
19.2 yrs  19.9 yrs   24.4 yrs N/A   
45.2 yrs  45.6 yrs   44.8 yrs   N/A   47.7546.3 yrs  38 yrs   36.7 yrs   37.8 yrs   
28.7
29.2 yrs  34.2 yrs   42 yrs  N/A 
N/A   N/A   19.9 yrs  N/A N/A N/A 15.32 yrs  13.5 yrs   9/10 yrs   15 yrs   N/A   N/A 
Study
Sib pairs
Diagnosis
Gender
Gender pairs
Age of onset
Interview age
Duration of illness
Study size
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APPENDIX 3. THE INFLUENCE OF SIBSHIP SIZE ON 
STATISTICAL ANALYSIS 
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APPENDIX 4. SUMMARY OF STATISTICAL METHODS 
USED IN SIB PAIR STUDIES 
 
Ross et al. 2000
Hierarchical 
log-linear regression
(saturated model with 
backward elimination)
Repeated
analysis 
picking
random pairs
Goodness of fit model
Likelihood ratio
statistics
Kendler et al. 1997
Log-linear regression
(removed linear effects 
of duration of illness
for all further analysis)
Co-variates and correlation
analysis  of
Age of onset
Gender
Duration of illness
Spearman ranked correlation
Kruskal-Wallis non-parametric 
one-way anova
Tested significance of resemblance 
with Wilcoxon non-parametric 
one-way analysis of variance
Random 
selection 
of pairs
Factor analysis with 
Varimax rotation
(Scree test for number 
of meaningful factors)
Latent class analysis
(maximum likelihood methods)
Dichotomized scores 
(median split)
Once assigned tested with
Chi-square + phi coefficent
Burke et al. 1996
Factor analysis with 
Varimax rotation
Kruskal-Wallis one-way
analysis of variance
Chi-square
Spearman’s correlation coefficent
(corrected for interrater variability)
Co-variate
Age of onset
Tsuang 1967
Observed versus expected resemblance
Chi-square
Fouldrin et al. 2001
Sib pair method 
(Hodge’s weighing applied)
Leboyer et al. 1992
Chi-square (p = one tailed)
Sibship method 
(Hodge’s weighing applied)
Chi-square 
Intraclass 
correlation:
Age of onset
Loftus et al. 2000
Exploratory factor analysis
(Varimax rotation)
Only factors with 
eigen value > 1
Spearman rank correlation
of factor
regression scores 
Post hoc Chi-square
(observed vs expected) 
Loftus et al. 1998
Within pair associations 
of previous factors (on-off)
Crosstabs
Chi-square 
Duration of illness
Age of onset
Hwu et al. 1997
Spearman rank correlation 
If high correlation then grouped
otherwise single factor
Sib pair wise concordance analysis
(kappa statistics + random error coefficient)
Negative symptom
dimension
DeLisi et al. 1987
Observed vs expected
(random concordance rates –
Calculated = frequency of trait)
Quantative traits –
analysis of variance on all
ill patients 
Used 1st two sibs
to get ill
Cardno et al. 1998
Kappa statistics (categorical) 
Spearman correlation (quantative)
Partial correlation SAPS/SANS Symptoms 
used to examine effect of:
Gender, age of onset, illness duration
Kendler and Adler 1984
Sib pair method
(all possible pairs)
Chi-square
(Goodness of fit analysis) 
Observed vs expected
Sibship method
Z-statistic
Observed vs expected
1 2 3 4
5
6
7
8
9
10
11 12
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Appendix 5. Concordance findings: individual symptoms 
 
Kendler 
et al. 1997
Burke 
et al. 1996
Tsuang 
1967
Fouldrin
et al. 2001
Leboyer 
et al. 1992
Loftus 
et al. 2000
Deficit vs Non deficit: Chi-square (Wald) = 5.34, df=1, p=0.02; OR=3.35,
95%CI=1.2-9.34 
Individual symptoms: Hallucinations (r=0.05, p=0.16); delusions (r=0.16, p=0.02);
Schneiderian delusions (r=0.16, p=0.02); positive thought disorder (r=0.23,
p=0.002); catatonic symptoms (r=0.11, p=0.04); affective deterioration (r=0.13,
p=0.02); negative thought disorder (r=0.15, p=0.02); depressive symptoms (r=0.28,
p=0.002); manic symptoms (r=0.43, p=0.0001); illness course (r=0.15, p=0.02); 
outcome (r=0.25, p=0.003)
Intra-pair correlation results: Negative symptom factor (negative thought disorder, 
flat affect, anhedonia, avolition): Case notes: p<0.05, r=0.226 (0.228 with
Corrections for unreliability) Interview data: p<0.01, r=0.258 (0.261); Disorganised
Symptom factor (inappropriate affect, positive thought disorder): Case notes: 
p<0.01, r=0.299 (0.280) Interview data: p=NS, r=0.127 (0.154); Reality distortion 
factor (hallucinations, delusions): Case notes: p<0.001, r=0.335 (0.447) Interview 
data: p=NS, r=0.071(0.079); Age of onset: Case notes: p<0.01, r=0.259 Interview 
data: p<0.01, r=0.242; Depressive symptoms: Case notes: p=NS, r=0.127 
Interview data: p=NS, r=0.095; Manic symptoms: Case notes: p<0.05, r=0.229 
Interview data: p=NS, r=-0.014; Outcome: Interview data: p<0.05, r=0.177
*Interview data reflects data gathered during direct interview of subject
** Case notes refer to data extracted from case notes
Results not applicable since wide diagnostic categories, but catatonia (p=0.025-
0.0125) and affective symptoms (p=0.0125-0.005)(depression alone p=0.005-
0.0025)
Deficit vs non-deficit: Chi-square=6.4, p<0.02, one-tailed (non-Caucasian group = 
Chi-square=2.1, p=NS)
DSM-R, DSM-II-R, ICD-10, Tsuang-Winokur subtypes=NS (slight excess of classic
paranoid/hebephrenic); Age of onset intrafamilial correlation: F=2.54, p=0.0007
Post-hoc Chi-square results: 3rd person auditory hallucinations p=0.05; control
p=0.02; broadcasting p=0.04
Ross et
al. 2000
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Hwu 
et al. 1997
DeLisi 
et al. 1987
Cardno 
et al. 1998
Kendler &
Adler 
1984
Loftus
et al. 1998 Krawiecka scale results: Positive symptoms (delusions + hallucinations) NS; disorganised symptoms (inappropriate affect + positive thought disorder) Chi-square
=9.15, p<0.01, phi=0.28 and when weighted Chi-square=8.69, p=0.01, phi=0.31; 
negative symptoms (poverty of speech + flat affect) NS; affective symptoms (mood 
elation + depression) NS; 1st Rank symptom results: audible thoughts NS, running
commentary NS, passivity experiences NS, 3rd person auditory hallucinations
NS, thought withdrawal NS, thought insertion NS, thought broadcasting NS,
delusional pre-occupation and made feelings NS
Positive symptom group (DHS)(hallucinations and delusions): Kappa=0.3, Random
error=0.3 and Kappa=0.55, RE=0.56 when controlled for negative symptoms; 
Negative symptom group (NGS) (flat affect + alogia + asociality – used global score):
Kappa=0.29, RE=0.35; If severe negative symptoms only (SNGS): Kappa=0.35, 
RE=0.43; Thought disorder (TDS): Kappa=0.21, RE=0.3 and Kappa=1.00, RE=1.00 
(controlled for negative symptoms) DHS+NGS+TDS is not independent
Concordance analysis results: diagnosis (schiz/schiz vs schi-affect/schiz-affect)
Chi-square=5.44 p=0.025; Visual hallucinations Chi-square=5.3, p<0.025 (p=0.15 
after multiple test correction), major depression Chi-square=8.16, p<0.005; auditory
hallucinations NS, paranoid delusions NS, thought disorder NS, negative symptoms
NS; Type 1 and 2 NS, Predominantly positive vs negative symptoms NS; age of 
onset r=0.39, p<0.004
Schizophrenia subtypes (paranoid/hebephrenic/undifferentiated and paranoid/
hebephrenic and paranoid-like/hebephrenic-like and type I/type II/mixed and 
1st rank symptoms present or absent) NS; SAPS/SANS scores (NS) for 
Inappropriate affect, affective flattening, alogia, hallucinations, delusions, bizarre 
behaviour, positive formal thought disorder NS; OPCRIT symptoms catatonia, 
speech difficult to understand (K=0.26, SE=0.1for schizophrenia group only), 
positive and negative thought disorder, restricted/inappropriate affect, persecutory 
delusions, grandiosity (K=0.21, SE=0.11 for schizophrenia group only), delusions of 
influence (K=0.23, SE=0.1 for schizophrenia group only), passivity and nihilism, 
bizarre delusions, thought insertion and broadcast, 3rd person voices, commentary
and abusive voices, other auditory hallucinations, any other hallucinations; affective
symptoms NS; age of onset (n=80, r=0.26, p=0.02); same-sex pairs NS; premorbid 
adjustment (K=0.23, SE 0.11); GAS (worst ever rating) (r=0.34, p=0.001)  
Paranoid versus non-paranoid (n=12) according to ICD-9 (Z=1.73, p=0.04), 
DSM-III (Z=1.59, p=0.056), Tsuang-Winokur (Z=0.11, NS) significant for sib pairs 
but not sibships
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APPENDIX 6. RESULTS FROM LATENT CLASS ANALYSIS 
 
Kendler 
et al. 1997
Class 1 
(Chi-square = 8.3)
Class 2
(Chi-square = 4.3)
Class 3
(Chi-square = 3.1)
High affective
High mania 
Moderate positive symptoms
Low negative symptoms
Very low poor outcome 
Late onset
High negative symptoms
High flat affect
High negative thought disorder
High catatonic symptoms
Low affective deterioration
Poor course and outcome
High positive and negative symptoms
Prominent delusions
Prominent flat affect
Prominent thought disorder
Class 4
(Chi-square = 0.3)
Class 5
(Chi-square = 9.1)
Very low negative symptoms
Low positive symptoms
Low affective deterioration
Late onset
Relative good outcome
High catatonic symptoms
High negative thought disorder
High flat affect
Very low negative symptoms
Remitting relapsing course
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APPENDIX 7. FACTOR ANALYSIS RESULTS 
Kendler 
et al. 1997
Fouldrin
et al. 2001
Negative symptom factor
(concordance: r=0.21, p=0.0007)
Positive symptom factor
(concordance: r=0.16, p=0.005)
Affective/manic symptom factor
(concordance: r=0.27, p=0.0001)
Affective deterioration +  poor outcome
+ chronic course + negative thought disorder
Hallucinations + any delusion + Schneiderian
delusions
Manic symptoms + positive thought disorder
Burke 
et al. 1996
Negative symptom factor
(analysis of variance: p=0.026 for 
case notes; p=0.025 for interview data
Reality distortion factor
( p=0.011 for case notes,
p=NS for interview data)
Disorganised symptom factor
( p=0.008 for case notes
p=NS for interview data)
Negative thought disorder, flat affect,
anhedonia, avolition
Hallucinations,  delusion
Inappropriate affect, positive thought disorder
Factor 1
49.8% of variance
Concordance: r=0.21, p=0.03
Factor 2
16.9% of variance
Concordance: NS
Thought broadcasting (0.83), 
Thought insertion (0.81)
Thought withdrawal (0.88),
delusions of control (0.72) 
If only sib 1 and 2 (delusions of 
control = 0.52)
3rd person (0.76)
Running commentary (0.69)
Thought echo (0.74)
If only sib 1 and 2 (delusions of 
control = 0.51)  
 144
   
CHAPTER 4  
 
CAN STUDIES IN THE XHOSA POPULATION 
HELP TO LIMIT THE HETEROGENEITY OF 
SCHIZOPHRENIA? SUITABILITY AS A STUDY 
POPULATION 
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1. THE XHOSA: A CONTEXTUAL HISTORY 
 
The Xhosa is the southernmost indigenous African population belonging to 
the Nguni linguistic group and is the second largest African grouping within 
South Africa.  It is estimated that the Nguni linguistic grouping (to which the 
Zulu also belongs) split linguistically 2000 years ago.  The large Xhosa-
speaking population of South Africa offers researchers a unique opportunity to 
study schizophrenia in a homogeneous population with an apparently 
common ancestry [1].  Since the first reported genealogical records (King 
Tshawe ruled the Xhosa in the sixteen hundreds), internal revolts have led to 
the political fragmentation of the Xhosa kingdom, although the cultural norms 
remained largely intact.  In addition to internal revolts the Xhosa was also 
closely linked to the protracted frontier wars and has played a key role in 
shaping the political landscape of South Africa through decades of protest 
action and the successful transformation to political and social freedom in 
1994 [1].  The socio-political situation in South Africa contributed to the 
relative geographic isolation in homelands within the Eastern Cape and 
townships in the major South African cities, thus ensuring a relatively 
homogenous cultural and genetic constitution.  
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2. THE XHOSA CULTURE AND SCHIZOPHRENIA 
2.1. BACKGROUND 
Early descriptions of the traditional Xhosa people revealed unique cultural 
norms with an emphasis on communal interests (“ Ubuntu” ) rather than 
individual autonomy, and strong beliefs in supernatural powers [1-3].  
Although the intricacies of culture fall outside the focus of this study, it would 
seem prudent that the reader have at least some insight into the influence of 
culture on the experience, interpretation of symptoms and subsequent health 
seeking pathways since these may have an influence on the conduct and 
outcome of studies within a culturally defined grouping such as the Xhosa.  
For a detailed analysis of the cultural influences on mental health, it is 
proposed that the reader study “ Culture and mental health: a Southern 
African view”  by Leslie Swartz (1998) [3] and “ Frontiers”  by Noël Mostert 
(1992) [1].  This discussion will focus on the influence of culture and belief 
systems on the perception regarding and treatment of schizophrenia within 
the Xhosa population. 
 
 
2.2. BELIEFS AND ATTITUDES TO SCHIZOPHRENIA 
The Xhosa population, as is the case with Caucasian populations, seems to 
have misconceptions regarding the causes and treatment of schizophrenia, as 
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is evident from studies conducted in lay communities and in Xhosa patients 
and their families [4-9].   
 
In a parallel study in the Xhosa population, the author and his colleagues 
found that the misconceptions seem to differ among various cultural 
groupings.  Studies in German lay people [10-12] found that they regard 
schizophrenia as being caused mainly by psychosocial stressors and 
biological and intra-psychic factors.  This contrasts with the parallel study 
conducted by the author and his colleagues on 100 caregivers or close family 
members of Xhosa patients with schizophrenia [13]. 
  
The participants were interviewed by a trained psychiatric nurse who visited 
the family at home and administered a structured questionnaire (English 
version) that was based on the work of Angermeyer and Matshinger et al. 
(1993, 1996) [5;14;15].  It focused on the respondents’  views on the causes, 
treatment options and course of schizophrenia.  The responses to the 29 
questions were recorded as yes, no or unsure.  Two additional items in the 
treatment section (a. the use of traditional healers' services and b. traditional 
rituals) assessed the role of traditional healing methods. 
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The respondents (76% female; mean age 61.1 (±13.0); 6.0 (±3.5) years of 
schooling; 59.2% mothers and 21.4% fathers) ascribed the development of 
schizophrenia to various causes (Table 1).   
 
TABLE 1. PERCEIVED CAUSES OF SCHIZOPHRENIA IN 100 
CAREGIVERS OR CLOSE FAMILY MEMBERS OF XHOSA PATIENTS 
WITH SCHIZOPHRENIA  
 Yes No Unsure 
Family relationship problems 12* 46 42 
Work difficulties 13 68 19 
Stressful events 38 40 22 
Brain disease 46 41 13 
Heredity 34 50 16 
Lack of will power 10 72 18 
Expecting too much of oneself 14 82 4 
Unconscious conflicts 3 84 3 
Being brought up in broken home 25 59 16 
Lack of parental affection 31 54 15 
Over protective parents 19 75 6 
Loss of traditional values 29 56 15 
Loss of a natural way of life 3 84 13 
Will of God  31 49 20 
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Witchcraft, evil spirits 67 18 15 
Being poisoned 37 48 15 
Signs of the Zodiac 2 52 46 
*All values are percentages 
 
Witchcraft or possession by evil spirits (67%), brain disease (46%) and a 
stressful life event (38%) were the most commonly reported causes.  
Unconscious conflict (3%), loss of natural ways of life (3%) and signs of the 
Zodiac (2%) were uncommon responses.  Nevertheless, it is of interest that 
supposedly more “ biomedical”  or “ Western”  causes, such as stressful 
life-events (38%), broken homes (25%) and lack of parental affection (31%) 
were also endorsed.  This suggests a complex explanatory model for 
schizophrenia in the Xhosa population (3-8). 
 
The Xhosa layperson’ s explanatory models of disease are intimately related 
to cultural beliefs such as an acceptance of the phenomena of witchcraft and 
possession by evil spirits, and the notion that ancestors play an important role 
in protecting the community [16-21].  It is therefore not surprising that the 
respondents emphasized the role of witchcraft and evil spirits as a cause for 
schizophrenia.   
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It is accepted within the cultural belief system that the ancestors require 
appeasement with rituals.  According to Xhosa beliefs, neglecting such rituals 
may lead to withdrawal of ancestral protection and may even precipitate 
mental illness.   
 
It follows that the development of mental illness in this context is likely to be 
closely linked to "culture bound syndromes".  This term refers to any one of a 
number of recurrent, locality-specific patterns of aberrant behaviour and 
experiences that appear to fall outside conventional Western psychiatric 
diagnostic categories [22].  Most of these patterns are indigenously 
considered to be "illnesses” , and most have local names [23;24].  However, 
the illnesses coined "amafufunyana" and "thwasa" are not (yet) included in the 
Diagnostic and statistical manual of mental disorders (4th edition) [25] as 
"culture bound syndromes"; but they are nonetheless considered to be 
cultural phenomena and found in the indigenous African Xhosa population 
[3;26;27].  
 
"Thwasa", a condition characterized by social withdrawal, irritability and 
auditory hallucinations, is an important cultural phenomenon according to the 
Xhosa belief system [3;28].  Within the context of this specific culture, 
"thwasa" is seen as a calling to serve the ancestors as a traditional healer, 
suggesting that this is a special, but normal, event.  However, according to 
 152
   
traditional healers, resisting this calling by the ancestors may lead to illness, 
whereas complying with this "divine calling" confers special powers.  
 
The term "Amafufunyana", on the other hand, was originally described as "a 
hysterical condition characterized by people speaking in a strange muffled 
voice in a language that cannot be understood, and strange and unpredictable 
behaviour" [3;29].  Despite apparent overlap with schizophrenia [25], it was 
viewed as a condition without any equivalent in Western culture, and one that 
could not be fitted into Western classification systems [30;31].  
 
Given that different explanatory models may have contrasting implications for 
health seeking behaviour, it might be helpful to understand when and why 
these models (i.e. "amafufunyana" and "thwasa") are applied.  Cultural 
concepts, values and beliefs influence health-seeking pathways, and 
traditional healers play an important role in the management of disease in 
many cultures (e.g. the Xhosa) where “ Western”  medicine is either 
unavailable, viewed with scepticism or used in parallel with traditional 
treatment methods [32;33].  In many societies, it is common practice for 
patients and/or families to seek help from the traditional healer first, and then 
to turn to, or be referred to “ Western”  medicine if the traditional methods 
fail [32;34].  
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The frequency with which culture-specific models ("amafufunyana" and 
"thwasa") are used by traditional healers to explain schizophrenia in the 
Xhosa population had not been studied systematically prior to a parallel study 
by the author [35].  Two hundred and forty-seven subjects (62 female and 185 
male) were allocated to one of 3 groups, viz. an "amafufunyana"-group, a 
"thwasa"-group, and a group with diagnoses other than 
"amafufunyana"/"thwasa" based on structured questions on the use of 
traditional treatment.  The structured questions were based on the 
researchers’  clinical experience and made use of available collateral 
information.  The questions on the use of traditional diagnostic and treatment 
methods consisted of four open-ended questions (interviewer rated) focusing 
on the life-time use of services, the explanatory model or diagnosis given by 
the traditional healer, the suggested treatment (medication/other and dosage) 
and the period of compliance to this treatment.   
 
Two hundred subjects (80.97%) had used traditional diagnostic and treatment 
services and were included in this analysis (i.e. the 47 patients who had not 
seen a traditional healer were excluded).  Of these 200 participants, one 
hundred and six (53%) were diagnosed with "amafufunyana" (82 male and 24 
female), and nine (4.5%) as having "thwasa" (4 male and 5 female).  Two 
patients were diagnosed with both "amafufunyana" and "thwasa", and were 
therefore excluded from the study.  Eighty-three subjects (63 male and 20 
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female) received other diagnoses (e.g., the patient had been poisoned, had 
made the ancestors angry, etc.).  
 
The mean age at interview was 34.1 years (±8.0) for the "amafufunyana" 
group and 43.9 years (±6.8) for the "thwasa" group (p=0.001; t=-3.6).  The 
age of onset was similar in both groups (21.9 years [±4.6] versus 22.9 years 
[±5.8]).  Forty-nine percent of the "amafufunyana" and thirty-three percent of 
the "thwasa" group were living in urban areas.  The majority of subjects in 
both groups were single at the time of interview (101/106 [95.3%] and 8/9 
[88.9%] in the "amafufunyana" and "thwasa" groups, respectively).  Forty-four 
percent of the "thwasa" group and fifty-eight percent of the "amafufunyana" 
group were unemployed.  
 
Comparisons between the two groups based on the OPCRIT measurements 
indicated that a family history of schizophrenia (χ2=8.059, p=0.004) or other 
psychiatric disorders (χ2=9.899, p=0.008) was significantly more common in 
the "thwasa" group.  Fifty-four (50.9%) subjects in the "amafufunyana" group 
had a positive family history of schizophrenia compared to nine (100%) in the 
"thwasa" group.  Fifteen (14.2%) of the subjects in the "amafufunyana" group 
and five (55.6%) of those in the "thwasa" group had a family history of other 
psychiatric disorders (Table 2).  No significant differences were detected for 
the core symptoms of schizophrenia.   
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TABLE 2. PHENOMENOLOGICAL CHARACTERISTICS OF THE 
"AMAFUFUNYANA" AND "THWASA" GROUPS 
PHENOMENOLOGICAL 
CHARACTERISTICS 
"AMAFUFUNYANA" 
GROUP (N=106) 
"THWASA" GROUP 
(N=9) 
GROUP 
DIFFERENCES 
(STATISTICAL 
SIGNIFICANCE) 
Family history of 
schizophrenia 
50.9* 100 χ2=8.059 p=0.004 
Family history of other 
psychiatric disorders 
14.2 55.6 χ2=9.899 p=0.008 
Bizarre or aggressive behavior 82 88.9 NS 
Positive formal thought 
disorder 
37.7 55.6 NS 
Negative formal thought 
disorder 
77.4 88.8 NS 
Affective changes: 
Restricted 
Blunting 
Inappropriate 
 
47.2 
65.1 
16.9 
 
77.8 
55.6 
44.4 
 
NS 
NS 
NS 
Delusions: 
Persecutory delusions 
 
94.3 
 
77.8 
 
NS 
Grandiose delusions 46.2 55.6 NS 
Delusions of influence 63.2 44.4 NS 
Bizarre delusions 37.7 33.3 NS 
Hallucinations: 
Auditory (3rd person) 
 
68.9 
 
77.8 
 
NS 
Running commentary 59.4 55.6 NS 
Hallucinations (any) 80.2 88.9 NS 
NS  NO SIGNIFICANT DIFFERENCE DETECTED  
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*    Values given as percentages 
 
 
The “ amafufunyana”  and “ thwasa”  groups were combined and then 
compared with those subjects who had received other diagnoses from the 
traditional healers (n=83).  Significantly more individuals from the non-
“ amafufunyana/thwasa”  group were married (p=0.007), from a rural 
environment (p=0.005), had a definite stressor prior to onset of illness 
(p=0.022) and had a history of cannabis abuse/ dependence with 
psychopathology (p=0.022) (Table 3).  
 
TABLE 3. STRATIFICATION BASED ON THE PRESENCE OR ABSENCE 
OF AN "AMAFUFUNYANA/THWASA" DIAGNOSIS. 
PHENOMENOLOGICAL 
CHARACTERISTICS* 
"AMAFUFUNYANA / 
THWASA" PRESENT  
(N=115) 
"AMAFUFUNYANA / 
THWASA" ABSENT 
(N= 83) 
GROUP 
DIFFERENCES 
(SIGNIFICANCE) 
Married 5.2* 18.1 p=0.004; χ2=8.37 
Urban environment 47.8 28.9 p=0.007; χ2=7.31 
History of a definite 
stressor 
5.2 14.5 
 
p=0.026; χ2=4.93 
History of Cannabis 
abuse/dependency  
0.9 7.4 p=0.015; χ2=5.92 
*   values given as percentages 
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** Only significant differences shown 
 
 
Our findings indicated that, in this group of Xhosa patients with schizophrenia 
no symptoms significantly differentiated between the diagnoses 
“ amafufunyana”  and “ thwasa” .  On the other hand, in contrast to 
patients with "amafufunyana" or "thwasa", patients with neither of these 
diagnoses were more likely to live in an urban environment, to be married, 
and to have had identifiable stressors or substance abuse apparently 
predating psychotic symptoms.  
 
In the Xhosa culture, persons with a history of schizophrenia may be 
diagnosed as "thwasa" or “ amafunyana”  by the traditional healer.  Our 
findings suggest that psychotic symptoms may in some instances be 
perceived as "good" and in other instances as an illness condition 
necessitating treatment.  We found that subjects with a family history of 
schizophrenia or other psychiatric disorders were more likely to receive the 
diagnosis of "thwasa" than “ amafunyana” .  This suggests that psychotic 
symptoms are more likely to be seen as "abilities" or "giftedness" passed on 
from one generation to the next in the case of "thwasa", but as illness in the 
sporadic ("amafufunyana") cases. 
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It is important to realize that "thwasa", although seen as a potentially positive 
event, may herald the onset of schizophrenia and that the family members of 
such an individual may be at greater risk for the development of psychiatric 
disorders.  Furthermore, although "thwasa" is not considered an illness in the 
Xhosa culture, our data suggests that, in at least a subgroup of subjects, 
"thwasa" is indistinguishable from "amafufunyana" in terms of the core 
symptoms of schizophrenia.  
 
Rural married subjects with identifiable stressors were less likely to be 
diagnosed as having “ amafufunyana”  or “ thwasa” .  One explanation for 
this finding is that the traditional explanatory models were more likely to have 
been applied in the less Westernized, rural patients than in urban subjects.  
Another possible explanation is that these terms were less likely to have been 
used in patients with higher levels of premorbid functioning (e.g. married 
subjects) and in those in whom other, more apparent explanations for their 
symptoms could be offered.  Our study was not designed to address the 
question whether subjects with “ thwasa”  and “ amafufunyana”  do in fact 
have a less severe form of schizophrenia with a milder course and although 
corrections for multiple testing were not employed, the significant differences 
found are certainly consistent with our clinical experience. 
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The discipline of cross-cultural psychiatry emphasizes the importance of 
determining patients’  explanatory models of their symptoms [36;37].  
Although the application of standardized "Western" diagnostic criteria (DSM-
IV or ICD-10) to illness/disease presentation in other cultures has brought 
about a degree of consistency in patient management, the danger exists that 
the application of these theoretical frameworks may hinder detection of 
unfamiliar categories and downplay socio-cultural influences on nosology [38].  
Certainly, in Xhosa-speaking patients with schizophrenia, our data underline 
the value of ascertaining which cultural diagnosis has been given in terms of a 
higher risk for multiple affecteds within a “ thwasa”  family.  However, in 
terms of the clinical phenotyping the core symptoms remain indistinguishable.    
 
The use of cultural/traditional treatment methods requires our consideration 
for possible influences on the clinical phenotyping.  From information 
gathered as part of the above-mentioned study Mbanga et al. (2000) [39] 
concluded that although psychotropic medication was the most commonly 
recommended form of treatment in the Xhosa population, the vast majority of 
respondents (care-givers and family members) supported the simultaneous 
use of traditional treatment methods.  Respondents most commonly 
recommended treatment with psychotropic medications (88%), traditional 
healer's methods (32%) and rituals (30%).  Psychotherapy (4%) and 
 160
   
meditation (1%) were the treatment methods least often recommended (Table 
4).   
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TABLE 4. TREATMENT METHODS PREFERRED BY 100 CAREGIVERS 
AND FAMILY MEMBERS OF XHOSA PATIENTS WITH SCHIZOPHRENIA 
 Yes No Unsure 
Relaxation  25* 64 11 
Pull oneself together 6 82 12 
Talk it over 7 87 6 
Nature will cure it 2 91 7 
Meditation 1 55 44 
Psychotherapy 4 56 40 
Psychotropic medications 88 5 7 
Traditional healer 32 58 10 
Traditional rituals 30 61 9 
*  Values given as percentages 
 
Many felt that traditional healers' methods protected individuals from invasion 
by "bad spirits", but that Western treatments prevented the symptoms from 
worsening.  In fact 92% of participants who favoured traditional health care, 
also endorsed the simultaneous use of “ Western”  medicine.  Most family 
members (63%) became concerned when probands discontinued medication 
for a month, with some (32%) becoming worried after even a week of non-
compliance. Non-compliance was only seen as a problem one month after 
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medication discontinuation.  This may be explained partly by the fact that 
many probands in this study received depot preparations).   
 
Results obtained during the above-mentioned study [40] revealed that 198 
(84%) of 236 Xhosa schizophrenia sufferers (recruited throughout the 
Western, Southern and Eastern Cape; mean age 36,25 (SD±9,41; 75% 
males) admitted visiting a traditional healer during some stage of their illness 
and following the treatment prescribed by the healer.  Treatments varied 
considerably and included: oral solutions (n=109), emetics (oral solutions or 
tablets) (n=89), washing (n=61), enemas (n=33), inhalation therapy 
(“ steam” ) (n=24), snuff (n=23), cutting (n=14), wearing beads (n=7) and 
the slaughter of cattle (n=2).  Contrary to expectation, ancestral appeasement 
methods e.g., slaughter of cattle and brewing traditional beer were not 
commonly prescribed treatment methods.  The mean number of treatments 
per patient was 1.87 (SD±1,43).  It is worth mentioning that 60% of the 
subjects who had used traditional treatment methods were urban residents.  
Gender and urbanicity did not have a statistically significant influence on the 
treatment method of choice.  
 
Traditional healers clearly play an important role in the treatment of 
schizophrenia in this population.  The traditional healer’ s involvement in the 
diagnoses and treatment of schizophrenia may imply a holistic view of the 
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causation of mental illness [41].   Alternatively, it may be seen as an 
indictment of “ the reality of mental health care in a country with eleven 
official languages (in which the health care workers are) unable to 
communicate in a patient’ s home language” .   The use of traditional 
treatment methods is, however, not limited to this population.   A recent study 
in KwaZulu/Natal of 300 physiotherapy patients showed that 70% preferred to 
consult a traditional healer as their first choice [42].  Further north on the 
African continent, a Nigerian study [32] found that the general population 
favoured the involvement of traditional healers in the treatment process, while 
the majority (69%) of Malaysian patients presenting for the first time at a 
psychiatric clinic admitted to having visited a traditional healer (“ bomoh” ) 
prior to the clinic consultation [43].  
 
The use of multiple models and interventions can arguably be seen as 
representing a flexible and pragmatic response to the occurrence of a serious 
medical disorder.  Xhosa family members most commonly supported 
psychotropic medications and traditional healing methods (for example, rituals 
such as beer brewing and the slaughter of cattle), in contrast to the poor 
support for psychotropic medication in, for example, Germany [44-47].  
 
Despite the encouraging support for psychotropic medication, our previous 
studies revealed several stigmas and misconceptions related to the course of 
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the illness [48;49].  Family members were of the opinion that probands were 
more dirty (52%), weak (48%), unpredictable (45%), dangerous (44%), 
delicate (41%) or foolish (39%) than the "average person".  Furthermore, 
forty-one percent of respondents believed the natural course of schizophrenia 
to be one of remission with the possibility of relapse, while 24.2% believed 
that the disorder could be cured without medication.  Twenty eight percent of 
respondents stated that if optimal treatment were to be given, cure could be 
possible, with 30.3% holding that optimal treatment led to remission with the 
possibility of relapse.  Two possible interpretations could be postulated for 
these results, namely that a lack of knowledge of the course of schizophrenia 
exists or that the Xhosa may have a unique course of illness.  
 
The results of these studies should be interpreted keeping a number of 
important limitations in mind.  Family members were generally relatively old 
and poorly educated; generalization of results to younger, more educated 
respondents should therefore be made with caution.  This is partly reflected in 
the number of "unsure" responses to concepts such a meditation, signs of the 
zodiac and even psychotherapy.  Furthermore, the fact that interviewers were 
nurses may have biased respondents away from endorsing traditional beliefs 
and towards endorsing the importance of psychotropic medication. 
Nevertheless, our impression was that respondents were open and frank 
about their agreements and disagreements with the standard biomedical 
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model.  These studies furthermore relied on recall of past events and as such 
are vulnerable to recall biases.  
 
Nevertheless, taken together these data only partially support a biomedical 
explanatory model of schizophrenia as a disease of the brain in Xhosa 
patients and their caregivers, and that although some underlying familial 
pattern could be observed in the diagnostic preference of cultural diagnosis, 
the stigma associated with mental illness was still evident.  Furthermore, the 
culture-bound syndrome "amafufunyana" and the culture-specific 
phenomenon of “ thwasa”  were both used to explain symptoms in patients 
with schizophrenia (DSM IV).  "Thwasa" and "Amafufunyana" as explanations 
for schizophrenia may distinguish between familial and sporadic cases.  
Whether the positive connotations associated with “ thwasa” , as opposed to 
the more negative connotations associated with “ amafufunyana”  hold any 
implications for treatment or prognosis, as well as the possibility of a 
population specific course of illness, remains to be clarified.  
 
 
3. RESEARCH ETHICS AND THE XHOSA POPULATION 
Like ourselves, other researchers in the field of genetics have shown a 
growing interest in samples from homogeneous populations [50-52].  Such 
biogenetic research is fraught with sensitive ethical issues.  The ethics of 
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genetic and other biomedical research is usually guided by the Nüremberg 
paradigm [53;54].  The status and integrity of ethical research guidelines 
based on the Nüremberg (1947) and Helsinki (1964) Codes, and later 
revisions thereof, are well established. However, strict adherence to the 
Nüremberg paradigm may at times be inappropriate [55].  For example, where 
the research population is non-Western and does not have a strong Judeo-
Christian orientation, the effect of the guidelines may be in direct conflict with 
the values of the relevant culture.  A case in point is the current emphasis on 
the right of autonomy of the individual in modern Western culture.  This 
Western individualism may not find favour in those cultures and subcultures 
that value communal interests rather than individual interests and as such 
conflict with the needs of the Xhosa population.   
 
Other problems associated with adhering to the Nüremberg paradigm whilst 
doing psychiatric research in general [56;57], and psychiatric genetic linkage 
studies in particular [58], have been highlighted.   For example, the difficulty 
involved in obtaining informed consent from people who have a diagnosis of 
schizophrenia is well-known to researchers in psychiatry [59;60].  For consent 
to be legally and ethically acceptable, individuals must understand the true 
meaning of what is communicated to them.  This implies that the method of 
communication, and the content of the message, must be appropriate to the 
participants' culture, language, cognitive abilities, academic qualification and 
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so forth.  In a study involving a large number of persons with schizophrenia as 
well as their family members, it is perhaps inevitable that when contacted, 
some probands are likely to be experiencing an episode of active illness.  
Some patients may not be competent to provide informed consent by virtue of 
the fact that they are psychotic at the time of evaluation.  In others, their 
clinical condition may have deteriorated to such an extent that they are no 
longer capable of understanding the information, or deciding rationally.   
 
In genetic research, further ethical problems are frequently encountered.  For 
instance, intrusion into research subjects’  personal lives is often 
unavoidable, and interviewers may reveal information of which the subjects 
may prefer to have remained ignorant.  There is at least a theoretical risk that 
significant distress may precipitate relapse.  
 
Preparing research protocols for use in different cultures is likewise 
problematic.  First, the concept of culture is fundamental to the understanding 
of mental illness.   While there is reason to believe that universal biophysical 
conditions exist, culture shapes the final presentation of these disorders [61].  
The meanings people give to their symptoms are a product of their 
interactions with other members of their culture, their beliefs, their customs 
and the symbols of their culture [62].  Second, in genetic research projects, 
information about biological family members of probands is essential.  
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Knoppers (1993) [63] points out that genetic research  requires reconstruction 
of biological pedigrees, during which process “ family secrets”  may be 
revealed.   
 
Finally, in some cultural settings individual autonomy is subsumed by 
collective or substituted decision making.  Therefore, while the prevailing 
current thinking in Western cultures emphasises the right of the individual to 
make decisions, some non-Western cultures believe that the clan, or head of 
the clan, should give such consent. The principle of cultural relativism 
suggests that researchers should consider the cultural beliefs of subjects and 
adjust procedures accordingly.  However, the use of cultural relativism to 
obviate the need to obtain informed consent from subjects has been criticized 
[64;65].  These critics point out that cultures are in a dynamic process of 
change and that many assumptions about specific cultures are based on 
dated anthropological data.  Another problem in respect of cultural relativism 
is the fact that people within a specific culture may be at different levels of 
acculturation.  Today it is therefore not possible to generalise within a culture.  
In fact, as Bodibe (1993) [66] demonstrates, specific individuals within a 
culture may have reached different stages of acculturation in respect of 
various aspects of their of functioning.  Bodibe (1993) [66] describes how he, 
an urbanised person with postgraduate qualifications in psychology who had 
adopted Christian practices, paradoxically felt the need to engage in 
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traditional practices when his paternal grandfather died: paradoxically, 
because the premises of these traditional practices go against Christian and 
rational Western thinking.  Therefore, while there is a need to be cautious 
about blind adherence to the principle of cultural relativism, researchers dare 
not ignore cultural diversity. 
 
 
 
4. THE XHOSA SCHIZOPHRENIC: APPROPRIATENESS FOR 
RESEARCH ON CLINICAL PHENOTYPING 
Taken together, the available data suggest that (1.) the Xhosa population 
seems to be a culturally homogenous group, given the historical and 
geographic influences that formed this group, (2.) the traditional belief 
systems are still active but do not seem to critically influence the presentation 
of the core symptoms of schizophrenia, (3.) the traditional belief systems do 
however raise questions to the possibility of a population specific course of 
schizophrenia both in terms of the “ culturally sanctioned”  “ thwasa”  and 
the perception of family members on the course of schizophrenia, (4.) finally, 
if the possible ethical issues are carefully considered the Xhosa population 
should provide an appropriate basis for a phenotypical subtyping study of 
schizophrenia. 
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CHAPTER 5  
 
CAN STUDIES IN XHOSA SIB PAIRS HELP TO 
LIMIT THE HETEROGENEITY OF 
SCHIZOPHRENIA? LESSONS LEARNT FROM 
COMORBIDITY WITH OBSESSIVE-COMPULSIVE 
DISORDER AND SUICIDE ATTEMPTS.  
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1. BACKGROUND 
Schizophrenia is a heterogeneous disorder, which is diverse in its phenotypic 
manifestations.  Since the development of the first operational criteria (first 
rank symptoms) for the diagnosis of schizophrenia, several revised criteria 
have been proposed, the DSM-IV (APA) and ICD-10 being two of the most 
extensively employed [1].  The use of operational diagnostic criteria has not 
adequately addressed the heterogeneity of schizophrenia, judging from the 
nine-fold increase in diagnosis when the most liberal of these criteria are used 
as opposed to the most conservative [2].   
 
In a classic example of the influence of phenotyping on genetics, Cardno et al. 
(2002) [3] studied 224 twin pairs from the Maudsley Twin Register for lifetime 
ever first rank symptoms, using the OPCRIT system.  They found a 
concordance rate of 26.5% for monozygotic twins and 0-4.3% for same-sex 
dizygotic twins, giving a heritability estimate of 71% (95% CI, 57-82%). This 
was lower than estimates arrived at when the following diagnostic criteria 
were used: RDC (82% CI, 71-90%), DSM-III-R (84% CI, 19-92%) and ICD-10 
(83% CI, 7-91%).  Even though heritability estimates vary depending on the 
diagnostic criteria used, calculating concordance rates in mono- and dizygotic 
twins offers some degree of consistency in research protocols and has thus 
been used in the search for genetic liability factors.  
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2. COMORBID OCD AND SUICIDAL BEHAVIOUR IN 
SCHIZOPHRENIA 
Two specific comorbid clinical entities, namely OCD and suicide attempts, 
allow us to investigate clinical heterogeneity in terms of criteria that rely on 
memory recall, observed behaviour and collateral information.  Furthermore, 
OCD is of interest as a prototype for genetic subtypes since OCD and 
schizophrenia share a possible common etiological factor in chromosome 
22q11-13.  This interesting chromosomal area is known for micro-deletions 
that are associated with an increased risk for schizophrenia and OCD [4].  In a 
sib pair study this would be a valuable departure point for future chromosomal 
analysis in this population.  Suicidal behaviour has a genetic component, but, 
in contrast to conceptions regarding OCD, several researchers believe that 
the environmental loading is significantly higher than that for OCD [5;6]. 
 
 
The neurobiology of diagnostic overlap may offer new insights into the 
pathophysiological process underlying these disorders, and have implications 
for the treatment and functional outcomes of these patients [7;8]. 
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3. COMORBID OCD IN SCHIZOPHRENIA  
The reported prevalence of OCD in patients with schizophrenia varies 
between 7.8% and 31.7% [8;9].  Eisen et al. (1997) [10] reported that when 
obsessions were defined as "persistent unwanted ideas not related to 
delusions", 7.8% of personally interviewed patients with schizophrenia or 
schizoaffective disorder (n=77) (SCID DSM-III-R) met the criteria for OCD.  
Using DSM-IV criteria, Bermanzohn et al. (2000) [11] found that 29.7% of 
consecutively admitted chronic schizophrenia patients met criteria for OCD.   
Community surveys such as the ECA study (n = 20 861) have yielded an 
OCD co-occurrence rate of 23.7%, but the measurement instrument used 
(DIS) did not contain diagnostic hierarchy rules [12].   In a study that did 
include diagnostic hierarchy rules (SCID - DSM-IV), 14% of 50 first episode 
schizophrenia, schizophreniform or schizoaffective patients met criteria for 
OCD [13].  Comparisons between studies and estimates of prevalence rates 
have been complicated by differences in study design (chart review versus 
direct interview, patient versus community samples, schizophrenia versus 
schizophrenia spectrum subjects, lay versus clinician assessments, cross-
sectional versus longitudinal design) and differences in the ways in which 
OCD was diagnosed (symptoms as opposed to disorder).  Nevertheless, 
calculated co-morbidity rates support the conclusion of many studies that 
comorbidity of OCD with schizophrenia is more than an incidental finding [14-
16] and raises the question of whether shared susceptibility factors, such as 
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dopamine dysregulation, characterize patients with comorbid OCD and 
schizophrenia.  
 
Studies to date have focused primarily on Caucasian patients.  Both 
schizophrenia and OCD are disorders with significant commonality across 
different cultures and ethnicities [17;18].  Nevertheless, there is some 
evidence of variation in the phenomenology of schizophrenia across ethnic 
groups [19], and it has also been suggested that OCD may be less common 
in certain communities [20;21].  To date, however, there has been little 
rigorous study of comorbid OCD in non-Caucasian patients with 
schizophrenia. 
   
 
4. SCHIZOPHRENIA AND COMORBID SUICIDAL BEHAVIOUR 
Suicidal behaviour is a large contributor to the mortality and morbidity of 
schizophrenia.  Although this phenomenon has an impact throughout the 
lifespan, it is especially significant in the first 10 years of illness [22].  Previous 
studies suggest that 18-55% of patients with schizophrenia attempt suicide, 
with 10%-13% succeeding, often after multiple attempts [23;24].   Indeed, the 
risk seems to be particularly high where a history of a previous suicide 
attempt exists, as well as in the period immediately after an acute psychotic 
episode and in the first 6 months after hospitalization [22;25].  
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Other reported risk factors for suicide include male gender, substance 
use/abuse, longer duration of untreated psychosis, the presence of mood, 
negative or psychotic symptoms and loss of social support systems 
[23;26;27].  The general population trend towards an excess of male suicide 
completers is less pronounced in schizophrenia, but is still present [28].  
However, no gender bias is present in the rates of attempts [23].  
 
Various studies have examined the influences of substance abuse, mood, 
positive symptoms and negative symptoms on suicide risk.  The findings 
regarding substance abuse and negative symptoms are inconclusive [29-31], 
but depressed mood and major depressive episode probably increase suicide 
risk in an already vulnerable individual [32].   
 
Positive symptoms on the other hand do exert a causative effect on suicidal 
behaviour [33;34], the majority (78%) of suicide completers experiencing 
psychotic symptoms at the time of suicide [35;36].  Reports indicate that 4% 
of patients with schizophrenia who engage in suicidal behaviour do so in 
response to command hallucinations, while 10% do so because of the 
distress caused by positive symptoms [37;38].   Research thus suggests a 
stress-diathesis model, whereby, when faced with environmental stressors, 
already vulnerable individuals engage in suicidal behaviour [39].  
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Several authors suggest that heritability of suicidal behaviour in schizophrenia 
is low; non-shared environmental factors may contribute to suicidal behaviour 
to a greater degree than shared familial  (including genetic) factors [6].  The 
investigation of schizophrenia sib pairs may prove useful in efforts to 
distinguish between shared and non-shared risk factors for suicidal behaviour.  
It is notable that previous studies dealing with concordance of clinical 
symptoms or demographic variables in schizophrenia sib pairs did not 
specifically report on suicidal behaviour (see chapter 3). 
  
Therefore, the data collected and published parallel to this study not only 
afforded us an opportunity to further investigate the universality of 
demographic risk factors for suicidal behaviour as well as the role of affected 
sibship status, but also a chance to broaden our knowledge base with regards 
to this indigenous African population. 
 
 
5. OCD AND SUICIDE ATTEMPTS IN A XHOSA POPULATION 
 
The author previously investigated suicidal behaviour and OCD in an earlier 
cohort of 454 participants included in the current study (Niehaus et al. in 
press).  This study is briefly described here, in order to highlight the possible 
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role that these factors might play in the search for shared familial factors.  
Two hundred and eight individuals (165 males and 43 females) constituting 
100 sib ships (95 pairs, 2 trios, 3 fours) were evaluated.  The pairs consisted 
of 65 same-sex (61 male-male and 4 female-female) and 30 opposite sex 
pairs.  The two trios comprised male participants only, while the fours had a 
mixed gender make-up (4 males; 3 males and one female; 3 males and one 
female).  
 
In order to examine predictors of suicidal behaviour, logistic regression was 
performed.  The following explanatory variables were employed in the model: 
socio-economic status, gender, religion, education, occupation, marital status, 
living arrangements, number of children, age of onset and duration of illness, 
number of suicide attempts and lethality of the most serious attempt.  Taking 
into account that some of these subjects were from the same sibship, 
Generalized Estimating Equations were used to deal with the correlated 
nature of the data.  The sibship responses were assumed to be equally 
correlated, implying an exchangeable correlation structure. 
 
First, a univariate model was fitted and the parameter estimates presented for 
each explanatory variable.  All explanatory variables with a p<0.25 were 
considered for the multiple model.  A sequence of models was fitted resulting 
in a multiple model with the estimates indicating the independent contribution 
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of the specific explanatory variable to the model.  All estimates, which were 
significant at the 5% level, were retained in the model.   
 
The sibship group did not differ significantly from the total group in terms of 
the demographic variables listed in Appendix 1A.  Ninety (19.8%; 21 female 
and 69 male) participants from the total group reported one or more suicide 
attempt (mean = 1.3; SD=0.8).  Thirty (14.6%; 21 male and 9 female) 
individuals from the one hundred sibships reported one or more suicide 
attempt. This was significantly fewer individuals than from the non-sib pair 
group (z=-2.41; p=0.016).  Four of the sib pairs (none of the trios or fours) 
were concordant for suicide attempts (mean number of attempts 1.25 [SD 0.5; 
Range 1-3]).  No concordance for suicide method was noted.  
 
Of the demographic variables tested, only marital status and age of onset of 
illness predicted suicide attempts in a univariate model (Appendix 1 A&B).  
Separation, divorce or no previous marriage increased the risk for suicide 
attempts significantly (z=-2.11; p=0.0345), with earlier age of onset (before 26 
years of age) showing a similar association (z=-2.65; p=0.008).  Religious 
affiliation, schooling, occupational status, living arrangements and parenthood 
did not predict suicide attempts (Appendix 1A&B). 
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The univariate model (Table 1) indicated that marital status, age of onset and 
sib pair status may contribute to an increased risk for suicide attempts.  
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TABLE 1 A AND B. NUMBER OF SUICIDE ATTEMPTS AND LETHALITY OF 
MOST SERIOUS ATTEMPT  
A. NUMBER OF SUICIDE ATTEMPTS 
   Number of Attempts 
Variable  N 0 1 More than 1 
No 248 188 (76%) 50 (68%) 10 (4.0%) Part of Sib pair 
Yes 206 176 (85%) 24 (12%) 6 (2.9%) 
 
B. LETHALITY OF MOST SERIOUS SUICIDE ATTEMPT 
  Lethality 
  N No attempt No 
danger 
Minimal 
danger 
Average 
Danger 
Average 
to serious
Very 
serious 
No 240 188 (78%) 9 (4%) 12 (5%) 6 (3%) 13 (5%) 12 (5%)Part of 
sib pair Yes 201 176 (88%) 6 (3%) 3 (1%) 4 (2%) 6 (3%) 6 (3%) 
 
 
The multiple model (Table 2) excluded marital status as an independent risk 
factor.  However, age of onset (< 26 years) (Odds ratio 2.5) and not being part 
of a sib ship (Odds ratio 1.7) significantly increased the risk for suicide 
attempts in this group of schizophrenic subjects.  Furthermore, the non-
sibship group reported about one and three quarters as many suicide 
attempts as the sibship group (z=2.3, p=0.02, 95%CI: 1.1 to 2.8).  The data 
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indicated that “ the most serious suicide attempt”  reported in the non-
sibship group was more lethal than that of found in the sibship group (z=2.5, 
p=0.01, OR=1.9; 95% CI: 1.2 to 3.2) (Table 1 A and B).  In addition to the 
environmentally based statistical model, the presence of comorbid mood, 
anxiety and substance abuse or dependency symptoms were considered but 
showed no significant association with suicide attempts.  
 
TABLE 2. PREDICTORS OF SUICIDE ATTEMPTS IN XHOSA PATIENTS 
WITH SCHIZOPHRENIA: A MULTIPLE MODEL 
Variable Parameter 
estimate 
SE Z P Odds 
ratio 
95% CI 
Age of 
onset  < 
26 years 
0.915 0.364 2.51 0.012 2.5 1.2 to 5.1 
Not part of 
sib ship 
0.538 0.260 2.07 0.038 1.7 1.0 to 2.9 
 
 
In this study, the prevalence of comorbid OCD in schizophrenia was very low 
in the Xhosa ethnic group (0.002%), with no concordance noted.  However, 
prevalence rates have tended to vary widely depending on patient and 
disease characteristics.  A recent study in hospitalized patients with chronic 
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schizophrenia found a 23.5% prevalence of OCD, while a 3.8% prevalence of 
OCD was documented in patients with first-admission psychosis [40]. Tibbo et 
al, (2000) [41] reported a 25% rate of OCD in a community sample of patients 
with schizophrenia.  However, despite the low rate, the four patients meeting 
criteria for OCD in our study displayed similar symptom patterns (as described 
in the case studies) to those reported in previous studies [42].  The low rate of 
comorbid OCD (1.2%) was partly supported by a study in two groups of South 
African male patients of mixed ethnic origin [43].  The first group of 
participants (n=24) had first-episode psychosis (schizophrenia, schizo-
affective disorder or schizophreniform disorder) and the second group (n=63) 
schizophrenia with at least one previous admission for a psychotic episode.  
Only one patient (diagnosis of schizophrenia; male; treatment-naive) in the 
first-episode (5%) and none in the multiple episode group fulfilled criteria for 
OCD.   
 
Only one participant was diagnosed with obsessive compulsive disorder.  This 
patient, who was in the non-sibship group, fulfilled the criteria for OCD in the 
relevant section of the DIGS.  He was a thirty-two year old, unmarried Xhosa 
male, with seven years of schooling, and was receiving a disability grant.  The 
patient had previously been treated for pulmonary tuberculosis (no temporal 
relationship to onset of symptoms).  Positive symptoms of psychosis had 
been present since the age of 19, but there was uncertainty regarding 
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prodromal symptoms.  The patient had experienced two prior episodes of 
psychosis (in 1985 and 1996/1997), with inter-episodic residual symptoms.  
Psychotic symptoms included auditory (more than two voices), tactile and 
gustatory hallucinations.  Delusions were paranoid and somatic in theme and 
included delusions of control (mind reading, thought broadcasting, thought 
insertion and thought withdrawal).  At interview, disorganized behaviour, 
echolalia, avolition, alogia and blunted affect were present.  He reported two 
previous suicide attempts occurring at the age of 16 years (non-psychosis 
linked) and 22 years (related to command hallucinations).  He had received 
treatment with trifluoperazine (15mg/day) and orphenadrine (100mg/day) for 6 
years.   
 
Apart from the psychotic symptoms, the patient also reported overwhelming 
intrusive thoughts about the cleanliness of his face. These intrusive thoughts 
had been present since his psychotic symptoms first appeared.  During 
psychotic episodes he experienced tactile facial sensations described as 
"itchiness", which he tried to relieve by repeated cleansing with various 
traditional medications, soaps and even abrasive material.  The latter had 
caused substantial scarring of his face.  Other compulsive behaviours 
included washing of clothes, bathing rituals, ordering, checking of doors and 
windows, compulsions related to symmetry, and pathological doubt.   These 
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concerns consumed more than one hour per day.   No other anxiety disorder 
was present.     
 
 
6. CONCLUSION 
The novel findings of a very low prevalence of obsessive-compulsive disorder 
and the protective nature of affected sibships on suicide attempts makes it 
possible that this population may yield unique susceptibility factors and clinical 
phenotypes,   
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APPENDIX 1 A. PREDICTORS OF SUICIDE ATTEMPTS 
IN XHOSA SCHIZOPHRENICS 
Suicide Attempt No Yes Parameter 
estimate 
SE Z P 
Total sample 
(N=460*) 
364 
(80.2%) 
90 (19.8%)     
  0.014 0.28 0.05 0.962 
349 69 (19.8%)     
Gender 
                   Male   
               Female 105 21 (20.0%)     
  -0.558 0.540 -1.03 0.304 
17 5   (29.4%)     
Religion 
                  None 
                  Any 433 85 (19.6%)     
  -0.223 0.256 -0.87 0.385 
276 59 (21.4%)     
Schooling (in 
years)           0-8 
        More than 8 162 29 (17.9%)     
  -0.229 0.309 -0.74 0.459 
350 71 (20.3%)     
Occupation 
Disability support 
Any other 91 15 (16.5%)     
  0.974 0.461 2.11 0.0345** Marital status 
    Widow/married 55 5   (9.1%)     
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    Sep/div/never    
    married 
391 84 (21.5%)     
  -0.613 0.254 -2.41 0.016** 
248 60 (24.2%)     
Part of sibpair 
                    No 
                    Yes 206 30 (14.6%)     
 
 
 -0.272 0.292 -0.93 0.352 
344 73 (21.2%)     
Living arrangement 
       With parents 
       Other 
100 17 (17.0%)     
  -0.936 0.354 -2.65 0.008** 
321 77 (24.0%)     
Age of onset*** 
                 11-25 
                 26-53 105 12 (11.4%)     
  -0.107 0.319 -0.33 0.738 
92 20 (21.7%)     
Children 
        None 
        Any number 151 31 (20.5%)     
 
 
 0.070 0.239 0.09 0.769 
216   44 (20.4%)     
Duration of illness 
        < 13 years 
        >= 13 years    
209 45 (21.5%)     
* Insufficient data in six patients (excluded for this analysis) 
**parameter values are significant at the 5% level 
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Appendix 1 B. *** Subjects with previous suicide 
attempts and the age of onset of schizophrenia 
Total number of 
subjects in age 
group 
Subjects with 
previous suicide 
attempt 
  20   6 (30.0%) 
145 31 (21.4%) 
156 40 (25.6%) 
  64   7 (10.9%) 
Age of onset **** 
 
               11-15 
               16-20 
               21-25 
               26-30 
               31-53  
  41   5 (12.2%) 
**** Subjects excluded if age of onset unsure 
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CHAPTER 6  
 
METHODOLOGY 
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6.1 METHODOLOGY OVERVIEW 
The following diagrammatic overview of the study is given here to serve as an 
outline of the research methods used.  
 
 
Recruitment 
 
513 Xhosa patients with schizophrenia were recruited as part of a large multi-site 
genetic study.  This sample was then divided into 104 affected sibling pairs 
(n=214 participants) and 299 patients with schizophrenia without an affected sib  
 
 Phenotyping 
 
 
 Statistical analysis (A) 
 
Descriptive statistics: demographic 
and clinical data of sibling pairs   
 
 
Statistical analysis (B) 
 
Factor analysis of SANS/SAPS items in the non-sib pair group and 
then in the sib pair group so that any factor unique to the sib pair 
group could then be analyzed for concordance within the sib pair 
group 
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Statistical analysis (C) 
 
Failing the identification of any unique factor, concordance analysis 
of the individual items from the SANS/SAPS was done.  Items with 
higher than expected concordance were further analyzed in terms of 
the influence of confounding variables, including gender. 
   
 
 
 
 
Interpretation of results  
Items or factors with higher than expected 
concordance were discussed in terms of 
t f i ib i ti
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6.2 STUDY SUBJECTS 
Subjects were recruited from in- and outpatient hospital services and 
community clinics throughout the Western, Southern and Eastern Cape 
Provinces of South Africa as part of a large multi-site genetic study.    
 
Potential participants had to be of Xhosa ethnicity (all of the grandparents of 
Xhosa origin), have one living parent and suffer from schizophrenia (Table 1: 
Inclusion/Exclusion Criteria).   
 
 
TABLE 1.  INCLUSION/EXCLUSION 
CRITERIA 
 
Inclusion criteria 
 
A. Diagnosis of schizophrenia (DSM-IV Criteria)  
B. In the case of affected sib pairs, participation of both siblings was 
required. 
C. Xhosa ethnic origin (4/4 grandparents reported as of Xhosa origin) 
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D. Inclusion depended on written approval for participation from the 
patients or their legal caregivers. 
E. Various stages of illness allowed 
 
Exclusion criteria  
 
A. Patients with known organic aetiology were excluded. 
B. Patients were excluded if they had prominent mood symptoms that 
could obscure the distinction between schizophrenia, schizo-
affective disorder and bipolar mood disorder.  
Mental health workers were asked to identify all possible participants, who 
were then screened for suitability and diagnosed according to DSM IV criteria 
[1].  Patients and their parents were included in the study after providing 
written, informed consent.  The father and/or mother and/or unaffected sib of 
the proband were contracted to the study in order to provide phenotypical and 
genealogical information.  
 
 
6.3 ASSESSMENT 
6.3.1 PRIMARY ASSESSMENT MEASURE  
The Diagnostic Interview for Genetic Studies (DIGS), version 2.0 [2] was the 
primary diagnostic tool and provided the basis for statistical analysis of clinical 
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measurements.  The DIGS is a clinical assessment tool designed for 
diagnosing major mood and psychotic spectrum disorders and includes the 
Schedule for the Assessment of Negative Symptoms (SANS) and the 
Schedule for the Assessment of Positive Symptoms (SAPS), validated 
assessment scales for positive and negative symptom complexes [3;4] 
(Appendix 1).  The interviewers also used hospital chart records (where 
available) and information gathered from family members, to supplement 
these interviews.  Relevant demographic data, medical history, treatment 
history and pedigree information were collected from the proband and family. 
 
A trained psychiatrist and/or Xhosa psychiatric nurse with extensive clinical 
experience interviewed each participant, using an English (oral translation to 
Xhosa) version of the standardized instrument (DIGS).  Where necessary, the 
help of an interpreter was utilized.   In order to maintain optimal rating 
consistency over the two-year period of recruitment, all subjects were 
assessed by both raters simultaneously during the first year of the study, 
followed by regular calibration meetings during year two.  
 
 
6.4 DATA ANALYSIS 
The goal of this study was to improve our understanding of the shared familial 
factors (genetic and non-genetic) implicated in schizophrenia.  As early as 
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1984, Risch and Baron suggested a polygenic (possibly even oligogenic) or 
mixed model for the development of schizophrenia [5].  The estimated 
components of variance for both of these models suggested that genes 
contributed more than 80%, while common sib environment (6.9% and 6.6% 
respectively) and random environment (11.2% and 11% respectively) 
accounted for only a small percentage of the variance [5-7].   
 
Given that sibling pairs share approximately half their genes, the use of 
affected sibling pairs enriches the genetic risk factors within the sample and 
findings will thus be less likely to reflect random environmental contributions.  
This study therefore allowed for the possibility of identifying “ more strongly 
familial”  subtypes based on exploratory factor structure and concordance 
analysis.  This study focuses only on the role of studies of sib pairs in the 
establishment of clinical subtypes of schizophrenia.   However, a non-sib pair 
group of patients with schizophrenia (n=299) was used to establish a baseline 
against which to measure the findings from the factor analysis of the SANS 
and SAPS.  Differences between the sib pair and non-sib pair groups in terms 
of certain factors would be of interest since these factors may suggest a 
shared familial underpinning (shared genes or shared sib environment).  Any 
factors that occur only in the sib pair group would then have to be evaluated in 
terms of their concordance within the sib pair group and, if concordance 
between siblings is established, the possible genetic or shared sib 
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environmental factors that may account for this.  Since this study forms part of 
a larger effort to identify the genetic causes of schizophrenia, such distinctive 
factors would serve as a benchmark against which candidate genes could be 
tested.   
 
6.4.1 VARIABLES 
6.4.1.1 DEPENDENT VARIABLES 
 
The initial primary dependent variables of interest were the clinical ratings of 
schizophrenic symptoms, assessed by the individual and global items of the 
SAPS and SANS, in both the sib pair (n=214) and non-sib pair group (n=299). 
 
 
6.4.1.2 INDEPENDENT VARIABLES 
The independent variables of interest were the various demographic (see 
6.4.2.1) and clinical (see 6.4.2.2) variables assessed by the DIGS. The non-
sib pair group’ s clinical data obtained from the DIGS forms part of another 
study.   
 
6.4.1.3 POTENTIAL CONFOUNDING FACTORS 
Potential confounding factors (age of onset, duration of illness, age at 
interview and gender) were identified prior to the analyses and were taken 
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into account during the factor analysis and concordance analysis of the 
gender groups. 
 
 
6.4.2 DESCRIPTIVE ANALYSIS  
6.4.2.1 DEMOGRAPHIC DATA 
Descriptive statistics were computed for the following demographic variables 
in the sib pair group: gender, geographic distribution, mean age at interview, 
level of education, religious affiliation, marital status and current employment. 
 
 
6.4.2.2 CLINICAL DATA 
Clinical variables such as medical and developmental difficulties, age of 
onset, presence of prodromal symptoms, number of psychotic episodes, 
number of hospitalizations, presence of residual symptoms, and the full DSM-
IV criteria for schizophrenia were assessed.  Comorbid diagnoses were 
assessed in terms of lifetime prevalence.  The presence of any significant 
mood or anxiety symptoms (i.e., fulfilling DSM-VI symptom descriptions) was 
noted and patients were classified as either category 1. absence of any 
symptom, or category 2. presence of any symptom.  Unsure responses or 
lack of collateral information were weighed up clinically by the investigators for 
classification into either category 1 or 2.   
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6.4.3 EXPLORATORY FACTOR ANALYSIS FOR POSITIVE AND 
NEGATIVE SYMPTOMS 
The study design allowed for an exploratory factor analysis of global and 
individual scores on the SANS and SAPS rating scales.  Only two sibs per 
sibship were used (n=208).  In sibships with more than one sib pair, only one 
pair was extracted (1st and 2nd to be evaluated).  This method was chosen, 
because it was considered the best way to ensure geographic proximity of 
study subjects during assessment and increase our chances of identifying 
shared familial factors.   
 
Principal component analysis was done (on the sib pair and non-sib pair 
group separately) on the nine global ratings and then on the individual items 
of the SANS and SAPS.  Alogia and concentration were excluded from the 
analysis based on previous published methodology and results [8;9].  Age of 
onset and duration of illness were taken into account as potential confounding 
factors for the principal component analysis.  The factor solution was then 
rotated using the varimax procedure.   
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6.4.4 CONCORDANCE ANALYSIS  
The sib pairs were used for further concordance analysis of sib pair specific 
factors identified in the factor structure solution.  The SANS and SAPS items 
(see Appendix 1) were dichotomised as follows:   
A rating of 0 or 1 was rated as absence of symptom 
Ratings of 2 or greater were rated as presence of symptom 
For these categorical variables, the observed distributions were compared to 
those expected under the null hypothesis (random distribution into three 
categories) using the chi-square test (one degree of freedom) [10] in the sib 
pair group.  
 
 
6.4.5 ANALYSIS OF CONFOUNDING VARIABLES 
Items that remained concordant after adjustment for the prevalence of 
individual symptoms were then assessed for the confounding influence of age 
at interview, years of schooling, age of onset, duration of illness, number of 
episodes, presence of any substance abuse or dependency, presence of 
significant mood symptoms, significant anxiety symptoms and a stressor prior 
to onset of illness.   
 
The sample was subdivided into male-male male-female subgroups in order 
to control for the possible confounding effect of gender. 
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The sib pair sample (male-male and male-female group separately) was then 
subdivided into groups concordant and disconcordant for presence and 
absence of the specific confounding variables.  Expected and observed 
concordance for each of the SANS/SAPS items were determined and 
compared (Chi-square method).  Concordant items that were not influenced 
by these variables were then considered candidates that could be used for 
subtyping schizophrenia, based on shared familial factors. 
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6.5 ETHICAL CONSIDERATIONS 
 The study formed part of a large multi-national effort to identify the genetic 
risk factors involved in schizophrenia and complied with the stringent ethical 
norms laid down by the Ethical Committee of the University of Stellenbosch 
(Project number: 97/005; Appendix 2). 
.   
The study procedures and aims were explained in lay terms to patients and 
their caregivers or legal guardians. Informed consent was accepted to be in 
order only if patients could understand and communicate this understanding 
to the researchers.  Legal guardians/caretakers were also asked to give 
consent if doubt existed as to any patient’ s competence in this regard.  
 
Participation was voluntary and a request for withdrawal was immediately 
effective upon receipt of such request.  The conclusions of the study are 
available to all participating individuals, should they require them.  
Participating individuals did not incur any costs. 
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APPENDIX 1.  SANS AND SAPS SCALES 
See SANS coding definitions (N. Anderson, 1984). 
Interviewer:  Ratings are to be based on the last 30 days 
 
 NONE                  SEVERE 
Affective Flattening or Blunting  
 
1. Unchanging Facial Expression 
The patient's face appears wooden-changes less than 
expected as emotional content of discourse changes 
0 1 2 3 4 5 U
2. Decreased Spontaneous Movements 
The patient shows few or no spontaneous movements, 
does not shift position, move extremities, etc 
0 1 2 3 4 5 U
3. Paucity of Expressive Gestures 
The patient does not use hand gestures or body 
position as an aid in expressing his ideas. 
0 1 2 3 4 5 U
4. Poor Eye Contact 
The patient avoids eye contact or stares through 
interviewer even when speaking. 
0 1 2 3 4 5 U
5. Affective Nonresponsivity 
The patient fails to laugh or smile when prompted. 
0 1 2 3 4 5 U
6. Inappropriate Affect 
The patient's affect is inappropriate or incongruous, 
not simply flat or blunted. 
0 1 2 3 4 5 U
7. Lack of vocal Inflections 
The patient fails to show normal vocal emphasis 
patterns, is often monotonous 
0 1 2 3 4 5 U
8. Global rating of Affective Flattening 
This rating should focus on overall severity of 
symptoms, especially unresponsiveness. 
Inappropriateness and an overall decrease in emotional 
intensity.  
0 1 2 3 4 5 U
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ALOGIA  
 
9. Poverty of Speech 
The patient's replies to questions are restricted in 
amount, tend to be brief, concrete, unelaborated. 
0 1 2 3 4 5 U
10. Poverty of Content of Speech 
The patient's replies are adequate in amount but tend 
to be vague, over concrete or over generalized, and 
convey little in information. 
0 1 2 3 4 5 U
 
 
SANS CODES 
0 - None/Not at all 
1 - Questionable 
2 - Mild 
3 - Moderate 
4 - Marked 
5 - Severe 
U - Unknown/ 
      Cannot Be Assessed/ 
      Not Assessed 
 
 
11. Blocking 
The patient indicates, either spontaneously or with 
prompting, that his train of thought was interrupted.  
0 1 2 3 4 5 U
12.  Increased Latency of Response 
The patient takes a long time to reply to questions, 
prompting indicates the patient is aware of the 
question. 
0 1 2 3 4 5 U
13. Global Rating of Alogia 
The core features of alogia are poverty of speech and 
poverty of content. 
0 1 2 3 4 5 U
NONE                  SEVERE 
 
AVOLITION / APATHY  
 
14. Grooming and Hygiene 
The patient's clothes may be sloppy or soiled, and he 
0 1 2 3 4 5 U
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may have greasy hair, body odor, etc. 
15. Inpersistance at Work or School 
The patient has difficulty seeking or maintaining 
employment, completing school work, keeping house, 
etc. If an inpatient cannot persist at ward activities, 
such as OT, playing cards, etc.  
0 1 2 3 4 5 U
16. Physical Anergia 
The patient tends to be physically inert. He may sit for 
hours and not initiates spontaneous activity. 
0 1 2 3 4 5 U
17. Global Rating of Avolition/ Apathy 
Strong weight may be given to one or two prominent 
symptoms if particularly striking 
0 1 2 3 4 5 U
 
 ANNEDONIA / ASOCIALITY
 
 
18.  Recreational Interests and Activities 
The patient may have few or no interest. Both the 
quality and quantity of interests should be taken into 
account. 
0 1 2 3 4 5 U
 
 
SANS CODES 
0 - None/Not at all 
1 - Questionable 
2 - Mild 
3 - Moderate 
4 - Marked 
5 - Severe 
U - Unknown/ 
      Cannot Be Assessed/ 
      Not Assessed 
 
 
NONE                  SEVERE 
 
19. Sexual Activity 
The patient may show decrease in sexual interest and 
activity, or no enjoyment when active. 
0 1 2 3 4 5 U
20. Ability to Feel Intimacy and Closeness 0 1 2 3 4 5 U
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The patient may display and inability to form close or 
intimate relationships, especially with opposite sex 
and family.  
21. Relationship with friends and Peers 
The patient may have few or no friends and may prefer 
to spend all his time isolated. 
0 1 2 3 4 5 U
22. Global Rating of Anhedonia / Asociality 
The rating should reflect overall severity, taking into 
account the patient's age, family status, etc. 
0 1 2 3 4 5 U
 
ATTENTION  
 
 
23. Social Inattentiveness 
The patient appears uninvolved or unengaged. He may 
seem "spacey". 
0 1 2 3 4 5 U
24. Inattentiveness During Mental Status Testing 
Refer to tests of "Serial 7" at least five subtractions 
and spelling "world" backwards 
0 1 2 3 4 5 U
25. Global Rating of Attention 
This rating should assess the patient's overall 
concentration, both clinically and on tests. 
0 1 2 3 4 5 U
 
SANS CODES 
0 - None/Not at all 
1 - Questionable 
2 - Mild 
3 - Moderate 
4 - Marked 
5 - Severe 
U - Unknown/ 
      Cannot Be Assessed/ 
      Not Assessed 
See SAPS Manual for detailed coding definitions (N. Andresson, 1984). 
 
NONE                  SEVERE 
HALLUCINATIONS  
 
 
1. Auditory Hallucinations 0 1 2 3 4 5 
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The patient reports voices, noises, or other sounds that 
no one else hears 
2. Voices Commenting 
The patient reports voices which makes a running 
commentary on his behavior or thoughts 
0 1 2 3 4 5 
3. Voices Conversing 
The patient reports hearing two or more voices 
conversing. 
0 1 2 3 4 5 
4. Somatic or Tactile Hallucinations 
The patient reports experiencing peculiar physical 
sensations in the body. 
0 1 2 3 4 5 
5. Olfactory Hallucinations  
The patient reports experiencing unusual smells which 
no one else notices. 
0 1 2 3 4 5 
6. Visual Hallucinations 
The patient sees shapes or people that are not actually 
present. 
0 1 2 3 4 5 
7. Global Rating of Hallucinations 
This rating should be based on the duration and 
severity of the hallucinations and their effects on the 
patient's life.  
0 1 2 3 4 5 
 
DELUSIONS 
 
 
8. Persecutory Delusions 
The patient believes he is being conspired against or 
persecuted in some way. 
0 1 2 3 4 5 
9. Delusions of Jealousy 
The patient believes his spouse is having and affair 
with someone. 
0 1 2 3 4 5 
10.Delusions of Guilt or Sin 
The patient believes that he has committed some 
terrible sin or done something unforgivable. 
0 1 2 3 4 5 
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11.Grandiose Delusions 
The patient believes he has special powers or abilities. 
0 1 2 3 4 5 
 
 
SAPS CODES 
0 - None/Not at all 
1 - Questionable 
2 – Mild 
3 - Moderate 
4 - Marked 
5 - Severe 
 
 
NONE                   SEVERE 
 
 
12. Religious Delusions 
This patient is preoccupied with false beliefs of a 
religious nature. 
0 1 2 3 4 5 U 
13. Somatic Delusions 
The patient believes that somehow his body is 
diseased, abnormal, or changed. 
0 1 2 3 4 5 U 
14. Delusions of References 
The patient believes that insignificant remarks or 
events refer to him or have special meaning. 
0 1 2 3 4 5 U 
15. Delusions of being controlled 
The patient feels that his feeling or actions are 
controlled by some outside force. 
0 1 2 3 4 5 U 
16. Delusions of Mind Reading 
The patient feels that people can read his mind or 
know his thoughts. 
0 1 2 3 4 5 U 
17. Thought Broadcasting 
The patient believes that his thoughts are broadcast so 
that he himself or other can hear them. 
0 1 2 3 4 5 U 
18. Thought Insertion 
The patient believes that thoughts that are not his own 
have been inserted into his mind. 
0 1 2 3 4 5 U 
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19. Thought Withdrawal 
The patient believes that thoughts have been taken 
away from his mind. 
0 1 2 3 4 5 U 
20. Global Rating of Delusions 
This rating should be based on the duration and 
persistence of the delusions and their effect on the 
patient's life. 
0 1 2 3 4 5 U 
 
BIZARRE BEHAVIOR 
 
 
 
21. Clothing and Appearance 
The patient dresses in an unusual manner or does other 
strange things to alter his appearance. 
0 1 2 3 4 5 U 
22. Social and Sexual Behavior 
The patient may do things considered inappropriate 
according to usual social norms (e.g., masturbating in 
public. 
0 1 2 3 4 5 U 
 
SAPS CODES 
0 - None/Not at all 
1 - Questionable 
2 - Mild 
3 - Moderate 
4 - Marked 
5 – Severe 
U - Unknown/ 
      Cannot Be Assessed/ 
      Not Assessed 
 
 
NONE                   SEVERE 
 
 
23. Aggressive and Agitated Behavior 
The patient may behave in an aggressive, agitated 
manner, often unpredictable. 
0 1 2 3 4 5 U 
24. Repetitive or Stereotyped Behavior 
The patient develops a set of repetitive actions or rituals 
that he must perform over and over. 
0 1 2 3 4 5 U 
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25. Global Rating of Bizarre Behavior 
This rating should reflect the type of behavior and the 
extent to which it deviates from social norms. 
0 1 2 3 4 5 U 
 
POSITIVE FORMAL THOUGHT DISORDER  
 
 
26. Derailment 
A pattern of speech in which ideas slip off track onto 
ideas obliquely related or unrelated. 
0 1 2 3 4 5 U 
27. Tangentiality 
The patient reply’s to a question in an oblique or 
irrelevant manner.  
0 1 2 3 4 5 U 
28. Incoherence 
A pattern of speech that is essentially 
incomprehensible at times. 
0 1 2 3 4 5 U 
29. Illogically 
A pattern of speech in which conclusions are reached 
that do not follow logically. 
0 1 2 3 4 5 U 
30. Circumstantiality 
A pattern of speech that is very indirect and delayed in 
reaching its goals. 
0 1 2 3 4 5 U 
31.  Pressure of Speech 
The patient’s speech is rapid and difficult to interrupt, 
the amount of speech produced is greater than that 
considered normal. 
0 1 2 3 4 5 U 
32. Distractible Speech 
The patient is distracted by nearby stimuli, which 
interrupt his flow of speech.  
0 1 2 3 4 5 U 
33. Changing 
A pattern of speech in which sounds rather than 
meaningful relationships govern word choice. 
0 1 2 3 4 5 U 
34. Global Rating of Positive Formal Thought Disorder 0 1 2 3 4 5 U 
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The frequency of this rating should reflect the 
frequency of abnormality and degrees to which it 
affects the patient’s ability to commicate.  
 
SAPS CODES 
0 - None/Not at all 
1 - Questionable 
2 – Mild 
3 - Moderate 
4 - Marked 
5 - Severe 
U - Unknown/ Cannot Be 
Assessed/ Not Assessed 
 
 
 232
   
CHAPTER 7 
 
RESULTS 
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1. DEMOGRAPHIC CHARACTERISTICS OF THE 
SUBJECTS 
 
Five hundred and thirteen Xhosa individuals with schizophrenia participated in 
the global study and were stratified into two samples: a sib pair group and a 
non-sib pair group (comparator group).  Two hundred and fourteen 
participants (41 [19.2%] female and 173 [80.8%] male) formed part of the 
sibling pair sample, and were included in the further analysis of the role of 
sibling pairs in identifying shared familial factors.   Twenty two percent of the 
siblings were recruited from the Greater Cape Town area and 14.4% from 
Port Elizabeth and East London, while the majority of patients were from rural 
Western, Southern and Eastern Cape areas.  
  
The majority of the siblings were single (78%), only 13.6% being married at 
the time of the interview.  Three percent were separated or divorced and 
another three percent widowed. Sixty-nine of the participants had children 
(range of 1-8 children; mean 1.46; SD 1.78).  Most patients stayed with their 
parent(s) (74.8%) or other relatives (5.6%).  Only 1% was in residential care 
and 3.3% were staying alone.  More than 90% of the participants were 
affiliated to a religious movement or church.  Seventy eight percent of the 
participants received disability grants and eleven percent were unemployed, 
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but not receiving disability allowances.  The remainder were either gainfully 
employed (5.8%) or students (1.4%).  Participants completed an average of 
6.8 (SD 3.02) years of schooling.  Approximately six percent of the 
participants had attained a level of education of grade twelve or higher (0.5% 
had some kind of tertiary education) and a similar percentage had never 
attended school.   
 
The age at interview (n=205; see footnote2) ranged from 17 to 70 years of 
age (mean 37.8 years SD 9.32; not significantly different from the non-sib pair 
group).  At the time of interview participants had been ill for a mean period of 
14.5 years (SD 8.71; range 6 months to 45 years; age at onset 23.2 [SD5.4]).  
 
 
2. CLINICAL FEATURES OF SIBLING PAIRS 
All clinical features reported in this chapter relate to lifetime symptoms and not 
merely to symptoms elicited at the time of interview, except for those rated in 
the SANS and SAPS which is linked to the previous 30 days and symptoms 
elicited at the time of the interview. 
 
 
2.1 PSYCHOSIS 
                                                 
2 Number of patients that was able to provide information.  Age of onset shown in Table 9. 
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In 17.7% of cases no history could be elicited regarding the prodromal period.  
Almost a quarter of the group had a sudden onset (less than 1 week before 
onset of overt psychosis), while 6% had a gradual onset lasting more than 6 
months.  Eight percent of cases reported a stressful life-event as the 
precipitating factor.  These events included marital or relational conflict (n=4), 
significant losses (death, financial) (n=6), pregnancy (n=6), stress associated 
with studies (n=3), cannabis use (n=1) and court cases, riots and assault 
(n=2).    
 
Most patients reported 1 or 2 episodes of psychosis (mean 2.5; SD 1.63; 
range 0 to 12) and the number of hospitalizations ranged from none (9.4% of 
the sample) to fourteen times (0.5% of the sample; mean 2.6; SD 2.34; 
n=177).  
 
The lifetime duration of florid psychosis (sum of episodes of psychosis) varied 
considerably (range 2 weeks to more than 500 weeks; mean duration 28.5 
(SD 66.8) weeks).  Twenty five percent of the subjects were floridly psychotic 
at the time of the interview.  Very few participants (3%) denied residual 
symptoms.  Establishing the exact duration residual symptoms was difficult 
within this patient group and only 57 individuals were able to give reliable 
information (mean = 231.7 (SD 225.8) weeks; range 2 weeks to 700 weeks).  
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2.1.1 DELUSIONS 
Eighty eight percent of subjects had experienced paranoid delusions during 
their lifetime, while grandiose (55%), religious (46.7%) and reference content 
(51.1%) was also found in a substantial proportion of the sibs.  The least 
common delusions involved erotomanic (8.3%) and nihilistic delusions 
(13.3%) and jealousy (11.7%) delusions (Figure 1).   
 
FIGURE 1. PERCENTAGE OF INDIVIDUAL CASES FROM THE SIB PAIR 
GROUP WITH A LIFE-TIME HISTORY OF SPECIFIC DELUSIONS  
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2.1.2 Hallucinations 
Auditory hallucinations had been experienced by 97.2% of the sibs.  The 
commonest types were those that were of a commentary nature (56.1%) and 
conversing voices (56.1%).  Patients reported hearing noises in 21.1% of 
cases and command hallucinations in 19.4% of cases.  A substantial 
proportion (46.7%) of the participants complained that the voices had a 
threatening nature.  Visual hallucinations had occurred in the majority of 
patients (56.7%).  Tactile hallucinations were also surprisingly common 
(45.6%) (Figure 2). 
 
FIGURE 2. PERCENTAGE OF INDIVIDUAL CASES FROM THE SIB PAIR 
GROUP WITH A LIFE-TIME HISTORY OF SPECIFIC HALLUCINATIONS 
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2.2 Behavioral features 
The vast majority of participants (96.7%) reported some behavioral 
abnormalities, of which aggression (verbal and physical) was the most 
common complaint (78.3%).  Bizarre behaviour, including hoarding (n=21) 
and arson (n=27), had occurred in half of the patients, while catatonic 
symptoms were reported in a third of the sample.  Stupor and excitement had 
occurred in 15.6% and 17.8% of patients, respectively (Figure 3).     
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Figure 3. Percentage individual cases from the sib pair group with a life-time 
history of specific catatonic symptoms 
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2.3 THOUGHT DISORDER 
Thought disorder occurred in 57.2% of the sample, while another 13.5% had a 
history suggestive of thought disorder (Figure 4). 
 
 
FIGURE 4. PERCENTAGE OF INDIVIDUAL CASES FROM THE SIB PAIR 
GROUP WITH A LIFE-TIME HISTORY OF SPECIFIC THOUGHT 
DISORDER SYMPTOMS  
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2.4 Affective changes 
Varying degrees of affective flattening was reported in 78.4% of this group 
(Figure 5). 
 
FIGURE 5.  PERCENTAGE OF CASES FROM THE SIB PAIR GROUP WITH 
SPECIFIC AFFECTIVE FLATTENING SCORES ON THE SANS 
 
 
Inappropriate affect was confirmed from collateral information and seen by the 
interviewer in 21.6% of the sample.  In an additional 4.4% of cases affect was 
possibly inappropriate.  The majority were mildly to markedly affected (Figure 
6). 
 246
   
 
 247
   
FIGURE 6.  PERCENTAGE OF CASES FROM THE SIB PAIR GROUP WITH 
SPECIFIC INAPPROPRIATE AFFECT SCORES ON THE SANS   
 
Alogia was noted in 72.6% and was almost evenly spread across the mild to 
markedly affected spectrum (Figure 7). 
 
FIGURE 7. PERCENTAGE OF CASES FROM THE SIB PAIR GROUP WITH 
SPECIFIC GLOBAL ALOGIA SCORES ON THE SANS 
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Avolition and anhedonia were found in approximately 80% of the participants 
(Figure 8). 
 
FIGURE 8.  PERCENTAGE OF CASES FROM THE SIB PAIR GROUP WITH 
SPECIFIC GLOBAL AVOLITION/APATHY SCORES ON THE SANS   
 
 
Concentration difficulties were reported in 25% of the sample. 
 
2.5 SUBTYPES 
The clinical impression of the interviewers was that the undifferentiated 
subtype (DSM-IV) occurred most commonly (49%).  Eight subjects fulfilled the 
criteria for the catatonic subtype and 22.5% for the disorganized subtype. 
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After compilation of all data sources two individuals had a history suggestive 
of schizo-affective disorder.   
 
 
2.6 TREATMENT 
The participants used a wide range of medications.  Only a small minority 
(4.3%) denied taking their prescribed or suggested medication.  In 10% of 
subjects, reliable information regarding medication use could not be obtained, 
because neither the patients nor the records could provide us with this 
information. Figure 9 shows the types of medication used at the time of 
interview.  Depot antipsychotics were still by far the most common treatment 
chosen by medical practitioners.  Surprisingly, fewer than 5% of patients used 
clozapine.     
 
FIGURE 9. BAR CHART SHOWING THE PERCENTAGE OF CASES FROM 
THE SIB PAIR GROUP USING VARIOUS MEDICATIONS 
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* Note that 54 of these patients used a combination of depot and oral antipsychotics. 
 
The depot antipsychotics were commonly used in combination with oral 
antipsychotic medication.  Four cases received clozapine in combination with 
depot antipsychotics. 
 
Slightly more than 20% of the participants used anticholinergic medication.  
Mood stabilizers were given to eight patients and antidepressants to three.  
 
2.7 COMORBID CONDITIONS 
2.7.1 MEDICAL CONDITIONS AND EARLY DEVELOPMENTAL INCIDENTS 
Twenty percent of the participants reported significant medical illnesses.  A 
history of respiratory illness (14 pulmonary tuberculosis and 4 for other 
respiratory illnesses) was the most commonly reported medical illness.  The 
others included convulsions (n=9), gastro-intestinal complaints (n=8), 
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hypertension (n=6), orthopaedic problems (n=3), head injuries (not related to 
the onset of schizophrenia) (n=2), ear nose and throat conditions (n=1) and 
arthritis (n=1).   
 
Early developmental incidents occurred in five percent of the participants 
(n=8).  Of these, five cases of antenatal and intra-partum complications 
(including pre-eclampsia, forceps delivery and prematurity) were reported.  
One patient was born with dysmorphic feet.  One patient was described as 
mildly mentally retarded, three had slow milestones and one had experienced 
significant difficulties at school.  
 
 
2.7.2 SUBSTANCE ABUSE AND DEPENDENCY 
Twenty seven percent of participants had a history of possible substance 
abuse or dependency (cannabis and/or alcohol).   Alcohol abuse was present 
in 3.4% of the participants and it was suspected –  but not confirmed by 
collateral information - in anther 3.4%.  Only 2% of the sample admitted to 
symptoms consistent with a diagnosis of alcohol dependence and another 
0.5% were suspected of being dependent on alcohol during their lifetime.  
 
Cannabis abuse was more prevalent, with confirmed abuse diagnosed in 
2.9% of cases and almost 9% giving a history suggestive of current or past 
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cannabis abuse.  Only 3.4% admitted to cannabis dependence while the 
history provided by another 0.5% suggested cannabis dependence. 
 
Most (69.2%) participants had a history of tobacco smoking.  
 
 
2.7.3 COMORBID MOOD AND ANXIETY DISORDERS  
Almost five percent of the siblings were diagnosed with mood disorders 
(adjustment disorder with a depressed mood, dysthymia, major depression, 
hypomania or mania) while in another 11.1% mood disorders was suspected. 
 
Almost four percent of the participants had symptoms of anxiety disorders 
(panic disorder, phobias), while another 7.2% of this group gave a history of 
suspected anxiety disorders. No OCD cases were identified in the sib pair 
group.  The prevalence of OCD in the sample (combined sib and non-sib 
groups) was 0.2%.  
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3. COMPARATOR GROUP 
3.1 SIMILARITIES BETWEEN THE SIB PAIR AND NON SIB PAIR 
GROUPS 
In order to establish a baseline and to identify possible confounding factors in 
a later analysis, the sib pair and non-sib pair samples were compared in terms 
of demographic features (Appendix 1) and the global items of the SAPS and 
SANS (factor analysis).  The non-sib pair group was similar to the sib pair 
group in that there was a predominance of male participants (non-sib pair 
group = 75.6% males) and subjects were mostly unmarried (82.9%), living 
with relatives (66.8%) and receiving disability allowances (72.9%).  
 
Seasonality of birth: Neither the sib pair group nor the non-sib pair group 
demonstrated increased birth rates during the southern hemisphere winter 
months, as determined by the monthly birth interval.  However, a control 
group from the general population is needed before any definite conclusions 
can be drawn.  Peaks were observed in January (non-sib group most 
pronounced) and June (Figure 12). 
 
FIGURE 12A.  SIB PAIR GROUP: MONTH OF BIRTH  
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FIGURE 12B.  NON-SIB PAIR GROUP: MONTH OF BIRTH 
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Careful examination of the birth dates revealed that an excess of births 
occurred on the 1st January (n=12) and the 6th June (n=7).  This is in line with 
anecdotal information that the Department of Home Affairs allocates fictitious 
birth dates to individuals where these are unknown.  The most common dates 
were 1 January (10 births in non-sib pairs and 2 births in the sib pair group) 
and 6 June (7 births in the non-sib pair group and 5 in the sib pair group). 
Other smaller peaks were observed for 8 August (n=3 in non-sib pair group), 
12 December (n=4 in non-sib pair group), 25 December (n=4 in non-sib pair 
group) and 3 March (n=3 in the non-sib pair group).  Two other dates were 
also more commonly reported, namely 1 March (n=5 in non-sib pair group) 
and 20 October (n=3 in sib pair group).   
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3.2 DIFFERENCES  
There were only a few significant differences between the two groups.  The 
mean age at interview was significantly greater in the sib pair group (37.8 
years [SD = 9] versus 35 years [SD = 10] and the mean number of years of 
schooling also differed between the groups (7.7 years for non sib pair group 
vs 6.7 years for the sib pair group; p=0.001).  
 
 
4. SAPS AND SANS: EXPLORATORY FACTOR ANALYSIS OF 
THE SIB PAIR GROUP AND NON-SIB PAIR (COMPARATOR) 
GROUP 
4.1 DESCRIPTION OF SIB PAIR GROUP EXTRACTED FOR 
FACTOR ANALYSIS 
Out of the 513 schizophrenic subjects, 104 affected sibships (100 pairs, 2 
trios, 2 fours) could be assembled.  The sibling pairs consisted of sixty-seven 
same-sex (64 male-male and 3 female-female) and thirty three opposite sex 
pairs.  The trios consisted of males only and the fours of three males and one 
female each.  One male-male sib pair (proband and second interviewed sib) 
was extracted from each of the trios and each of the fours.  The age at 
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interview (n=204) ranged from 17 to 70 years (mean 37.8 years SD 9.32; not 
significantly different from non-sib pair group).  At time of the interview 
participants had been ill for a mean period of 14.5 years (SD 8.71; range 6 
months to 45 years).  
 
The SAPS and SANS formed the basis of the factor analysis.  The SANS and 
SAPS mean global rating scores (sum of global ratings) were 10.35 (SD 4.74; 
range 0-24) and 3.35 (SD 4.2; range 0-18), respectively, while table 1 shows 
the ratings of the individual items.  
 
TABLE 1. PERCENTAGE OF INDIVIDUAL CASES FROM THE SIB PAIR 
GROUP (N=208) SHOWING THE RATINGS (0 TO 5) FOR EACH OF THE 
SAPS AND SANS ITEMS  
                                  Rating  
 
           Item 
None 
(0) 
Questionable 
(1) 
Mild 
(2) 
Moderate 
(3) 
Marked 
(4) 
Severe 
(5) 
Affective 
changes 
12.5 5.8 43.8 21.2 12.0 2.9 
Alogia 25.0 6.4 29.4 18.6 16.2 4.4 
Avolition 8.3 3.4 28.4 31.4 23.0 5.4 
SANS  
Anhedonia 7.8 4.9 19.6 33.8 27.5 6.4 
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Attention 81.3 7.4 4.4 2.5 2.0 0.5 
Hallucinations 68.5 1.0 7.4 14.3 8.4 0.5 
Delusions 68.6 0.0 9.8 9.8 10.8 1.0 
Bizarre 
behaviour 
77.3 3.9 6.9 3.4 5.9 2.5 
SAPS 
Thought 
disorder 
70.9 2.5 15.8 6.9 3.4 0.5 
*Values given as percentages 
       
4.2 EXPLORATORY FACTOR ANALYSIS DATA 
Exploratory factor analysis was first applied to identify homogeneous 
symptom dimensions (or factors) represented by the items of the SAPS and 
SANS.  Analysis of the global and individual items of the SAPS and SANS 
revealed that the global items could replace the respective individual items.  
Principle component analysis of the global items of the SAPS and SANS 
identified two factors with eigenvalues > 1 (a positive factor, accounting for 
22.6% of the variance, and a negative factor, accounting for 48.8% of the 
variance) (Table 2).  
 
TABLE 2. FACTOR LOADINGS FOR THE SANS AND SAPS GLOBAL 
ITEMS WITH THE TWO ROTATED FACTORS (SIB PAIR GROUP; N=208).   
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Items Factor 1 (Negative factor) 
Factor 2 
(Positive factor) 
Affective changes 0.821 0.169 
Alogia*   
Avolition 0.879 0.203 
Anhedonia 0.883 0.137 
SANS 
Attention*   
Hallucinations 0.049 0.786 
Delusions 0.080 0.889 
Bizarre behaviour 0.250 0.635 
SAPS 
Thought disorder 0.330 0.573 
 Eigenvalue** 3.218 1.418 
 % Variance   48.80   22.6 
 Cumulative 
proportion 
  45.97   66.23 
Extraction Method: Principal Component Analysis.  Rotation Method: Varimax 
with Kaiser Normalization. 
Rotation converged in 3 iterations. 
Highlighted factor loadings indicate that the relevant SAPS and SANS items 
can be considered a major constituent of the corresponding factor. 
*The inclusion of alogia (factor 1) and attention (factor 2) yielded the same 
solution. 
** Only components with eigenvalues > 1 were retained. 
In a forced five-factor solution (i.e., irrespective of eigenvalue) the first two 
factors accounted for 66.2% of the variance.  The solution indicated that 
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thought disorder loaded highly on factor 3, bizarre behaviour on factor 4 and 
affective changes on factor 5, while factor one and two constituted a negative 
and positive symptom dimension (Table 3).  The individual item factor 
analysis reinforced the five factor solution of the global scores, except for a 
shared loading of delusions items (data not shown). 
 
TABLE 3.  FIVE FACTOR STRUCTURE FOR SANS AND SAPS GLOBAL 
RATINGS FOR THE SIB PAIR GROUP (N=208) 
Items 
Factor 
1 
Factor 
2 
Factor 
3 
Factor 
4 
Factor 
5 
Com
munal
ity 
Affective changes 0.444 0.086 0.140 0.119 0.870 
  
0.996 
Avolition 0.880 0.118 0.087 0.194 0.229 0.885
SANS 
Anhedonia 0.911 0.108 0.141 0.011 0.199 0.901
Hallucinations 0.110 0.934 -0.003 0.060 0.094 0.897
Delusions 0.108 0.803 0.326 0.254 0.084 0.827
Bizarre behaviour 0.135 0.206 0.170 0.944 0.100 0.978
SAPS 
Thought disorder 0.165 0.172 0.938 0.166 0.119 0.991
 % Variance 45.97 20.25 11.47 8.77 6.02  
 Cumulative 
proportion 
45.97 66.23 77.70 86.47 92.49 
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Extraction Method: Principal Component Analysis.  Rotation Method: Varimax 
with Kaiser Normalization. 
Rotation converged in 5 iterations. 
Highlighted factor loadings indicate that the relevant SAPS and SANS items 
can be considered a major constituent of the corresponding factor. 
 
The factor solution (eigenvalues more than 1) of the non-sib pair group 
revealed a two-factor solution similar to that of the sib pair group with the 
positive factor (hallucinations, delusions, bizarre behaviour and thought 
disorder) and negative factor (affective changes, avolition and anhedonia).  
The forced five factor solution also showed a similar factor structure to that of 
the sib pair group (Table 4).  
 
TABLE 4.  FIVE FACTOR STRUCTURE FOR SANS AND SAPS GLOBAL 
RATINGS FOR THE NON-SIB PAIR GROUP (N=299) 
Items 
Factor 
1 
Factor
2 
Factor 
3 
Factor 
4 
Factor 
5 
Com
munal
ity 
Affective changes 0.362 0.143 0.108 0.108 0.907 
  
0.997 
Avolition 0.874 0.055 0.200 0.150 0.163 0.856
SANS 
Anhedonia 0.898 0.036 -0.072 0.061 0.215 0.863
SAPS Hallucinations 0.064 0.908 0.162 0.162 0.037 0.881
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Delusions 0.029 0.885 0.208 0.148 0.140 0.868
Bizarre behaviour 0.085 0.329 0.911 0.170 0.103 0.986
Thought disorder 0.168 0.256 0.1641 0.932 0.102 0.999
 % Variance 23.592 44.214 9.158 8.063 7.128  
 Cumulative 
proportion 
23.592 67.806 76.964 85.027 92.156 
 
Extraction Method: Principal Component Analysis.  Rotation Method: Varimax 
with Kaiser Normalization. 
Rotation converged in 5 iterations. 
Highlighted factor loadings indicate that the relevant SAPS and SANS items 
can be considered a major constituent of the corresponding factor. 
 
5. CONCORDANCE OF SANS AND SAPS ITEMS 
A wide range of concordant items was found in the analysis of the SANS and 
SAPS items in the sib pair group (Table 6; see appendix 2 for complete 
ordinal data).  
 
TABLE 6. CONCORDANCE OF SANS AND SAPS INDIVIDUAL ITEMS 
BETWEEN THE 104 SIB PAIRS (N=208) 
Symptom Concordant for 
presence of 
symptom  
Concordant for 
absence of 
symptom 
Disconcordant CHISQU
ARE 
P-value 
(5% 
level) 
 263
   
Total group 
SANS Items 
Observ
ed 
Expect
ed 
Observ
ed 
Expect
ed 
Observ
ed 
Expect
ed 
Unchanging facial 
expression 
61 60.4 6 5.4 35 36.17 0.107 NS 
Decreased 
spontaneous 
movements 
39 33 25 19 38 50.04 5.904 0.015 
Paucity of expressive 
gestures 
46 42.7 16 12.7 40 46.59 2.040 NS 
Poor eye contact 38 31.9 26 19.9 38 50.29 6.095 0.014 
Affective non 
responsivity 
38 33 24 18.9 40 50.04 4.106 0.043 
Inappropriate affect 3 1.3 82 80.3 17 20.41 2.843 NS 
Grooming and 
hygiene 
33 24.5 35 26.5 34 50.98 11.316 0.0008 
Impersistence 83 81.2 3 1.2 16 19.63 3.484 NS 
Physical anergia 53 50.8 11 8.8 38 42.35 1.077 NS 
Recreational 
interests 
78 73.4 7 2.4 17 26.29 12.735 0.0001 
Relationships 70 68.4 5 3.4 27 30.29 1.203 NS 
SAPS items  
Auditory 
hallucinations 
16 9.7 55 48.7 31 43.54 8.465 0.004 
Voices commenting 5 2.2 77 74.2 20 25.59 4.865 0.027 
Voices conversing 8 4.3 68 64.3 26 33.35 4.957 0.026 
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Somatic/tactile 
hallucinations 
3 0.9 86 83.9 13 17.23 6.149 0.013 
Olfactory 
hallucinations 
3 1.1 84 82.1 15 18.84 4.234 0.04 
Visual hallucinations 1 0.6 88 87.6 13 13.90 0.425 NS 
Persecutory 
delusions 
8 6.9 57 55.9 37 39.23 0.330 NS 
Delusions of jealousy 0 0.01 100 100.01 2 1.98 0.010 NS 
Delusions of guilt or 
sin 
0 0.2 93 93.2 9 8.60 0.217 NS 
Grandiose delusions 1 0.7 86 85.7 15 15.58 0.143 NS 
Religious delusions 2 1.1 83 82.1 17 18.84 0.971 NS 
Somatic delusions 0 1.4 78 79.4 24 21.18 1.813 NS 
Delusions of 
reference 
3 1.8 78 76.8 21 23.43 1.094 NS 
Delusions of being 
controlled 
3 0.7 88 85.7 11 15.58 8.824 0.003 
Delusions of mind 
reading 
4 1.5 81 78.5 17 21.94 5.165 0.02 
Thought 
broadcasting 
2 0.9 85 83.9 15 17.23 1.709 NS 
Thought insertion 2 0.6 89 87.6 11 13.90 4.433 0.035 
Thought withdrawal 1 0.3 92 91.3 9 10.41 1.864 NS 
Clothing and 
appearance 
0 0.7 85 85.7 17 15.58 0.843 NS 
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Social and sexual 
behaviour 
3 1.3 82 80.3 17 20.41 2.843 NS 
Aggressive, agitated 
behaviour 
3 1.5 80 78.5 19 21.94 1.828 NS 
Repetitive behaviour 0 0.2 94 94.2 8 7.69 0.170 NS 
Derailment 4 2.8 72 70.8 26 28.33 0.692 NS 
Tangentiality 5 3.4 70 68.4 27 30.29 1.203 NS 
Incoherence 5 2.7 74 71.7 23 27.66 2.897 NS 
Illogicality 6 2.7 75 71.7 21 27.66 5.916 0.015 
Circumstantiality 4 3.4 69 68.4 29 30.29 0.185 NS 
Pressure of speech 0 0.01 100 100.01 2 1.98 0.010 NS 
Distractible speech 0 0.01 100 100.01 2 1.98 0.010 NS 
Alogia items, intimacy and clanging items not reflected in table.  See methods 
for reasons. 
NS  non-significant 
Only valid cases with full information included, see individual items 
All observed and expected values expressed as counts 
 
 
The global items of hallucinations (p=0.002), delusions (p=0.01) and 
anhedonia (p=0.037) had higher than expected concordance, while global 
affect (p=0.725), global alogia (p=0.367), global avolition (p=0.13), global 
bizarre behaviour (p=0.108) and global thought disorder (p=0.669) showed no 
significant concordance. 
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Neither the negative nor the positive symptom factors revealed higher than 
expected concordance (p=0.256 and p=0.524 respectively). 
 
6. Limiting concordant symptoms 
6.1 Gender based analysis 
The sib pair group was divided into a male-male sib pair group and a male-
female group.   It could be argued that the concordant factors in the male-
male sib pair group, by neutralizing the gender effect, would be more likely to 
represent shared familial factors, and more likely shared genetic variation 
within for example the pseudo-autosomal region [1-6].  
 
In the concordance analysis (Table 6) seventeen items, mostly from the SAPS 
(14/17) had higher than expected concordance.  Only 4 of the items (Table 7) 
were found in the male-male group namely eye contact (p=0.027), grooming 
(p=0.003), auditory hallucinations (p=0.010), global hallucinations (p=0.017) 
and delusions of control (p=0.001).  
 
Table 7. SANS and SAPS items with higher than expected concordance in the 
Male-Male (n=67) sib pair group 
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Symptom Concordant for 
presence of 
symptom 
Concordant for 
absence of 
symptom 
Disconcordant CHISQU
ARE 
P-value 
(5% 
level) 
Male-Male group Observ
ed 
Expect
ed 
Observ
ed 
Expect
ed 
Observ
ed 
Expect
ed 
  
Eye contact 26 21.6 17 12.55 24 32.90 4.899 0.027 
Grooming 28 22.1 18 12.12 21 32.75 8.628 0.003 
Auditory 
hallucinations 
9 4.8 40 35.84 18 26.33 6.704 0.010 
Global 
hallucinations 
9 5.1 39 35.11 19 26.78 5.658 0.017 
Delusions of 
control 
2 0.3 60 58.30 5 8.40 10.960 0.001 
 
 
6.2 ITEM PREVALENCE AND CONCORDANCE FINDINGS 
However, the stratification of the sample by gender pairs made it imperative 
for us to evaluate whether any significant differences existed in the 
prevalence of the individual symptoms between the male-male and male-
female group, since this would directly impact on the interpretation of the 
concordance analysis.  The prevalence of grooming difficulties and religious 
delusions differed significantly between the gender pairs (more common in 
male-male pairs) while mind reading approached significance (Table 8).  
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Based on the preset exclusion criteria (see Methods) grooming difficulties was 
excluded from further analysis. 
 
 
TABLE 8. COMPARISON OF INDIVIDUAL SYMPTOM PREVALENCE 
BETWEEN THE MALE-MALE AND MALE-FEMALE SIB PAIR GROUPS  
 
Differences between M-M and M-F groups (%) 
Symptom M-F M-M z p 
Grooming 35.9 57.0 -2.51 0.012 
Religious* 3.1 14.2 -2.92 0.004 
* item did not show a higher than expected concordance in gender groups. 
 
6.3 CONFOUNDING VARIABLES AND CONCORDANCE 
FINDINGS 
In order to exclude the possible effects of confounding variables on the 
findings of concordance analysis it was important to further compare the 
groups in terms of potential confounding variables.  Certain DIGS variables 
(developmental history, drug use and demographic variables) were identified 
as possible confounding variables.  The sample size of the sib pair group 
allowed comparisons between the male-male and male-female groups in 
terms of 9 of these variables (Table 9).  
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TABLE 9. COMPARISON OF CONFOUNDING VARIABLES BETWEEN THE 
MALE-MALE (67 PAIRS) AND MALE-FEMALE (32 PAIRS) SIB PAIR 
GROUPS 
 
Differences between M-M and M-F groups (%) 
Confounding 
variables 
M-M M-F z P* 
Age at interview 37.5 (8.8) 40.0 (10.8) 1.32 0.188 
Age at onset 23.2 (5.4) 23.3 (6.8) -0.04 0.969 
Duration of 
illness 
14.4 (8.0) 16.1 (10.2) 0.93 0.350 
Years of 
schooling 
6.6  (3.0) 6.9  (3.1) 0.50 0.620 
Episodes 2.5  (1.9) 2.4  (1.1) -0.77 0.441 
Substance use 12.5 35.6 -3.72 0.0002 
Mood 9.3 3.3 1.53 0.125 
Anxiety 1.7 4.2 -0.99 0.321 
Stress 21.4 3.4 3.14 0.002 
Mean (SD) or percentages 
*Significance levels 
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The male-male and male-female groups differed significantly in terms of two 
variables: the abuse of or dependency on any substance (p=0.0002), and a 
history of a stressor prior to the onset of illness (p=0.002).  The concordance 
analysis with the variable “ any substance abuse or dependency”  
(categorised into concordance for the presence, concordance for the absence 
and disconcordance for “ any substance abuse or dependency” ) revealed 
that eye contact, auditory hallucinations and global hallucinations did not have 
a higher than expected concordance for the presence of any substance abuse 
or dependency (Appendix 3).  No concordance for the presence of any 
substance abuse or dependency was noted for delusions of control and thus 
no concordance analysis was necessary for this item. 
 
The second covariate of interest namely presence of a stressor prior to the 
onset of illness showed similar results for eye contact, auditory hallucinations 
and global hallucinations.  Delusions of control again did not show any 
concordance for the presence of the covariate.  
 
The age of onset was, despite the lack of significant difference between the 
gender groups, evaluated in more detail given the conflicting findings of age of 
onset on symptomatology [1;7-9].  Only in the male-male group did 
concordance of the earlier age of onset (less than 23 years of age; 
dichotomised around the mean age of onset) showed significantly higher than 
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expected values (p=0.038).  However, the concordance of the SANS and 
SAPS items namely eye contact (p=0.431), auditory hallucinations (p=0.629), 
global hallucinations (p=0.473) and delusions of control (p=0.917) were not 
higher than expected in the earlier age of onset group.  
 
The final analysis compared the concordance rates of the DIGS life-time items 
with the SAPS and SANS items of interest to investigate whether life-time 
symptomatology are reflected in the concordance findings on the SANS and 
SAPS of the male-male group.  The items on the life-time DIGS that had 
higher than expected concordance were conversing voices (p.0.002), 
delusions of jealousy (p=0.001), thought insertion (p=0.0001), thought 
withdrawal (p=0.01), delusions of reference (p=0.012) and delusions of control 
(p=0.0001). Global hallucinations had a one hundred percent concordance for 
lifetime symptomatology.  Delusions of control and global hallucinations 
therefore seems to represent the only items that remained with a higher than 
expected concordance in both the lifetime and SANS/SAPS analysis.    
 
 
7. SUMMARY OF FINDINGS 
The factor analysis of the SANS and SAPS individual and global items 
identified the same symptom factors in the comparator and sib pair group.  
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The concordance analysis identified 3 global items (hallucinations, delusions 
and anhedonia) and 14 individual items from the SANS and SAPS with higher 
than expected concordance.  However, only grooming difficulties, eye contact, 
auditory hallucinations, global hallucinations and delusions of control had a 
higher than expected concordance within the male-male sib pair group 
(chosen to factor out the possible confounding effect of gender).  Grooming 
difficulties were excluded since the prevalence differences between the male-
male and male-female groups may be responsible for the findings of higher 
than expected concordance.  None of the tested confounding variables played 
a significant role on the higher than expected concordance detected for eye 
contact, auditory hallucinations, global hallucinations and delusions of control.  
The delusions of control item was the only item to have higher than expected 
concordance on the SAPS and the lifetime DIGS analysis. This item would 
therefore be of specific interest for a genotype-phenotype analysis.  A visual 
summary of all the concordance findings is represented in the following figure. 
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APPENDIX 1. THE DEMOGRAPHIC CHARACTERISTICS OF THE SIB PAIR 
AND THE NON-SIB PAIR COMPARATOR GROUP  
 Sib pair group  
(n=214) 
Non-sib pair group 
(n=299) 
Gender 
            Male 
            Female 
 
173 (80.8%) 
  41 (19.2%) 
 
226 (75.6%) 
  73 (24.4%) 
Marital status 
            Single 
            Married            
Separated/Divorced/ 
Widowed 
 
162 (75.7%) 
  24 (11.2%) 
 
  14 (4%) 
 
248 (82.9%) 
  24 (8%) 
 
  23 (7.7%) 
*Residence 
    Alone 
    With parents  
    Residential care 
    With other people 
 
    7 (3.3%) 
160 (74.8%) 
    2 (0.9%) 
  33 (15.4%) 
 
7 (2.3%) 
187 (62.5%) 
1 (0.3%) 
46 (15.4%) 
*Employment 
      Disability grant 
      Unemployed 
      Employed 
      Student  
 
158 (73.8%) 
  25 (11.7%) 
  14 (6.5%) 
    3 (1.4%)  
 
218 (72.9%) 
45 (15.1%) 
15 (5%) 
 9 (3%) 
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Schooling 
      Mean (SD) 
      Range 
      Median 
 
6.7 (3.02) years 
0-13 years 
7 years 
 
7.7 (3.16) 
0-16 years 
8 years 
Age at interview 
       Mean (SD) 
       Range 
       Median 
 
37.8 (9.32) years 
17-70 years 
37 years 
 
35 (10) years 
13-84 years 
34 years 
Age of onset 
       Mean (SD) 
       Range 
       Median 
 
23.1 (5.78) years 
14-42 years 
22 years 
 
22.5 (6.15) years 
11-53 years 
21 years 
*Only selected categories.  
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APPENDIX 2. SANS AND SAPS ITEMS: ORDINAL DIFFERENCES 
BETWEEN SIBS IN THE SIB PAIR GROUP  
SANS items Concordant 
(concordant 
for absence 
of symptom) 
1 point 
difference 
2 points 
difference 
3 points 
difference 
4 or 5 
points 
difference 
Unchanging facial 
expression 
22 (3) 34 29 13 4 
Decreased spontaneous 
movements 
30 (17) 28 27 12 5 
Paucity of expressive 
gestures 
25 (7) 30 33 8 6 
Poor eye contact 30 (10) 27 24 10 9 
Affective non responsivity 25 (9) 34 27 9 7 
Inappropriate affect 77 (74) 8 8 2 7 
Grooming and hygiene 40 (24) 26 16 10 11 
Impersistence 32 (1) 31 24 10 4 
Physical anergia 27 (5) 30 29 10 5 
Recreational interests 32 (1) 40 15 9 5 
Intimacy and closeness 27 (4) 33 19 5 6 
Relationships 30 (2) 30 22 11 6 
SAPS items Concordant 
(concordant 
for absence 
of symptom) 
1 point 
difference 
2 points 
difference 
3 points 
difference 
4/5 points 
difference 
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Auditory hallucinations 61 (51) 7 10 14 8 
Voices commenting 78 (76) 2 9 4 6 
Voices conversing 72 (67) 4 8 8 7 
Somatic/tactile 
hallucinations 
86 (84) 2 6 2 4 
Olfactory hallucinations 85 (82) 3 6 2 3 
Visual hallucinations 84 (81) 2 6 2 6 
Persecutory delusions 58 (53) 5 13 11 14 
Delusions of jealousy 96 (95) 3 2 1 0 
Delusions of guilt or sin 92 (92) 3 6 1 1 
Grandiose delusions 84 (84) 2 5 4 6 
Religious delusions 83 (83) 3 7 7 3 
Somatic delusions 85 (84) 3 8 7 9 
Delusions of reference 76 (73) 5 12 8 9 
Delusions of being 
controlled 
80 (77) 3 4 4 0 
Delusions of mind reading 81 (78) 3 9 4 5 
Thought broadcasting 83 (81) 2 11 4 1 
Thought insertion 86 (84) 3 8 0 2 
Thought withdrawal 82 (81) 3 5 1 2 
Clothing and appearance 79 (79) 3 8 4 7 
Social and sexual 
behaviour 
80 (80) 6 3 8 4 
Aggressive, agitated 
behaviour 
76 (76) 3 10 3 9 
Repetitive behaviour 93 (93) 0 5 1 2 
 280
   
Derailment 73 (69) 2 19 3 4 
Tangentiality 69 (67) 6 17 6 3 
Incoherence 70 (68) 8 13 8 2 
Illogicality 71 (68) 7 16 5 2 
Circumstantiality 64 (61) 10 17 7 3 
Pressure of speech 96 (94) 4 1 0 0 
Distractible speech 98 (98) 1 1 1 0 
Clanging 101 (101) 0 0 0 0 
*Sibs only included if all variables rated (n=214) 
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APPENDIX 3. THE INFLUENCE OF “ ANY SUBSTANCE ABUSE OR 
DEPENDENCY”  AND “ STRESSOR PRIOR TO ONSET OF ILLNESS”  
ON CONCORDANCE FINDINGS IN THE SIB PAIR GROUP (N=214) 
(SELECTED ITEMS ONLY) 
++ -- +- ++ +- -- 
Items Covariates Observed Expected Chi-square P value  
Eye contact sub ++ 3 5 6 2.57 4.57 6.86 0.219 0.640   
  sub -- 27 10 21 24.25 7.25 26.51 2.505 0.114  
  sub +- 7 10 8 4.84 7.84 12.32 3.074 0.080   
  Stress++ 2 3 3 1.53 2.53 3.94 0.454 0.501   
  Stress-- 27 15 23 22.80 10.80 31.39 4.645 0.031 *  
  stress+- 8 7 9 6.51 5.51 11.98 1.484 0.223   
Inappropriate 
affect sub ++ 1 13 1 0.15 12.15 2.70 5.947 0.015 * 
  sub -- 1 49 8 0.43 48.43 9.14 0.899 0.343   
  sub +- 1 16 8 1.00 16.00 8.00 0.000 1.000   
  stress++ 1 7 0 0.13 6.13 1.75 8.000 0.005 **  
  stress-- 2 49 14 1.25 48.25 15.51 0.614 0.433   
  stress+- 0 22 3 0.09 22.09 2.82 0.102 0.750   
Global affect sub ++ 8 6 1 4.82 2.82 7.37 11.204 0.001 ** 
  sub -- 40 2 16 39.72 1.72 16.55 0.064 0.800   
  sub +- 17 0 8 17.64 0.64 6.72 0.907 0.341   
  stress++ 5 1 2 4.50 0.50 3.00 0.889 0.346   
  stress-- 43 1 21 44.03 2.03 18.93 0.777 0.378   
  stress+- 17 1 7 16.81 0.81 7.38 0.066 0.797   
Global 
anhedonia sub++ 10 1 4 9.60 0.60 4.80 0.417 0.519   
  sub-- 48 1 9 47.52 0.52 9.96 0.536 0.464   
  sub+- 18 2 5 16.81 0.81 7.38 2.600 0.107   
  stress++ 5 2 1 3.78 0.78 3.44 4.022 0.045 * 
  stress-- 50 2 13 49.11 1.11 14.78 0.940 0.332   
  stress+- 21 0 4 21.16 0.16 3.68 0.189 0.664   
Auditory 
hallucinations sub ++ 1 8 6 1.07 8.07 5.87 0.008 0.930   
  sub -- 8 27 17 5.24 24.24 22.53 3.132 0.077   
  sub +- 6 22 3 1.81 17.81 11.37 16.800 0.000 **  
  stress++ 1 5 2 0.50 4.50 3.00 0.889 0.346   
  stress-- 5 38 21 3.75 36.75 23.49 0.720 0.396   
  stress+- 8 9 8 5.76 6.76 12.48 3.222 0.073  
Commenting 
voices sub++ 0 12 3 0.15 12.15 2.70 0.185 0.667  
  sub-- 4 41 11 1.61 38.61 15.78 5.134 0.023 *  
  sub+- 1 21 3 0.25 20.25 4.50 2.778 0.096   
  stress++ 0 7 1 0.03 7.03 0.94 0.036 0.850   
  stress-- 2 52 9 0.67 50.67 11.66 3.276 0.070   
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  stress+- 3 15 7 1.69 13.69 9.62 1.854 0.173   
Tactile 
hallucinations sub++ 0 12 3 0.15 12.15 2.70 0.185 0.667  
  sub-- 3 47 7 0.74 44.74 11.52 8.769 0.003 **  
  sub+- 0 24 1 0.01 24.01 0.98 0.010 0.919   
  stress++ 0 7 1 0.03 7.03 0.94 0.036 0.850   
  stress-- 1 56 7 0.32 55.32 8.37 1.709 0.191   
  stress+- 2 20 3 0.49 18.49 6.02 6.292 0.012 **  
Olfactory 
hallucinations sub++ 0 13 2 0.07 13.07 1.87 0.077 0.782  
  sub-- 2 46 9 0.74 44.74 11.52 2.723 0.099   
  sub+- 1 23 1 0.09 22.09 2.82 10.413 0.001 **  
  stress++ 1 7 0 0.13 6.13 1.75 8.000 0.005 **  
  stress-- 0 57 7 0.19 57.19 6.62 0.214 0.644   
  stress+- 2 18 5 0.81 16.81 7.38 2.600 0.107   
Global 
hallucinations sub++ 1 8 6 1.07 8.07 5.87 0.008 0.930   
  sub-- 9 27 21 6.67 24.67 25.66 1.879 0.171   
  sub+- 5 17 3 1.69 13.69 9.62 11.839 0.001 ** 
  stress++ 1 5 2 0.50 4.50 3.00 0.889 0.346   
  stress-- 5 38 21 3.75 36.75 23.49 0.720 0.396   
  stress+- 9 9 7 6.25 6.25 12.50 4.840 0.028 * 
Delusions of 
control sub++ 0 15 0 0.00 15.00 0.00 No concordance    
  sub-- 2 45 10 0.86 43.86 12.28 1.966 0.161   
  sub+- 1 24 0 0.04 23.04 1.92 25.000 0.000 **  
  stress++ 0 8 0 0.00 8.00 0.00 No concordance    
  stress-- 2 57 5 0.32 55.32 8.37 10.365 0.001 **  
  stress+- 1 19 5 0.49 18.49 6.02 0.718 0.397  
Mind reading sub++ 0 12 3 0.15 12.15 2.70 0.185 0.667  
  sub-- 4 44 9 1.27 41.27 14.46 8.136 0.004 ** 
  sub+- 0 20 5 0.25 20.25 4.50 0.309 0.579   
  stress++ 0 6 2 0.13 6.13 1.75 0.163 0.686   
  stress-- 1 53 10 0.56 52.56 10.88 0.414 0.520   
  stress+- 3 17 5 1.21 15.21 8.58 4.352 0.037 *  
Thought 
insertion sub++ 0 13 2 0.07 13.07 1.87 0.077 0.782  
  sub-- 2 48 7 0.53 46.53 9.94 4.983 0.026 *  
  sub+- 0 24 1 0.01 24.01 0.98 0.010 0.919   
  stress++ 0 8 0 0.00 8.00 0.00 No concordance    
  stress-- 0 59 5 0.10 59.10 4.80 0.106 0.745   
  stress+- 2 18 5 0.81 16.81 7.38 2.600 0.107   
Global 
delusions sub++ 1 8 6 1.07 8.07 5.87 0.008 0.930   
  sub-- 9 30 19 5.90 26.90 25.20 3.509 0.061   
  sub+- 6 11 8 4.00 9.00 12.00 2.778 0.096   
  stress++ 1 5 2 0.50 4.50 3.00 0.889 0.346   
  stress-- 9 36 20 5.55 32.55 26.89 4.270 0.039 * 
  stress+- 6 8 11 5.29 7.29 12.42 0.327 0.568   
Global bizarre 
behaviour sub++ 1 8 6 1.07 8.07 5.87 0.008 0.930   
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  sub-- 2 41 14 1.42 40.42 15.16 0.333 0.564   
  sub+- 3 16 6 1.44 14.44 9.12 2.926 0.087   
  stress++ 0 5 3 0.28 5.28 2.44 0.426 0.514   
  stress-- 6 44 14 2.64 40.64 20.72 6.730 0.009 ** 
  stress+- 0 16 9 0.81 16.81 7.38 1.205 0.272   
Incoherence sub++ 1 11 3 0.42 10.42 4.17 1.176 0.278  
  sub-- 3 42 13 1.56 40.56 15.89 1.916 0.166   
  sub+- 1 19 5 0.49 18.49 6.02 0.718 0.397   
  stress++ 1 7 0 0.13 6.13 1.75 8.000 0.005 ** 
  stress-- 2 48 15 1.39 47.39 16.22 0.369 0.543   
  stress+- 2 17 6 1.00 16.00 8.00 1.563 0.211   
Illogical 
thought 
process sub++ 1 11 3 0.42 10.42 4.17 1.176 0.278  
  sub-- 3 40 15 1.90 38.90 17.20 0.948 0.330   
  sub+- 2 19 4 0.64 17.64 6.72 4.096 0.043 *  
  stress++ 1 7 0 0.13 6.13 1.75 8.000 0.005   
  stress-- 3 47 15 1.70 45.70 17.61 1.426 0.232   
  stress+- 2 16 7 1.21 15.21 8.58 0.848 0.357   
Global thought 
disorder sub++ 1 9 5 0.82 8.82 5.37 0.070 0.791   
  sub-- 5 29 23 4.78 28.78 23.45 0.021 0.885   
  sub+- 2 14 9 1.69 13.69 9.62 0.104 0.747   
  stress++ 1 7 0 0.13 6.13 1.75 8.000 0.005 ** 
  stress-- 4 34 26 4.52 34.52 24.97 0.109 0.741   
  stress+- 3 11 11 2.89 10.89 11.22 0.010 0.922   
*Sub   any substance use 
  Stress   stressor prior to onset if illness 
++   Concordant for presence of the symptom 
+-   Disconcordant for the presence of the symptom 
--   Concordant for the absence of the symptom 
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CHAPTER 8 
 
DISCUSSION AND CONCLUSION  
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1. CLINICAL FINDINGS  
 
This chapter is organized into a number of sections.  Section 1 deals with the 
demographic features, symptom patterns, treatment, and comorbid conditions 
of the sib pairs.  In section 2, the factor analysis results are discussed.  
Sections 3 to 5 discuss the findings pertaining to concordance analysis and 
the implications of these findings for further targeted genetic studies. The final 
section deals with incidental but important issues arising from the study.  
These include the ethical implications of research in indigenous populations 
and procedural challenges for future research. 
 
 
1.1 DEMOGRAPHIC VARIABLES 
The mean age at interview (38 years) and the mean duration of illness (14 
years) were similar to those of other sib pair study populations (range 28.7 to 
47.75 years and 9 to 19.9 years respectively).  As expected, some impairment 
in social and occupational functioning can be inferred from the small 
proportion of individuals who were married (13.6%) and the high rate of work 
disability (78%).   Of major concern was the impact of the socio-political 
history of the Xhosa people on their levels of education, as a low educational 
status may affect the legitimacy of informed consent and the reliability of the 
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information obtained.   However, our subjects had attained an average of 
nearly 7 years of schooling, and fewer than 1% had never attended school.     
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1.2 PRODROMAL SYMPTOMS AND TRIGGERING EVENTS 
Prodromal symptom duration varied considerably, with a quarter having 
experienced an acute onset of psychosis. However, a history of prodromal 
symptoms (when assessed retrospectively) is a difficult variable to evaluate 
accurately because it is prone to recall bias and furthermore, symptoms may 
be difficult to identify by the patient or family members [1].  
 
Surprisingly few participants reported a triggering event, although the 
occurrence of gestational and post-partum triggers in some of our cases lend 
support to the importance of this vulnerable period in the life of female 
participants [2].  The triggering events that did occur did not reflect a clear 
predominance of cultural influences, as would have been expected from the 
importance attached to supernatural phenomena by the Xhosa population.  
The patients could have been reticent about revealing their traditional beliefs 
because they wanted to accommodate the “ Western”  biological framework 
of the researchers. In any event, no structured assessment tool exists for 
capturing ethnic-specific trigger events, and further research along these lines 
is necessary.  
 
 
1.3 PSYCHOTIC SYMPTOMS 
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Consistent with international data, many of the participants in this study 
reported repeated hospitalizations, most displayed residual symptoms and 
psychotic features were present in a substantial number. Lifetime paranoid 
delusions were the most common delusions (88%).  Grandiose delusions, 
delusions of reference and religiose delusions were found in 55%, 51% and 
47% of subjects, respectively.  Cassano et al. (1998) also reported 
persecutory delusions to be the most common (58%), closely followed by 
reference (54.8%), grandiose (19%), guilt (16%), somatic (13%) and control 
type delusions (13%) in a first episode sample of patients with schizophrenia 
[3]. Thought broadcasting was present in only 10% of their sample.  Koen et 
al. (2004) found paranoid delusions in 44 (61.9%) out of six African and 65 
mixed ethnic origin South African schizophrenia inpatients [4].  Grandiose 
delusions were found in 42.3% and control delusions in 60.6% of this sample.  
Although the Xhosa sibling pairs showed a higher overall rate of delusions 
than the study by Koen et al. (2004), paranoid and grandiose delusions were 
also the most common [4].  
 
Of interest is that delusions of a religious nature most commonly had 
traditional healing practices as a central theme, and although the concern was 
that it would be difficult to separate culture-bound themes from psychotic 
themes, family members distinguished between what they accepted as 
“ normal”  cultural beliefs and what they perceived as psychosis.  This is in 
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keeping with the viewpoint of delusions being beliefs that are not shared 
within the specific cultural context of the patient.  The challenge for future 
studies would be to delineate the divisions between normality and pathology 
on the spectrum of religious (traditional) beliefs and religious delusions in the 
Xhosa population. 
 
Auditory hallucinations were very common in the Xhosa sample.  This was 
also the most common symptom (61%) in the Cassano et al. (1998) first 
episode sample [5], followed by visual (16%), gustatory (6%) and tactile (3%) 
hallucinations.  The South African sample of Koen et al. (2004) likewise 
reported similar rates of auditory (70.4%) and visual (12.7%) hallucinations 
[4].   Gustatory and olfactory hallucinations are classically associated with an 
organic lesion such as an epileptic focus, and it was therefore not surprising 
to find these two perceptual changes to be the least common in this sample, 
especially considering the low rate of significant neurological or 
developmental difficulties reported by the patients.  There was no significant 
relationship between a history of physical illness and any of these 
hallucinations. 
 
 
1.4 BEHAVIOURAL SYMPTOMS AND THOUGHT DISORDER 
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The high rate of reported aggressive behaviour (78%) might be a reflection of 
the way in which we defined this term.  The DIGS does not specify any 
specific criteria for aggression.  Thus, for the purpose of this study, any verbal 
or physical abuse linked to the illness was reported as positive for aggression.  
This may have led to the over-reporting of aggressive incidents.  
Nevertheless, in the light of these results, it seems that families and health 
care workers are at an increased risk for violence.  Further support for this is 
provided by a study by Koen et al. (2004) that showed a high incidence of 
violence associated with specific delusions and substance abuse in a South 
African inpatient sample [4].  
 
The catatonic subtype was of interest, given that previous reports [6] have 
suggested the existence of a gene specific for catatonic schizophrenia. Very 
few patients (n=8) were classified as having catatonic subtype, and none of 
the sibling pairs were concordant for this subtype.  The prevalence of 
catatonia seems to be in keeping with other studies that also reported a low 
prevalence (6%) [3]. 
 
Thought disorder was common, as expected, with circumstantiality, 
incoherence, derailment and/or tangential thinking occurring in between 15% 
and 25% of subjects.  Loosening of associations was less common (fewer 
than 5% of subjects) and lower than that reported by Cassano et al (1998) [3].  
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Negative symptoms, such as affective flattening, alogia and anhedonia, were 
common, with over 78% of the sample rated as mildly to markedly affected.  
Inappropriate affect, ranging from mild to marked, was found in only one out 
of every five patients.   
 
 
1.5 TREATMENT IN THE XHOSA SCHIZOPHRENIA SIB PAIR 
SAMPLE 
The majority of patients (96%) were using medication at the time of the 
interview and, as expected from clinical experience, depot medications were 
the treatment of choice.  Although the high level of medication use could be 
explained by an over-representation of medication compliant recruits in this 
sample, another South African sample (Mbanga et al. (2003) [7]) reported a 
high rate of medication use and belief in the combined use of traditional and 
western medication.  This suggests that the high rates of compliance found in 
our Xhosa sample are not unusual.  Whether the high compliance rates are 
an authentic finding or are due to selection bias will have to be addressed in a 
follow-up study on this sample.  Such a study can, however, be complicated 
by the migratory patterns of patients as they move between the Eastern and 
Western Cape.  A possible solution would be to involve multiple clinics to tract 
patients across this migration. 
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The low rate of clozapine use (<5%) was of concern in view of the presence of 
ongoing psychotic symptoms in 67 (> 10%) of the patients.  In a few cases 
clozapine was used together with depot antipsychotic medication, a 
combination known to increase the risk for significant morbidity from 
agranulocytosis.  The medication requirements of these cases needed 
reassessment.  Despite these concerns, it was obvious that monotherapy was 
most often reported, with only 11 patients receiving mood altering drugs.    
 
Nearly a quarter of subjects (24%) received anticholinergic drugs.  Since the 
DIGS does not allow for a detailed analysis of movement disorders, we could 
not draw any practical conclusions regarding associations between specific 
extrapyramidal symptoms and medication use history.  Future studies wishing 
to examine such associations should make use of rating instruments designed 
to assess specific movement disorders.   
 
This investigation found an alarming lack of specific knowledge of the drugs 
used (e.g. a participant would know that he or she was using a depot 
preparation, but knew neither the name nor the dose) and poor record 
keeping and access to records in the rural communities.  Future studies 
should consider performing objective measurements rather than relying on the 
patients’  history.  An example of such an approach would be a 
morphological evaluation of the participants.  The results of such a study 
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could shed light on the possible role of developmental factors on 
schizophrenia with minimal dependence on historical data.  
 
 
1.6 COMORBID CONDITIONS AND SYMPTOMS 
Comorbid conditions form an integral part of the complexity of schizophrenia.  
Thirty-six percent of the sample had confirmed or suspected comorbid 
depression, anxiety, substance abuse or substance dependency.  This is 
significantly lower than the 93% comorbidity reported by Kendler et al. (1996) 
in a community sample [8] and the 58.1% comorbidity reported by Cassano et 
al 1998 [3], but in line with the reported life-time comorbidity for first admission 
psychosis (affective and non-affective) of 40.2% [9].   
 
The comorbidity of schizophrenia with specific disorders varies widely.  
Substance and alcohol abuse rates range from 6.5% in non-affective 
psychosis [3;9] to 43.2% in alcohol dependence and 37.7% in drug 
dependence, in community samples [8]. 
 
This study relied on patient and collateral reports of drug use and this may 
possibly have led to underreporting of substance abuse and dependency.  
However, family members and health professionals were able to provide 
reliable collateral information.  Koen et al. (2003) [10] interviewed fifty Xhosa 
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schizophrenia patients to determine the prevalence of comorbid substance 
abuse or dependency.  Sixty percent of the total sample admitted to cannabis 
use at some time, with only 10% occasionally using other drugs.  Thirty two 
percent of the sample was considered to be ongoing cannabis users.  Of the 
total sample, 5 patients (11%) gave an inaccurate self-report (4 denied use 
and 1 falsely admitted use).   The majority (71%) of patients gave a history of 
tobacco smoking, which is in line with international data [11].   
 
Our findings of a lower rate of substance abuse than that observed in the 
foregoing studies may be attributable to methodological and population 
specific differences between our study and the others, including first versus 
multiple admissions, gender and race differences, differences in education, 
differences in mean age of onset, inclusion of patients using atypical 
antipsychotics - which may potentially increase comorbid anxiety disorders 
and the use of community samples, that might have included untreated 
patients with high affective disorder comorbidity (74%) [8].  We did not 
formally evaluate subjects for the presence of all anxiety disorders or for 
mixed depression and anxiety. 
 
 The substance abuse comorbidity may also have been influenced by the 
implementation in the Eastern Cape of a new disability allowance policy, 
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which stipulates that patients would be denied disability allowances should 
they test positive for cannabis at their regular clinic appointments.   
 
It was already obvious early in the study that the mood section of the DIGS 
elicited few positive responses, although subclinical depressive symptoms 
were noted.  To allow for a degree of uncertainty in the diagnosis of mood 
disorders, a category, “ possible mood disorders”  (defined as any 
depressive symptom that had led to impairment, independent of the time 
period) was included in the analysis.  Nevertheless, the observed rate of 
16.2% of possible and confirmed mood disorders is low relative to previous 
studies, which have shown rates ranging from 40% to 93% [3;8;9].     
 
Interpretation of the results relating to mood and anxiety disorders in the sib 
pair study is, subject to a number of limitations. The criterion for recruitment 
into the study (diagnosis of schizophrenia in the proband and lack of 
significant mood symptoms) have biased the sample against the inclusion of 
mood symptoms. Caution should therefore be exercised in extrapolating these 
findings to the general schizophrenic population.  Patient ratings were cross-
sectional since the diagnosis of mood and anxiety disorders was based on a 
single interview.  Important historical information may therefore have been 
missed.  This may be specifically important in this context since the symptom 
dimensions of depression (or anxiety) and schizophrenia may have different 
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patterns of exacerbation and remission during the course of the illness [12].  
Another limitation is that assessment instruments were translated into Xhosa 
orally by the Xhosa nurse.  While the majority of patients were conversant in 
English, and every attempt was made to ensure equivalence when questions 
relating to mood and anxiety symptoms were put to Xhosa-speaking patients, 
cross-cultural adaptation of instruments is preferable in multilingual research.  
Determining and ensuring equivalence across primary and secondary 
language tools is often problematic and will remain a significant consideration 
in the design of research protocols in this population.  
 
Further work is needed to characterize mood and anxiety symptom profiles in 
patients with schizophrenia across different ethnic populations.  Cross-
national comparative studies suggest that cultural factors may affect the 
symptom expression of mood and anxiety symptoms, although the exact 
reasons for the wide variation in prevalence (e.g. much lower rates of OCD in 
some Asian countries) are not known [13].  Should the low prevalence of 
mood and anxiety disorders be replicated in other studies of patients with 
schizophrenia who are of Xhosa descent or mixed race, it may well suggest 
that cultural or genetic factors play a role in protecting against comorbid 
conditions in these persons.  However, proper assessment of this hypothesis 
requires a follow-up study designed to avoid the recruitment biases of the 
present study. 
 299
   
 
Further work is needed to develop culturally sensitive instruments to screen 
and diagnose mood and anxiety disorder in patients with schizophrenia and 
other psychotic disorders.  While it is recognized that specific biological 
mechanisms, including genetic and auto-immune mechanisms, may play a 
role in the pathogenesis of mood and anxiety disorders, ethnic variations in 
these underlying factors are likely to be protective in certain groups.  Further 
comparative studies to delineate these putative factors are warranted.  
 
This study [14] found the lifetime prevalence of suicide attempts in this group 
of Xhosa patients with schizophrenia to be at the lower end of the spectrum 
(19.8%), but still comparable to studies in other patient populations [15;16].  
The low rate of mood symptoms and the pre-requisite of having at least one 
first degree family member may have contributed to the slightly lower rate of 
attempts [17].  
 
Separation, divorce or unmarried status significantly increased the risk of 
suicide attempts in this schizophrenia population and are consistent with the 
role of social support systems and the stress diathesis model in predicting 
suicidal behaviour.  Factors that were not significantly associated with 
attempted suicide included religious affiliation, level of schooling, occupational 
status (specifically disability support), living arrangements and parenthood.  
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The presence of an affected sibling seems to be protective in this group of 
patients with schizophrenia.  One explanation might be that the presence of 
affected siblings lowers the expectations of the patient and family, lessening 
the emotional stress linked to failure to achieve an expected level of 
functioning.  However, these findings, together with the very low concordance 
rate, may reflect a delineation between the underlying pathophysiology of 
schizophrenia and suicidal behaviour.  
 
In summary this study highlights the universality of suicide attempts (although the 
most common suicide methods varied from some other studies [18;19]) in 
schizophrenia patients.  Furthermore, these findings raise the possibility that affected 
sib pair status may be protective in nature and supports ongoing efforts to understand 
the complex pathophysiological processes underlying suicidal behaviour in 
schizophrenia.  
 
 
2. FACTOR SOLUTIONS 
Similar two and five factor solutions for the global items of the SANS and 
SAPS were found in both the sibling pair and the non-sibling pair groups of 
Xhosa schizophrenic subjects.  These accounted for more than 90% of the 
variance.  A forced five-factor solution was used to allow comparisons with 
earlier studies, but the two-factor solution was the appropriate approach when 
eigenvalues larger than one were the minimum criterion.  This was also found 
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to be the case by Dolfus et al. (1998) [20].  The forced 5-factor solution 
concurred with previous reports in Caucasian populations [21];[22].  The 
previously reported positive, negative and “ disorganized”  dimensions were 
again reflected in the global item solution of the Xhosa population (in both sib 
and non-sib pair groups).  The positive dimension did not separate into 
separate delusions and hallucinations factors.  The “ disorganized”  and 
negative symptom dimensions separated into “ thought disorder”  and 
“ bizarre behaviour”  factors and “ affective changes”  and 
“ avolition/anhedonia”  components, respectively. 
 
Emsley et al. (2001)[23], in an article describing a smaller cohort of 
schizophrenic subjects from the pool from which these subjects were drawn, 
showed no separation between the negative symptom and the disorganization 
domain [24].  However, the differences between the original report by Emsley 
et al. (2001) and the current analysis may reflect the expansion and 
stratification of the sample.  Alogia and concentration difficulties were 
excluded in this study, based on the findings of Emsley et al. (2001) [25].   
 
The findings of this study correlated well with factor analysis findings on 
schizophrenic sib pair samples [26-28], despite the use of different 
assessment scales.  Kendler et al. (1997) also reported a negative and 
positive symptom factor.  Their affective/manic symptom factor included 
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thought disorder [29].  Similarly, Burke et al. (1996) found a positive, negative 
and disorganized symptom factor.  SANS and SAPS instruments do not 
include mood symptoms as a separate item and thus this study cannot 
comment on mood symptoms [30].   
     
Nevertheless, the core finding remains that very little difference exists 
between the Caucasian and Xhosa factor solutions, even in a sib pair sample.  
This despite the fact that the SAPS and SANS have proven validity in a factor 
analysis approach to subtyping schizophrenia [20] and the assumption that 
the ethnic homogeneity of this African population (the Xhosa) contributes to 
limiting the confounding cultural and genetic factors (so-called “ background 
noise” ) associated with heterogeneous groups.  In addition, the large 
number of single sets (two affected siblings per family) lessened the impact of 
large sibships on the statistical analysis.   
 
Furthermore, our study represents a more homogenous clinical sample with 
very few schizo-affective patients relative to other studies and a broad 
recruitment basis with both urban (1/5) and rural participants (4/5), 
hospitalized subjects and outpatients.  The predominance of male patients 
(4:1) is slightly higher than that of most previous studies (mostly 2:1) and may 
limit the generalizability of this study.  Conceivably, a predominantly female 
group might demonstrate other unique shared familial factors.  The power of 
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this study is not sufficient to address this issue and it should be the focus of 
an extended sample of patients with schizophrenia.  The specific underlying 
reason for the more pronounced gender effect in the South African sample 
remains unknown since no specific criteria unduly discriminated against the 
recruitment of female participants.  Whether this gender difference reflects 
different health seeking pathways by male patients with schizophrenia in the 
Xhosa population remains to be studied. 
 
 
3. CONCORDANCE ANALYSIS 
Since no factor specific to the sib pair group could be found and the negative 
and positive symptom factors did not reveal higher than expected 
concordance in the total sib pair group, the possibility exists that the 
structured symptoms as depicted by the SANS and SAPS may not be a 
valuable tool for genetic subtyping in the Xhosa population.  However, 
concordance analysis of the SANS and SAPS (after dichotomising the values 
into presence or absence of the symptom), did reveal higher than expected 
concordance for forty individual items, mostly from the SAPS.  In addition, the 
global items of hallucinations (p=0.002), delusions (p=0.01) and anhedonia 
(p=0.037) had higher than expected concordance.  
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It was therefore necessary to limit the number of items in order to increase the 
likelihood of identifying a specific subgroup large enough and specific enough 
to allow for a reasonable hypothesis and subsequent candidate gene studies.  
 
Stratification by gender, and more specifically, the use of male only sib pairs, 
neutralized the gender effect, and thus concordant factors were more likely to 
represent shared familial factors because male siblings were more likely to 
share genetic variation within, for example, the pseudo-autosomal region [31-
36].  Only five items remained concordant between sib pairs, and only in the 
male-male group, after this process, namely eye contact (p=0.027), grooming 
(p=0.003), auditory hallucinations (p=0.010), global hallucinations (p=0.017) 
and delusions of control (p=0.001).   
 
Four of these five items (eye contact, auditory hallucinations, global 
hallucinations and delusions of control) were shown, by statistical means, to 
be independent of the prevalence differences between the gender groups.  
The nine confounding variables tested for independence against the 
remaining four items found that only the confounders “any substance abuse or 
dependency” and “a stressor prior to onset of illness” had some differential 
influence in the male-male and male-female sib pair groups.  None of these 
confounders had a significant influence on the higher than expected 
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concordance found for the four items, eye contact, auditory hallucinations, 
global hallucinations and delusions of control. 
 
 
4. HIGHER THAN EXPECTED CONCORDANCE:  A 
REFLECTION OF CLINICAL SUBTYPES? 
 
These four remaining items (eye contact, auditory hallucinations, global 
hallucinations and delusions of control) appear to be likely candidates for 
closer scrutiny in the genetic analysis of the Xhosa sample.  These results will 
be evaluated individually, and discussed in the light of other published 
schizophrenia sib pair studies (see chapter 3).  It is imperative to note that 
these studies, not counting that of Cardno et al. (1998) [37], used diagnostic 
assessment tools other than the SANS/SAPS and DIGS.  Comparisons 
across studies should therefore be approached with the necessary caution.  
 
 
4.1 EYE CONTACT 
Eye contact has not previously been reported to have a higher than expected 
concordance between sib pairs.  Troisi et al. (1991) showed that reduced eye 
contact and an increased rate of eye closures were linked to poor prognosis in 
a schizophreniform group.  However, those exhibiting a poor prognosis also 
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demonstrated higher affective flattening and alogia.  In line with these 
findings, Davison et al. (1996)[38] showed that no single measurement of 
facial communication could reliably distinguish between patients with 
schizophrenia, depressed patients, demented patients and patients with 
Parkinson’ s disease. Although it seems unlikely that eye contact as a single 
item should be diagnostic for schizophrenia, Pitman et al. (1987)[39;39] found 
that non-paranoid schizophrenic patients had significantly less eye contact 
than a normal control group, while the paranoid schizophrenic group differed 
only in that they showed fewer eyebrow and lower facial movements. It is 
possible that subgroups of patients with schizophrenia might differ as regards 
single items of facial expression, but it remains to be proven whether this is 
indeed the case.  Eye contact might merely serve as a proxy marker for other 
phenotype markers.  Indeed, it seems plausible that eye contact abnormalities 
may be linked to the occurrence of delusions as part of a distorted 
appreciation of complex stimuli [40].  From the inconsistent results in the 
literature and a paucity of genetic association studies on eye contact it seems 
that eye contact as a single item will need further research to more clearly 
define whether this item will be useful in the investigation of genotype-
phenotype relationships in the Xhosa population.  
 
 
4.2 AUDITORY AND GLOBAL HALLUCINATIONS 
 307
   
Loftus et al. (2000)[41] reported significant intra-pair concordance for auditory 
hallucinations in sib pairs, based on a chi-square approach. However, DeLisi 
et al. (1987)[42], Cardno et al. (1998)[43] and Loftus et al. (1998)[44] failed to 
show significant intra-pair concordance for this item.  Kendler et al. (1997)[45] 
reported a higher than expected concordance for global hallucinations.    
 
Hallucinatory phenomena form an integral part of schizophrenia and 
associations have been reported between these and specific anatomical 
structures and their functions in schizophrenia. For example, an event-related 
PET paradigm design demonstrated that hallucinations and delusions of 
persecution were associated with increased mesotemporal and ventral striatal 
activity [46].   
 
Rosa et al. (2002)[47] also suggested linkage of the reality-distortion 
syndrome of schizophrenia spectrum disorders to chromosome 1.  More 
specific to auditory hallucinations, Wei and Hemmings (1999) [48] reported a 
significant excess of the A1-A1 and A1-A2 allele of the cholecystokinin type A 
receptor gene in patients with schizophrenia with auditory hallucinations 
compared to a group of patients with schizophrenia without auditory 
hallucinations.  Autosomal dominant partial epilepsy with auditory features 
also provides some clues as to the genetic basis of auditory phenomena.  In 
this rare form of temporal lobe epilepsy 67-100% of the affecteds have 
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associated auditory phenomena.  This disease has been linked to 
chromosome 10q24 and thus the overlap between this disorder and 
schizophrenia may represent a shared genetic mechanism.   
 
Despite the promising results, the high rate of auditory hallucinations in both 
the sib pair and non-sib pair groups makes it more likely that the underlying 
disease mechanism is shared by most patients with schizophrenia.  A case-
control design based subtyping on the basis of the presence of these items 
will unfortunately require significantly larger sample sizes than ours to acquire 
a significantly large group without auditory hallucinations.  
 
 
4.3 DELUSIONS OF CONTROL  
Our findings are in keeping with Loftus et al. (2000) who found significant 
correlation between sib pair status and delusions of control [49].  This was 
also the only item to show similar concordance in the SAPS/SANS and 
lifetime symptom evaluation.  The question is whether a plausible model 
exists for a possible genotype-phenotype relationship for a subgroup of Xhosa 
patients with schizophrenia with delusions of control. 
 
The aim of the current study was not to elucidate a biological basis for 
schizophrenia, but rather to identify a genetic mechanism for a specific 
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subgroup.  An item such as delusions of control should thus show specific 
properties, in addition to having higher than expected concordance, to make it 
suitable for the genotype-phenotype evaluation.  Firstly, a neurocognitive 
model specific to delusions of control would be of particular value.  Althought 
some disagreement exists, it has been suggested that delusions of control 
might be related to problems in motor control and feedback mechanisms that 
involve efference copy and comparators [50;51].  To understand this concept 
it is helpful to compare delusions of control with the neurological sign known 
as “ anarchic hand” .  Anarchic hand results from damage to the 
supplementary motor area and/or the anterior corpus callosum.  The hand 
contralateral to the lesion will perform unintended goal-directed activities and 
may interfere with activities performed by the “ good”  hand.  Although the 
anarchic hand is not under the patient’ s control, the individual still 
recognizes the unintended activities of the hand and does not conclude that it 
is under alien control.  On the other hand, in delusions of control the individual 
carries out intentional activities, but lacks the awareness of his own control 
over his hand or body.   Differences between these entities suggest the 
possibility of abnormalities in the motor system and feedback mechanisms.  In 
the case of the anarchic hand the feedback mechanism is faulty and the hand 
responds only to the current context.  For example, it will reach for a pencil if it 
appears within the patient’ s field of vision, even if this activity does not form 
part of the current goals of the individual (also described as impairment of the 
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inverse modeling of motor movement).  In delusions of control, the part of the 
motor system involved in the awareness of the predicted state of the hand is 
abnormal (also described as a “ forward”  model abnormality).  The 
individual hand therefore seems to move from the desire to move to the actual 
movement in one step.  The person therefore does not have the sensation 
that the motor system has selected and checked the appropriate movement.  
A feeling of lack of control therefore exists. 
 
It is thus not surprising that patients with schizophrenia, particularly those with 
delusions of control, have been reported to have a reduced ability to make 
rapid motor error corrections [52].  
  
The anatomical basis for the control of the motor system seems to be situated 
in the prefrontal cortex (formulation of plans and goals), the medial premotor 
cortex (responsible for the development of appropriate sequences of motor 
commands and initiates the actions without external cues) and the superior 
parietal cortex (refining the reaching and grasping movements based on 
visual input).  It seems likely that the parietal lobe is also responsible for the 
representation of the current and predicted limb position.  Frith et al. (2000) 
[53] strongly suggest that the inverse and “ forward”  modeling takes place 
in the cerebellum.  In keeping with this proposed defect in central monitoring 
[54;55].  Blakemore et al. (2003)[56] used hypnosis in normal controls to 
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induce delusions of control.  These individuals then underwent a positron 
emission tomography and the results suggested abnormalities in the 
cerebellar-parietal network.  Spence et al. (1997)[57] also found 
hyperactivation of the parietal and cingulate cortices in schizophrenic patients 
with delusions of control when compared to normal controls and patients with 
schizophrenia without the delusions of control.  This hyperactivation remitted 
as the delusions ameliorated [58].  The physiological abnormality is therefore 
likely to be situated in the area responsible for the inhibition of the parietal and 
cingulate cortices, assuming that the motor control model described above is 
accurate.  Prefrontal cortical under-activity may be the mechanism of reduced 
inhibition.  However this would not explain why only 30% of our sample 
developed delusions of control.  One possible explanation is that different 
disconnections between the prefrontal cortex and other brain areas may lead 
to different symptomatology.  In delusions of control, the disconnection would 
involve the parietal cortex, while in hallucinations the temporal cortex may be 
involved [59].  
 
Ceccherini-Nelli et al. (2003)[60] furthermore suggested that auditory 
hallucinations and delusions of control may differ in their relationship to 
linguistic deviations found in schizophrenia.  Delusions of control seemed to 
be associated with speech poverty while auditory hallucinations were 
associated with sematic or phonemic paraphasias.  
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Previous studies have also suggested that delusions of control might represent a 
specific genetic vulnerability.  Catalano et al. (1993)[61] compared a 12 base pair 
repeat polymorphism in the dopamine 4  receptor gene in two groups of patients, 
namely a delusions disorder group (n=59) and a schizophrenic patient group (n=79) 
against a control group of 75 individuals.  They found that significantly more of the 
delusional group (27%) carried the rarer A2 allele compared to the control and 
schizophrenic groups (8%).  This suggests that delusions may have a specific genetic 
underpinning that is not necessarily causative for schizophrenia as a whole.  
 
This item will most likely be the best candidate for an investigation of the 
genotype-phenotype relationship in the Xhosa schizophrenia population, 
given the occurrence rate of ±30% and the higher than expected concordance 
on both the SAPS and lifetime DIGS assessment tools. 
 
This study specifically used the SANS and SAPS to subtype schizophrenia in 
the Xhosa population in order to find a genotype-phenotype relationship.  
However, the SAPS and SANS may not necessarily reflect life-time 
symptomatology, since conversing voices, delusions of jealousy, thought 
insertion, thought withdrawal, delusions of reference and auditory 
hallucinations findings differed between the DIGS life-time and SANS/SAPS 
analysis.  The items that differed were restricted to the SAPS and this fits in 
with Arndt et al. (1995) who illustrated that the negative component of the 
SANS seems stable over time while there seems to be some variation in the 
other positive domains, albeit independent from one another [62].  Possibly 
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the other dimensions may be influenced by the time-period demanded by the 
SAPS.  Conceivably, the SANS items might more closely correlate with life-
time negative symptoms, suggesting state rather than trait characteristics, as 
is the case with the thought disorder component of the SAPS.  Hallucinations 
and delusions may be more aptly considered state markers in the context of 
factor analysis of the SAPS/SANS and lifetime symptomatology.  This would 
not, however, explain our findings regarding delusions of control.  Could 
delusions of control represent a positive domain symptom that independently 
remains a trait marker within the SAPS items?  
 
 
5. SUMMARY OF DEMOGRAPHIC, CLINICAL, FACTOR 
ANALYSIS AND CONCORDANCE ANALYSIS 
This study constitutes the third largest reported collection of affected sibling 
pairs with schizophrenia and the only one in an African population.  As such, 
the information gathered may contribute significantly to our understanding of 
schizophrenia in this population and offer unique future research 
opportunities.  To optimize the contribution of this study, a critical evaluation 
of the clinical data and research process will be presented in order to offer 
suggestions for developing effective protocols for further studies in this 
population.      
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In short, the factor analysis approach to the SANS and SAPS failed to identify 
specific “ familial”  symptom factors.  Concordance analysis however, did 
identify symptoms that could be investigated further for possible candidate 
gene areas and delusions of control seem the most logical candidate.  
However, these factors may merely represent peripheral manifestations of 
underlying pathology or symptoms not considered in this analysis.  In addition, 
the identified items are limited to the male-male subgroup as the mixed and 
female-female group sizes were too small to draw sufficient conclusions 
regarding the items identified in those groups.  The low incidence of OCD and 
the concordant items on the SANS and SAPS raises possibilities that unique 
genetic loci may be present in the Xhosa population.   
    
 
6. ETHICAL AND PROCEDURAL CHALLENGES 
Psychiatric genetic research studies raise many ethical issues that are 
compounded when the relevant study involves more than one culture.  It 
would be foolish to negate the ethical and methodological challenges we 
encountered during this study.  In particular, those caused by the different 
ways in which different cultures conceptualize the family, value communal 
interests rather than individual autonomy, and view mental disorders.  
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We became aware of the ethical problems involved in cross-cultural genetic 
studies of psychiatric disorders when we assembled this sample of Xhosa-
speaking subjects with schizophrenia and their family members.  The study 
design complied with international ethical and practical guidelines, based on 
the Nüremberg paradigm for clinical research, and was approved by the 
relevant internal review boards.  To ensure optimal communication with 
participants, the team included an experienced Xhosa-speaking psychiatric 
nurse as a core member of the team.   
 
 
6.1 THE PROCEDURAL CHALLENGES  
In common with genetic research projects of this nature, the design of this 
study required the collection of extensive and detailed psychiatric, family and 
genealogical information. A blood sample was also taken from which material 
for DNA analysis could be extracted in the follow-up study.  
 
The research protocol further specified that the researchers should interview, 
and obtain blood samples, from at least one parent and one healthy sibling. 
We consequently invited probands to nominate relatives who would be willing 
to co-operate.  The researchers then approached the nominated relatives and 
requested their assistance.  In many instances, the relatives lived in remote 
rural communities, and reaching them was in itself a difficult task.  Informed 
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consent was then obtained from each of the relatives for collection of a blood 
sample and participation in a structured diagnostic interview. 
 
 
6.2 THE CONCEPT OF FAMILY IN TRADITIONAL XHOSA 
CULTURE 
The researchers were aware that the distinction between the nuclear family, 
extended family and the community in the Xhosa culture differs from that of 
Western cultures.  As an example, in the Xhosa culture there exists a custom 
of substitution of close relatives.  If a close relative is absent, another relative 
will act as a substitute for the absent family member.  For instance, in the 
absence of a biological father a male relative will act as a substitute father.  
The substitute, who could be an uncle, nephew or cousin, is regarded as the 
father of the relevant person.  He is also referred to, and addressed, as father. 
The substitute father is, for all practical purposes, considered the biological 
father, and it is impolite to imply that he is not the actual father.  
 
While inquiring about the proband’ s family and obtaining information about 
the nominated parent and sibling the researchers had to consider two things.  
First, we had to ensure that the people involved were in fact biological parents 
and siblings, and not substituted relatives.  Second, it was necessary to make 
these inquiries without transgressing cultural restraints.  The researchers 
 317
   
therefore took care not to differentiate between family members based on 
their genealogical distance from the proband. In an attempt to distinguish 
between biological and culturally nominated substitutes, the researchers used 
terms such as “ blood brother”  as synonym for a biological brother.  
 
However, despite great care in trying to obtain accurate information, the 
researchers found, upon receipt of the results of the DNA analysis (in the 
follow-up study), that some of the nominated people were in fact not the 
biological parents or siblings of the proband.  
 
 
6.3 INDIVIDUAL AUTONOMY VERSUS COMMUNAL 
INTERESTS 
This emphasis on the extended family is a manifestation of the emphasis that 
many African cultures traditionally place on communal interests, rather than 
individual autonomy. We came across another demonstration of this when we 
interviewed the nominated parent or sibling. We found that members of the 
extended family, and even community members, considered it their right to 
attend these interviews. The willingness of participants to share confidential 
information in the presence of extended family and community members 
struck us as notable.  Only on one occasion did a subject, suspected to have 
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schizophrenia and paranoid delusions, insist that a member of the family 
leave the interview.  
 
This had important implications because the research protocol reflected the 
emphasis placed by Western ethical committees on privacy and 
confidentiality. However, at first sight this appears to be a surmountable 
problem because subjects can waive their right to privacy and confidentiality. 
The principle of autonomy provides that participants can do this provided that 
they are fully informed about their rights, of the implications of such a waiver, 
and that they make the decision freely and without any coercion.  
Furthermore, even in the absence of such consent it may have been possible 
to justify a deviation from the research protocol based on cultural relativism.  
The researchers could argue that the expectations of the members of the 
community were in accordance with their culture, and that we as researchers 
should therefore accept the decision of subjects to relax guidelines, especially 
since these guidelines were put in place to protect the rights of the subjects. 
 
However, we believed that a number of factors made such relaxation unwise.  
First, when interviewing the nominated parent and sibling, confidential 
information was sometimes revealed about the proband who was not present, 
and whose consent had not been obtained for the release of information.  
Second, the principle of beneficence imposed on the researchers the 
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obligation to prevent harm to subjects.  We believed that there was a potential 
of harm to the subjects if extended family and community members attended 
the interviews.  We took into account the very personal questions we had to 
ask, the pathology involved, and the mental status of some of the participants.  
Third, there is a general belief that private interviews produce more accurate 
information [63].  Fourth, we were alert to the danger that we could be using 
culture as an unjustifiable excuse to lower ethical standards.  As was 
mentioned above, cultural relativism is not widely accepted as an ethical 
theory [64;65] and its use to obviate ethical rules is controversial.   Finally, the 
question arose as to whether the subjects really had the freedom to exclude 
extended family and community members.  Or, was this a form of “ cultural”  
coercion where cultural pressures were forcing participants to accept a lesser 
degree of privacy than they would ideally like themselves?   
 
We decided that we had a duty to protect vulnerable patients who may want 
the interviews to take place in private, away from peer, community and 
cultural pressure.  We therefore had to find a way to ensure that subjects 
were not coerced into accepting a lesser degree of privacy and confidentiality 
than they wished to have.  The researchers consequently made sure that the 
initial interview with the potential participant took place in private.  While 
informing potential participants about the nature of the study, the researchers 
suggested to them that the rest of the interview should also take place in 
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private, with the possible exception of immediate family members.  
Participants usually accepted the researchers’  suggestion, although it often 
caused substantial dissent from outsiders.  While extended family and 
community members allowed the interviews to take place in private, they were 
clearly displeased by their exclusion. 
 
As one might expect, the Xhosa people’ s concept of mental illness differed 
from that of Western mental health professionals. Many Africans’  perception 
of mental illness is influenced by the belief that ancestors play an important 
part in their lives [66-68].  The appeasement of the ancestors is a protective 
measure and if the ancestors are displeased they will withdraw their 
protection, and this can lead to the onset of mental illness [69].  
 
While not all Xhosas believe in supernatural powers, preliminary analyses of 
an attitude questionnaire demonstrated that about 90% of participants in this 
study believed that schizophrenia is caused by supernatural powers.  In 
comparison Angermeyer and Matschinger [70] found that less than 12% of lay 
people in Europe believe this to be the case.  
 
As a consequence of this belief, one family withdrew from the study after the 
death of a relative (a child) who had been run over by a car.  The family 
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members construed this incident as an indication that their ancestors were 
displeased with their involvement in the study, and had cast a spell over them.  
The fact that healthy members of the family also supported this opinion, 
excludes the possibility of folie a deux.   
 
The validity of the research hinged on the accurate diagnosis of 
schizophrenia.  The diagnostic criteria of the DSM IV were used. The Xhosa 
belief system includes two conditions that are relevant here, viz. 
“ amafufunyana”  and “ thwasa” . [71].  The researchers found that patients 
regarded as having “ amafufunyana” , satisfied the DSM-IV criteria for a 
number of disorders such as schizophrenia, other psychotic disorders, 
conversion disorders and mood disorders.  
 
We found, furthermore, that there were traditional healers in a number of 
participating families and that parents and siblings who where described as 
healthy by the proband also often reported psychotic symptoms to the 
researchers.  
 
The entities “ amafufunyana”  and “ thwasa”  provide a clear illustration of 
the distinction made by Kleinman (1978) [72] between disease, as a 
biomedical construct, and illness, as a sociocultural experience.  While 
Western diagnostic categories are clearly useful for the various analyses 
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undertaken in modern genetic studies, it is crucial for interviewers to be aware 
of the impact of cultural understandings of mental illness on disease 
presentation, experience, and subsequent course.  
 
Indeed, the distinction between cultural and non-cultural influences on the 
research procedure may not always be clear.  This was brought to light when 
the seasonality of birth was assessed.  Considerable evidence exists that 
suggests that a greater than expected number of schizophrenic births occur in 
winter and spring [73], suggesting that intra-partum factors might be at play in 
the genesis of schizophrenia.  In our study, an excess of birth dates on 
specific days (1 January, 6 June) strongly suggested the introduction of 
artifactual data resulting from the procedural management of missing birth 
dates by Government institutions.  It seems unlikely that reliable conclusions 
can be drawn from data relying on this data management system.  It would be 
of interest to investigate the birth date frequencies of other seasonality 
studies, to find out if the same problem, albeit attenuated, may have occurred 
and whether this unique to the Xhosa population.     
 
 
6.4 PROBLEMS ASSOCIATED WITH INFORMED CONSENT 
The different ways in which people from different cultures conceptualize 
mental illnesses also influenced the acquisition of informed consent from 
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subjects. As already mentioned consent for participation in a research project 
is ethically and legally acceptable only if participants understand the 
information presented to them.  It follows that subjects must understand the 
concepts used.  In this study the protocol and instruments used Western 
concepts of mental disorders and Western nomenclature, de-emphasizing 
Kleinman’ s (1978) [72] warning that while there exists a universal 
biophysical condition, culture shapes the final presentation of disorders. It was 
therefore a major challenge to us to ensure that when we explained the 
condition and symptoms we used appropriate Xhosa terminology and were 
sensitive to the sociocultural meaning participants may give to the symptoms 
they described.  
 
Researchers who undertake cross-cultural genetic studies of psychiatric 
disorders must expect to come across problems not covered by existing 
guidelines.  Our experiences in this study illustrate some of the complications 
in cross-cultural research situations, and the need for researchers to be 
attentive to the cultural context in which they will operate.   
 
We believe that for psychiatric genetics to achieve the same success as that 
found in other areas of human genetics, researchers who undertake cross-
cultural studies will have to pay more attention to the intersection between 
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nosology and medical anthropology [74] .  Researchers must appreciate that 
culture is fundamental to the understanding of mental disorders.  In this 
regard, Western trained mental health researchers must apply the DSM IV 
criteria with care and sensitivity when they deal with people from different 
cultural groups.  Ensuring that research protocols are appropriate for all the 
cultures to be included in a study may be daunting.  When preparing these 
documents, researchers should take into consideration the innumerable 
cultural variations in respect of mental disorders.  One way of doing this may 
be to include terms such as “ amafufunyana”  as a descriptive term in the 
information document, and to specify the symptomatology.  
 
Culture also influences communication between people and determines how 
people view aspects such as privacy, confidentiality and autonomy.   
Westernized study guidelines may arguably be inappropriate in certain 
cultures. However, for a researcher who has a Western training it may be 
difficult to decide what course to follow.  The researchers’  decision to 
recommend private interviews in this study can be used to demonstrate this.  
At one level this decision was driven by the principle of beneficence; the 
researchers wanted to prevent subjects from the harm that may follow an 
interview in the presence of community members.  But, this can also be 
described as paternalistic and insensitive to the culture of their Xhosa 
subjects.  Nevertheless, if the researchers had decided to heed community 
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demands it may have been dangerous as well.   Public interviews may 
theoretically have triggered a psychotic episode with negative consequences 
for both the subject and the researchers. People who do not support cultural 
relativism might have argued that the public interviews would have 
compromised ethical standards to the detriment of participants from non-
Western cultures.  Finding a balance may be difficult for researchers who 
embark on this type of research, and there may not always be a ready answer 
to some of the dilemmas that confront them. 
 
Patients with schizophrenia of Xhosa origin, and more specifically affected sib 
pairs, can contribute significantly to the current knowledge base, but inherent 
difficulties related to research in this population necessitate careful 
consideration of study protocols.  We further consider the need for such 
researchers to be attentive to the cultural context within which they operate, 
as culture is fundamental to the understanding of mental disorder. 
 
 
7. CONCLUSION 
Despite the fact that the factor analysis approach did not reveal unique 
genetic subtypes, concordance analysis did bring to light three items or 
symptoms of interest for future genetic research.  Research in this population 
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will challenge the researcher to consider confounding ethnic, ethical and 
methodological factors.   
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APPENDIX A.  LIST OF TERMS AND 
ABBREVIATIONS USED IN TEXT 
 
Terms or abbreviations Definition 
Affected sibling pairs 
Two siblings affected with a disorder.  For the purposes of this 
study both siblings suffered from schizophrenia 
Affected sibship 
Two or more siblings affected with a disorder.  For the purposes 
of this study all siblings suffered from schizophrenia 
Affective changes 
Changes in the pattern of observable expression of subjective 
emosional experience 
Alogia Decreased production of speech (not linked to motor aphasia) 
Anhedonia/Asociality Impaired ability to enjoy activities and decreased socialization 
Avolition Impairment of conation 
Catatonic symptoms 
Motor abnormalities such as negativism, rigidity, posturing, stupor 
and waxy flexibility 
Concordance 
Refers to the presence of a symptom or disease or other variable 
in both sibs 
Delusions 
A false unshakeable personal belief based on incorrect 
conclusions drawn from external reality.  The belief falls outside 
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of the belief system of the sub culture of the person. 
DIGS Diagnostic Interview for Genetic Studies 
Familial 
Refers to any condition which is commoner in relatives of an 
affected individual than in the general population 
Genotype The genetic constitution of the individual 
Hallucinations 
A sensoric observation without external stimulation of the specific 
sensory organ 
Heritability 
A statistical measure of the degree to which a trait is genetically 
determined 
Linkage 
Linked genes have their loci within measurable distance of one 
another on the same chromosome 
Locus The precise location of a gene on a chromosome 
Microdeletion 
Chromosomal deletion whose size is close to the limit of 
resolution using the light microscope 
Negative symptoms 
A group of symptoms that include affective changes, alogia, 
avolition, apathy, anhedonia and asociality 
OCD Obsessive compulsive disorder 
Oligogenic model 
In an oligogenic model a few genes of moderate effect is needed 
to cause the disease 
Penetrance The frequency of expression of the genotype 
Phenotype The observable characterstics of an individual 
 338
   
Poligenic model 
In a poligenic model several genes of small effect is needed to 
cause the disease  
Positive symptoms 
A group of symptoms that include hallucinations, delusions, 
thought disorder and behavioural abnormalities 
SANS Schedule for the assessment of negative symptoms 
SAPS  Schedule for the assessment of positive symptoms 
SCID Structured Clinical Interview for DSM-IV 
Thought disorder 
An abnormality in the form of thought and includes loose 
associations, incoherence and illogical thought processes 
Variance A quantity equal to the square of the standard deviation 
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